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Abstract 
A variety of inflammatory markers, coupled with changes in a number of 
haematological and biochemical parameters have classically been used to 
diagnose, monitor, and prognosticate disease in horses. Unfortunately these 
traditional markers respond fairly slowly to the presence of disease and 
inflammation and have wide normal ranges (Allen and Cold 1988; Pepys et al., 
1989). Serum amyloid A (SAA), and haptoglobin are acute phase proteins 
common to humans, cattle, sheep, mice, and several other species, including 
the horse. In several of these species, plasma concentration of SAA has been 
shown to increase 1000-fold following tissue injury, cellular necrosis, 
inflammation, and infection and decline rapidly in the recovery phase. 
In the studies presented here the concentration of serum amyloid A (SAA), 
haptoglobin and fibrinogen and other indices of health were measured in a 
number of different groups of horses, including; normal horses, those subjected 
to operative surgery, horses with surgical colic, racehorses in training, some of 
which had evidence of gastric ulceration, and foals with respiratory disease. 
Acute phase protein concentration was modeled with the outcome and with 
other commonly measured indices of health relevant to the disease states of 
interest. 
The study indicates that there is an association between acute and chronic 
inflammation and between the present of disease both overt and latent and 
suggests that the concentration of a number of acute phase proteins could be 
used to aid decision making when planning diagnostic or treatment interventions 
in horses.  
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Chapter 1 
Introduction and literature review 
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1.1   Introduction 
“Measurements of SAA should make a significant contribution to diagnosis 
and management of viral and bacterial infection in horses, and routine 
serial assays could provide an objective criterion for monitoring 
prospectively the general health of horses in training and racing” (Pepys et 
al., 1989). 
Twenty-six years ago, Pepys and his colleagues, on the basis of a pilot study of 
SAA in the horse, made this statement which, as Pepys observed further in his 
paper, has not been implemented to a significant degree. 
“The results reported here of SAA monitoring in a stable of horses in training 
and racing raises the exciting prospect that this procedure could become an 
objective criterion for assessing general health of the animals and therefore 
contribute to evaluation of their prospective health and performance. More 
extensive investigation will be necessary to confirm this suggestion, with 
prospective analysis of SAA results and training and racing performance”.  
Since the time of Pepys’ paper things have changed. There exist, assays of SAA 
that can give specific and highly accurate instant readings of the serum 
concentration of this acute phase protein (APP). But, whilst some studies have 
been made of SAA in the horse as a monitor of general health and for use as an 
adjunct to diagnosis and early detection of disease, the adoption of SAA 
measurement for horses is still in its infancy.  
The work presented in this thesis explored SAA concentration in various common 
pathological conditions in the horse in order to provide evidence that will help 
to move us forward to the more widespread use of SAA, in the same manner that 
CRP is deployed in human clinical practice, as a necessary part of clinical 
investigation of health status.   
In this study, emphasis was placed largely on competition horses. In addition, 
estimations were made of both fibrinogen and haptoglobin concentrations. The 
former is widely used as a marker of inflammation in horses and the latter was 
included to act as comparator for SAA and fibrinogen. Throughout the study the 
standard clinical parameters that were available from routine clinical 
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biochemical and haematological investigation were derived and recorded to 
demonstrate that SAA measurement provides information to inform clinical 
decisions over and above that obtained using these indices alone.  
The development of markers that can be used to identify disease that is 
fulminant and overt, latent, or subclinical has become commonplace in human 
medicine (van der Linden et al., 2010; Tilemann et al., 2011; Kiefer et al., 2012) 
and some veterinary species. However, to date this approach has not gained 
widespread acceptance in the horse. The studies presented in this thesis explore 
the use of the acute phase protein Serum Amyloid A (SAA) and other acute phase 
proteins (APPs) for the diagnosis, prognostication and for monitoring response to 
treatment in a number of common clinical scenarios.  
1.1.1 The contrast to human medicine 
In human medicine, measurement of acute phase proteins in clinical medicine is 
routine. C-reactive protein (CRP) measurement forms part of the standard 
database of testing following admission to hospital across the globe. The CRP 
response is non-specific and CRP, and indeed all acute phase proteins, as we 
presently understand it, can never be diagnostic for any particular condition. 
They should never be used in isolation and their values can only usefully be 
interpreted in combination with other clinical parameters and pathological data 
(Pepys and Hirschfield, 2003). Used in this way, the measurement of acute phase 
proteins contributes powerfully to the management of patients and it is 
generally accepted, amongst human practitioners, that patients with a normal 
CRP concentration are not suffering from significant disease (Pepys and 
Hirschfield, 2003). 
In horses, the only molecule that displays sensitivity, response speed and 
dynamic range comparable to CRP is Serum Amyloid A (SAA) (Pepys and Baltz, 
1993).  
1.2 The use of acute phase proteins in clinical medicine and 
veterinary medicine 
The first acute phase protein to be used clinically was human C-reactive protein 
(CRP) (de Beer et al., 1982). Increased serum concentration of CRP in humans 
has been associated with an increased mortality following aortic aneurysm 
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(Domanovits et al., 2002; Schillinger et al., 2002) and with increased mortality 
in cases of myocardial infarction (Lindahl et al.,  2000). It is reported to be a 
sensitive, non-specific and non-expensive marker of inflammation for early 
diagnosis of bacterial infection following orthopaedic surgery (Waleczek et al., 
1991). Monitoring the concentration of this protein has been shown to be 
superior to the simple use of erythrocyte sedimentation rate, white blood cell 
count, development of drainage, ultrasound, and observation of clinical signs of 
infection, in diagnosing post operative orthopaedic infection (Singhal et al., 
2011).  
Since the discovery of CRP over 90 years ago (Tillett and Francis, 1930), a 
number of other protein markers of inflammation have been recognised, 
including fibrinogen (Fb), serum amyloid A (SAA), haptoglobin (Hp), a-1-acid 
glycoprotein, a-1-antiprotease, and ceruloplasmin (Thompson et al., 1992). The 
production of the various acute phase proteins in response to inflammation or 
disease varies greatly between species. For example, CRP is a major acute phase 
protein marker of inflammation and disease in dogs (Conner et al., 1988), pigs 
(Eckersall, 2000), and humans, but serum concentration of CRP is reported as 
not to be altered in ruminants or horses by the presence of inflammation or 
disease (Eckersall et al., 1988). In the bovine animal, the APPs, haptoglobin, 
ceruloplasmin and a1-acid glycoprotein have been shown to be sensitive 
indicators for mastitis (Conner et al., 1986).  
Serum concentration of SAA is used as an aid to diagnose, monitor, and predict 
the course of disease in humans and dogs. Serum amyloid A is produced rapidly 
in horses in response to the presence of infectious and non-infectious 
inflammatory conditions (Hulten et al., 2002;). Studies have examined the effect 
of disease on production of SAA in many species (Pepys et al., 1989; Hulten et 
al., 1999; Stoneham 2001; Hulten et al., 2002; Hulten et al., 2002; Cohen et al., 
2005; Vandenplas 2005; Jacobsen et al., 2005; Jacobsen et al., 2006; Duggan et 
al., 2007; Jacobsen et al., 2009). Table 1.1.  
In humans a number of specific disease states have either no effect or a 
negligible effect on the concentration of CRP, the most useful acute phase 
protein in this species. These diseases include systemic lupus erythematosus, 
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scleroderma, dermatomyositis, ulcerative colitis, leukemia and graft versus host 
disease (Pepys and Hirschfield, 2003). Although a number of these diseases are 
recognised in domestic animals, their effects on the concentration of acute 
phase proteins in these species has yet to be elucidated. The reasons for the 
lack of measurable acute phase response in response to these diseases that 
result in significant tissue damage, inflammation, morbidity and mortality is not 
known. 
1.2.1 The acute phase response, acute phase proteins, synthesis and 
regulation 
The acute phase response is a systemic, non-specific response to infectious, 
inflammatory, immunological and traumatic disease states and reflects a 
combination of local and systemic events that go hand in hand with 
inflammation. At a local level, vasodilation, platelet aggregation, neutrophil 
chemotaxis, and the production and release of histamine, kinins, oxygen, free 
radicals and enzymes takes place. Systemically, pyrexia, activation of the 
pituitary-adrenal system, alterations in metabolism and, critically, alterations of 
gene expression are involved, leading to the synthesis by hepatocytes of an array 
of APPs (Van Leewuwen et al., 1994).  
Acute phase proteins are defined by Kushner et al., (1982) as ‘hepatic proteins 
that show a serum concentration increase (positive APPs) or decrease (negative 
APPs) of 25% or more within the first seven days following trauma, infection or 
other disturbances of body physiology many of which can be referred to as 
inflammatory processes’. The principal APPs along with their putative functions 
are listed in Table 1.2.  
Regulation of acute phase protein production is complex; a number of workers 
have shown that synthesis of APPs by hepatocytes is induced by cytokines and 
that each cytokine exerts its effects via the agencies of specific genes. There is 
evidence that in some instances a combination of cytokines is required and that 
these combinations can lead to increases or decreases in concentrations of acute 
phase reactants (Ramadori et al., 1985; Perlmutter et al., 1986; Gauldie et al., 
1987; Bauman et al., 1987). The significance of these findings is that particular 
pathological conditions that lead to the production of a unique combination of 
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Table 1.1 Diseases, injuries (by body system) and disease states in which SAA 
concentration has been noted to rise in horses. 
Disease Description Reference(s) 
Sugery Miscellaneous procedures 
Ex-Laparotomy 
Castration 
Colic 
Pepys et al., 1989 
Jacobsen et al., 2009 
Busk et al., 2010 
Pollock et al., 2005 
Nunokawa et al., 1993 
Hulten et al., 1999 
Jacobsen et al., 2005 
Pihl et al., 2015 
Synovial Induced arthritis 
Naturally occurring arthritis 
Jacobsen et al., 2006a 
Jacobsen et al., 2006b 
Pepys et al., 1989 
Hulten et al.,  2002 
Inflammation IM injection of turpentine Nunokawa et al., 1993 
Vaccination Andersen et al., 2012 
Gastrointestinal disease Grass sickness 
Colic 
Diarrhoea 
Copas et al., 2013 
Pihl et al., 2015 
Vandenplas et al., 2005 
Nunokawa et al., 1993 
Reproductive disease Placentitis 
Abortion 
Parturition 
Endometritis 
AI 
Canisso et al., 2014 
Coutinho da Silva et al., 2013 
Christoffersen et al.,2010 
Tuppits et al., 2014 
Respiratory disease Rhodococcus equi pneumonia 
Strangles 
Heaves 
Hulten and Demmers 2002 
Cohen et al., 2005 
Chavatte et al., 1991 
Lavoie-Lamoureux et al., 2012 
Hobo et al., 2007 
Musculoskeletal/excersie Laminitis 
Exercise 
Menzies-Gow et al., 2014 
Cywińska et al., 2012 
Parasitic disease Cyathostominosis and strongyles Andersen et al., 2014 
Neonatal Prematurity 
Neonatal maladjustment 
syndrome 
Sepsis 
EED 
Chavatte et al., 1991 
Husebekk et al., 1986 
Pepys et al., 1989 
Nunokawa et al., 1993 
Paltrinieri et al., 2008 
Stoneham et al., 2001 
Hulten and Demmers 2002 
Krakowski et al., 2011 
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cytokines may, in turn, have a unique acute phase profile (Ganapathi et al., 
1991) and this may be a key diagnostic target for the future. 
Figure 1.1. illustrates the relative complexity of physiological systems that 
interact in the activation of the APP responses.  
The supposed purpose of the acute phase response is far from fully understood. 
It has been suggested that it facilitates the inflammatory process and protects 
the organism from the potentially detrimental effects of inflammatory mediators 
(Jensen and Whitehead, 1998). The activities of a number of the APPs have, 
however, precisely been defined: for example, haptoglobin is a scavenger of 
free haemoglobin (Nyman, 1959), while a1-antitrypsin antagonises the activities 
of a number of proteolytic enzymes.  
The first APP to be discovered was the pentraxin (evolutionary conserved family 
of proteins containing a calcium dependent ligand), C-reactive protein (CRP). 
The serum concentration of CRP and other APPs are now well established as non 
specific diagnostic general tests for organic disease, and as a means of 
monitoring the course of disease and response to treatment in humans (Kushner 
et al., 1987; Lindahl et al., 2000). CRP concentration, and that of other APPs 
have also been utilised as sensitive tests for intercurrent microbial infection 
(Hind et al., 1985; Conner et al., 1989; Pepys et al., 1989). Haptoglobin and 
fibrinogen concentration are currently routinely used as markers of inflammation 
in veterinary medicine, although these compounds have a number of 
disadvantages, including slow response to inflammation and wide “normal” 
ranges (Pollock et al., 2005).  
In humans and a number of other domestic animals including cattle, dogs 
(Conner et al., 1988) and horses, SAA concentration has been demonstrated to 
have the following clinically useful characteristics in the diagnosis, monitoring of 
response to treatment and prediction of outcome in disease and tissue injury:  
(1) Consistently low ‘normal’ serum concentrations.
(2) Rapid change in concentration in response to changes in disease status
and tissue injury.
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(3) Synthesis rate is the only important determinant of serum
concentration. (Gorevic et al., 1976; McAdam et al., 1978; deBeer et
al., 1982a; deBeeer et al., 1982b; Pepys et al., 1983; Hulten et al.,
1997).
Recently, several workers have demonstrated that SAA concentration in equine 
serum increases in response to a number of infectious disease conditions and in 
response to trauma, both accidental and surgical (Hulten et al., 1999; Stoneham 
et al., 2001; Hulten et al., 2002; Cohen et al., 2005; Pollock et al., 2005; 
Vandenplas 2005; Jacobsen et al., 2005; Jacobsen et al., 2006; Duggan et al., 
2007; Jacobsen et al., 2009). 
To date, the major bodies of work regarding SAA and APPs, including haptoglobin 
and fibrinogen, in horses, have focused on their identification and description of 
their behaviour in response to a variety of diseases, injuries and infestations 
rather than testing for clinical utility or to inform treatment planning or monitor 
recovery and or disease progression.  
1.2.2 Fibrinogen 
Fibrinogen is a complex glycoprotein, composed of three pairs of peptide chains 
(a, b and g) joined by disulphide bonds. It is synthesised by hepatic parenchymal 
cells and has a half-life of approximately 36 hours (Dodds, 1989). Synthesis and 
turnover rates for fibrinogen are markedly influenced by tissue damage, 
inflammation, stress and ACTH concentration (Dodds, 1989). The primary 
function of fibrinogen is in haemostasis and blood clotting, as the substrate for 
thrombin. In addition to this, fibrinogen is the precursor of fibrin and so plays a 
key role in the inflammatory process. Fibrin formation, although in many cases 
beneficial, if excessive may lead to adhesions between serosal surfaces.  
Increased utilisation of fibrinogen beyond normal homeostatic functions leads to 
an increase in synthesis and this is reflected in the serum concentration (Schalm, 
1979). Consequently, fibrinogen concentrations are routinely used in equine 
practice in the diagnosis and evaluation of disease. Fibrinogen concentration in 
serum gradually increases over a period of five to seven days to attain peak 
concentration. 
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Figure 1.1 The Acute Phase Response in Mammals 
The acute phase response to injury and disease is common to all mammals, 
although the specific APPs are often specific to individual species or groups of 
species. (Diagram from Jacobsen and Andersen, 2007) 
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While the increase in fibrinogen concentration is non-specific, increased 
concentrations have been demonstrated following surgery, infection, 
immunological, tissue injury and other non-specific inflammatory processes 
(Schalm, 1979; Allen et al., 1988; Auer et al., 1989; Hulten et al., 2002; Pollock 
et al., 2005). 
For reasons that are not fully understood by this author, veterinary practitioners 
have clung to the use of fibrinogen in the clinical scenario despite its slow 
response to both the onset of disease and to changes in disease status (Pollock 
et al., 2005). 
1.2.3 Serum amyloid A- History, structure and isoforms 
Serum Amyloid A (SAA) was first identified in serum due to its cross reactivity 
with antisera to the amyloid AA protein isolated from deposits of secondary 
amyloid (Levin et al., 1973; Husby and Natvig, 1974).  Husbebekk et al., 1986 
first isolated equine SAA in 1985 and equine SAA was subsequently measured, 
with an electro-immunoassay, postoperatively and during infectious conditions 
by Pepys et al., 1989. SAA is an acute phase reactant protein common to 
humans, cattle, sheep, cats, mice and several other animal species, including 
the horse.  It is an apolipoprotein and is heterogeneous in all of the species in 
which it has been identified so far. SAA generally consists of a 104-amino acid 
poplypeptide (12kd) in association with a high-density lipoprotein (HDL) class of 
serum lipoproteins (Sletten et al., 1989). Three isoforms of SAA have been 
characterised in the horse (Hulten et al., 1997). The SAA group of APPs are so 
named due to their immunological and biochemical similarity to Amyloid A fibril 
protein, which is found in reactive systemic amyloidosis. SAA is principally found 
in serum, however, it has also been isolated from the milk of cattle with mastitis 
(Eckersall, 2001), from the synovial fluid of horses with arthritis (Jacobsen et 
al., 2006) and the peritoneal fluid of horses with gastrointestinal disease (Pihl et 
al., 2015).  
1.2.3.1 Synthesis and regulation of serum amyloid A (SAA) 
Serum amyloid A is chiefly produced by hepatocytes, however, in the mouse, 
SAA mRNA is also expressed in extra-hepatic (Meek et al., 1986). It is produced 
in response to stimulation by a number of inflammatory mediators, including 
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interleukin-1, interleukin-6 and tumour necrosis factor (Jacobsen and Anderson, 
2007). Concentrations of SAA have been shown to increase 1000-fold following 
tissue injury, cellular necrosis, inflammation and infection and to decline rapidly 
in the recovery phase. A normal, virtually undetectable concentration of SAA, 
probably excludes many serious pathological infections, particularly those 
associated with microbial infection (Pepys et al., 1989; Horadagoda et al., 
1994). Indeed several studies indicate that treatment and response to 
antimicrobials is associated with a rapid fall in SAA concentration (Hulten et al., 
2003).  
In humans and mice there are a number of isoforms of SAA encoded by multiple 
genes (Gorevic et al., 1978; Sack, 1983; Yamamoto and Migita, 1985; Raynes et 
al., 1991). Recent research suggests that this is also the case in equidae (Hulten 
et al., 1997). However, in the work subsequently presented in this thesis the 
reagents used do not take account of this diversity.  
In the same manner as a prolonged inflammatory response can be detrimental, 
prolongation of the acute phase response can also have damaging consequences 
(Jensen and Whitehead, 1998). Currently, the mechanisms of regulation and 
resolution are not entirely understood, although it seems that a number of 
pathways are involved. These pathways include repression of transcription 
(Edbrooke et al., 1991), receptor antagonists and decoys, glucocorticoids, and 
cytokines which have a direct or indirect effect on down regulation of synthesis 
(Jensen and Whitehead, 1998). In addition to the mechanisms above, a number 
of natural mediators, including, reactive oxygen species (ROS) (reactive 
molecules that contain oxygen, including oxygen ions and peroxides formed as a 
natural byproduct of the normal oxygen metabolism and that have a role in cell 
signaling and homeostasis), antioxidants and vitamin E may be involved in 
stopping the target cells for SAA from responding, thus returning these cells to 
their normal profiles (Sen and Packer, 1996). Interleukin 1(IL-1), a key mediator 
in the activation of the production of SAA, is inhibited by the production of 
Interleukin 1 receptor antagonist protein (IL-1Ra), which has been detected at 
low concentrations in the serun of normal humans and at increased 
concentrations in patients with infectious, inflammatory and neoplastic disease 
(Lennard, 1995), and in horses with gastrointestinal and joint disease (Todhunter 
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et al., 1996; Lopes et al., 2010). Recently, IL-1Ra has been used therapeutically 
in the joints of horses in an attempt to reduce the development and progression 
of degenerative joint disease (Moreira et al., 2014). 
1.2.3.2 Function of serum amyloid A (SAA) 
The function of SAA is not well understood. However, since SAA is highly 
conserved throughout all of the species studied, it has been suggested that it is 
important for survival (Hulten et al., 1997). A number of functions for SAA have 
been proposed, including a role in cholesterol transport (Meek et al., 1994), 
platelet function (Syversen et al., 1994) and as a chemoattractant for 
polymorphonuclear leukocytes and monocytes (Badolato et al., 1994). Preciado-
Patt et al., (1994) published results demonstrating the inhibitory effect of SAA 
on inflammatory processes, mediated by a reduction in cell adhesion to 
extracellular matrix.  A study by Shainkin-Kestenbaum et al. (1991) noted that 
there was a feedback effect between SAA and some inflammatory cytokines in 
mice, suggesting that SAA also had a role in tissue repair.  
1.2.3.3 Clinical use of serum amyloid A (SAA) in the horse 
Serum Amyloid A is measured with increasingly frequency in horses: some of the 
indications for doing so are given in Table 1.1. To date, the majority of workers 
have focused on changes to SAA concentration following disease or injury, rather 
than specifically using the kinetics of the concentration change as an aid to the 
identification of disease. Despite all the research outlined in Table 1.1, routine 
adoption of measures of SAA in equine clinical practice has not yet taken place 
and the work to be presented in this thesis will concern the collection and 
presentation of evidence as to whether more attention should be paid to 
determination of SAA concentration as a non specific marker for disease or 
injury. 
1.2.4 Haptoglobin structure, synthesis and regulation 
Haptoglobin is a glycoprotein composed of two polypeptide subunits (a and b) of 
108,000 and 105,000 daltons molecular weight. It is synthesised in the liver and 
can be found within the a2-globulin fraction. The primary function of 
haptoglobin is to complex free haemoglobin following intravascular haemolysis 
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(Putnam, 1975). The haptoglobin-haemoglobin complex is removed by the 
reticuloendothelial system of the liver, thus reducing the risk of haemoglobin-
induced nephrotoxicity (Nyman, 1959). Removal of haemoferrum, thus limiting  
that available for bacterial growth, has led to the term natural bacteriostat 
being used for haptoglobin (Eaton et al., 1982). 
A reduction in serum haptoglobin concentration in cases of haemolytic disease, 
and an increase following inflammatory, infectious, neoplastic and endocrine 
disease has been reported in cattle, cats, dogs, rats, mice, horses and humans 
(Engler et al., 1970; Palmer, 1976; Harvey, 1978; Harvey et al., 1984; Taira et 
al., 1991; Hofner et al., 1994; McGrotty et al., 2003, Mischke et al., 2007). In 
addition, haptoglobin has been shown to be an effective measure of health 
status in production animals (Armory et al., 2007). 
1.2.5 Acute phase proteins as prognostic indicators 
There are numerous examples in human medicine of the use of APPs as aids to 
determining prognosis and in the use of APPs to stage, plan, and evaluate the 
efficacy of treatment regimens. Although never considered in isolation, 
increased serum concentration of CRP in human beings has been associated with 
an increased mortality following aortic disease (Schillinger et al., 2002) and is a 
marker for bacterial infection following surgery (Waleczek et al., 1991). The use 
of APPs to determine overall survival rates in urogenital (Ito et al., 2011), 
breast, and head and neck carcinoma patients is also well documented 
(Dhankhar et al., 2011).  
In veterinary medicine, APPs have been evaluated as prognostic markers in small 
animals (Eckersall and Bell, 2010), including in dogs with immune mediated 
(Griebsch et al., 2009), neoplastic, infectious, parasitic, (Köster et al., 2009; 
Andersen et al., 2014) and endocrine disease (Artega et al., 2010) and following 
chemotherapeutic treatment (Merlo et al., 2007). 
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Table 1.2 Known functions of the major positive acute phase proteins. 
Action Acute Phase Protein 
Coagulation proteins Fibrinogen 
Prothrombin 
Factor VIII 
Plasminogen 
Protease Inhibitors a1-antitrypsin 
Complement C3, C4 and C5 
Transport proteins Haptoglobin 
Haemopexin 
Ceruloplasmin 
Miscellaneous actions Serum Amyloid A 
C reactive protein 
Fibronectin 
a1-acid glycoprotein 
Known acute phase proteins grouped by their proposed biological function. 
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Recently, CRP has been measured in dogs with acute gastrointestinal disease 
(Galezowski et al., 2010), indicating that increased concentrations of the acute 
phase marker were associated with reduced mortality and were a more sensitive 
marker of tissue damage than white blood cell count measured at presentation.  
1.3 Stress, Inflammation and disease 
Stress and inflammation in domestic animals are characterised by a range of 
physiological, biochemical and behavioural changes (Allen and Kold, 1988; 
MacKay, 2000).  In the horse, such changes are of use in the diagnosis, treatment 
and prognostication of disease (Patterson et al., 1988; Pollock et al., 2005; 
Jacobsen and Andersen, 2007). The acute phase response is characterised by an 
increase in circulating concentrations of a number of proteins. This occurs 
following tissue injury, inflammation and infection in all mammals that have 
been investigated (Pepys and Baltz, 1983; Auer et al., 1989). To date, markers 
of inflammation including fibrinogen and haptoglobin, coupled with changes in a 
number of haematological and biochemical markers have been used to diagnose, 
monitor and prognosticate disease and to evaluate response to training in horses 
(Eurell et al., 1993; Jacobsen and Andersen, 2007; Kristensen et al., 2014). 
Unfortunately these traditional markers respond fairly slowly to the presence of 
disease and have wide normal ranges (Sheldrick et al., 1982; Allen et al., 1988; 
Pepys et al., 1989). As a result, disease states may be well advanced by the time 
they are identified and, to date, it is widely believed that these traditional 
markers are of limited value during the identification of subclinical disease. 
Thoroughbred horses are principally bred for use in the racing industry and are 
subject to significant levels of wastage (Rossdale et al., 1985). Horses reared for 
the purpose of racing are subject to a variety of diseases and stress related 
conditions that affect their ability to perform, and in some instances that lead 
to their permanent loss from the industry (Wilsher et al., 2006). Wastage has 
been defined as any injury or disease which interferes with the training schedule 
of the horse, resulting in lost days in work, a prolonged spell of rest, or 
retirement from racing (Rossdale et al., 1985; Bailey et al., 1997; Jackson et 
al., 2005). Several studies have evaluated losses occurring in the thoroughbred 
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racing industry. A variety of injuries and conditions are noted as causes of lost 
days, including lameness, respiratory disease, wounds, colic, and epistaxis 
(Rossdale et al., 1985; Bailey et al., 1997; Wilsher et al., 2006). The financial 
consequences of losses in the Thoroughbred industry are significant. 
Furthermore, there is clearly a welfare issue with regard to the numbers of 
animals subjected to euthanasia or left with chronic health problems (Jeffcott et 
al., 1982). In some cases, diagnosis of potentially career threatening injuries or 
disease may be delayed due to limitations in currently available diagnostic 
techniques, this in turn may lead to an increased level of wastage. Moreover, it 
is generally believed that some of these horses may suffer from significant stress 
during training. This stress may play a part in the development of subclinical and 
clinical disease but can be difficult to identify (Scoppetta et al., 2012; Cappelli 
et al., 2013). 
The stress response to training has been characterised by haematological 
changes, in particular, changes in erythrocyte parameters and in the neutrophil/ 
lymphocyte ratio (Snow et al., 1983). Increases in cortisol concentration have 
been recorded in horses in training and those with clinical evidence of disease, 
although a study by Irvine and Alexander (1994) found no significant changes in 
circulating serum cortisol concentration in response to training. Gastric 
ulceration is prevalent among racehorses in training (Murray et al., 1989; 
Luthersson et al., 2009a and b) and, in humans, stress has been documented as a 
cause of peptic ulcer disease (Monning and Prittie, 2011). Similarly, gastric 
ulceration has been noted in foals with concurrent disease (Furr et al., 1992). 
Based on these and other reports, the evidence suggests that there are 
associations between common stressors and disease. However, many of the 
disease states associated with stress, such as gastric ulceration, have non-
specific clinical signs and may be difficult to diagnose without advanced 
diagnostic equipment. In these circumstances, a new capacity to monitor the 
response to the stress of daily activity, training, and fulminant and subclinical 
disease would be of great value to owners, trainers and veterinary surgeons 
alike, who, using such information, could modify the care patterns of their 
animals.  
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1.3.1 Where we are today? 
As noted above, a number of APP markers have been identified in horses. Serum 
Amyloid A (SAA) is one such, and a growing number of articles highlight 
concentration changes in this and other markers in response to trauma, disease 
(Copas et al., 2013; Canisso et al., 2014; Pihl et al., 2013), parasitism (Andersen 
et al., 2014), exercise (Mack et al., 2014) and stress (Paltrinieri, et al., 2008; 
Belgrave et al., 2013;). Nevertheless, the fact that only a relatively small 
number of veterinary clinical laboratories offer measurement of SAA 
concentration, and fewer still as part of a commercial profile, as standard, 
demonstrates that veterinary medicine has yet to embrace the philosophy of 
using specific APP markers in the investigation, treatment planning and 
prognostication of disease.  
1.3.2 Defining stress and inflammation, and its consequences in the 
horse  
In 1975, Fraser, Richie and Fraser, defined stress as: 
“an abnormal or extreme adjustment in the physiology of an animal to 
cope with adverse effects of its environment or management”.  
Stress is such a broad term and can result in a myriad of different signs in 
humans and in the veterinary species. The difficulty for the researcher and 
clinician is that defining, quantifying and subsequently identifying the effects of 
stressors can be extremely challenging. Stressors include; changes in 
environment, which may be natural or artificial, handling, disease, treatment, 
and surgical intervention. Stressors potentially lead to pathophysiological 
reactions in the host producing changes in behaviour, physiology and disease 
susceptibility (Capelli et al., 2013). While the stress response may be important 
for survival initially, long-term exposure to stressors leads to a variety of 
detrimental changes (Griffin, 1989).  
“The indiscriminate manner in which the stress response is activated by 
afferent nerve stimulation may lead to production of excess hormones which 
may be life-saving in some patients but life threatening in others” (Bailey et 
al., 1987).  
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In domestic animals and humans, the stress response leads to increased oxygen 
consumption by a number of key tissues and organs (Korthuis, 2011). This may 
result in the development of a relative hypoxia in a number of body systems and 
organs non-vital to the stress response, e.g., kidneys and gastrointestinal tract 
(Berne and Levy, 1998). In humans, increasing blood pressure, heart rate and, 
therefore, cardiac output may be detrimental in patients with existing 
cardiovascular pathology. Furthermore, increased concentrations of 
catecholamines are arrythmogenic in all species (Bailey et al., 1987) and the 
development of acidosis may inhibit myocardial function (Berne and Levy, 1998). 
Finally, animals and humans subjected to chronic stress may enter a catabolic 
state, resulting in the mobilisation of proteins from muscle. This in turn can 
delay wound healing (Ellis et al., 1992). 
The inflammatory response occurs in all mammals in response to tissue damage 
and is characterised by a set of clinical signs first described in antiquity by Aulus 
Cornelius Celsus (ca 30B.C.-38A.D.) and added to by Virchow in the 19th century. 
These clinical signs of heat, pain, swelling, redness and loss of function can be 
recognised in some form or another in all inflammatory processes and are 
associated with both repair and protection of tissue as well as further damage. 
The different forms of inflammation are determined by the inciting cause, which 
may be traumatic, infectious or immunological, and the standard inflammatory 
response is known to consist of four components: inducers of inflammation, the 
sensors that detect them, inflammatory mediators and target tissues (Medzhitov, 
2010). It is generally accepted that acute inflammation plays an important role 
in tissue protection and repair, and that chronic states may become damaging 
(Wilmink et al., 1999). Recognition and identification of the inflammatory 
process are one of the main bases for the identification and treatment of 
disease. 
1.3.3 Physiology of the inflammatory and stress response 
Inflammation is a complex response to trauma, and to the invasion of the 
organism by foreign substances including infectious particles (Jacobsen et al., 
2009). The type of response is almost entirely governed by the nature of the 
inflammatory trigger, such that bacterial invasion leads to activation of 
receptors of the innate immune system, which in turn induce inflammatory cells 
19 
at the site, i.e, macrophages and neutrophils, to produce an enormous array of 
mediators, including, inflammatory cytokines, interleukins and prostaglandins 
(MacKay, 2000). The production of these chemicals is one of the hallmarks of the 
process, and different inducers lead to the production of different inflammatory 
mediators. These mediators include, but are not limited to, cytokines (e.g. 
Tumour necrosis factor (TNF), interleukins (IL1, IL4, IL5, IL6, IL13) and 
interferons (IFN- α, IFN-β), chemokines (CCL2 and CXCL8) and prostaglandins 
including, prostaglandin E2 (PGE2). These chemical mediators have a variety of 
effects both local and systemic; they induce the expression of selectins 
(carbohydrate-binding membrane proteins) on endothelial cells in the locality of 
the insult, which promote the recruitment of more inflammatory cells from the 
circulation. The quantities and quality of the recruited cells are dependent on 
the type of insult (Jensen and Whitehead, 1998).  
Other effects include locally increased tissue permeability and vasodilation of 
blood vessels, which lead to migration of white blood cells (mainly neutrophils 
and macrophages) into the damaged tissue to assist in the containment and 
destruction of invading pathogens and to remove necrotic debris. These 
processes are assisted by antibody activation and the production of complement 
(MacKay, 2000). Systemic effects of the inflammatory mediators include the 
induction of hepatocytes to produce acute phase proteins and the activation of 
local and central neurones to produce specific behavioural changes (Pecchi et 
al., 2009). In the case of sterile tissue damage, which may occur during 
wounding, the inflammatory response acts to prevent colonisation of the 
damaged tissue by microbes and other pathogens. The mediators produced 
during this type of tissue damage are not well understood, but are likely to be 
related to the products and components of dying cells, such as ATP and 
bradykinin (Basbaum et al., 2009). Activation of nociceptors in the damaged 
area leads to inflammatory pain: these receptors are activated by some of the 
clinical signs of inflammation such as swelling and exudation; additionally, 
prostaglandins increase the sensitivity of nociceptors (Medzhhitov, 2010). In 
order to be effective in the resolution of the infection, or trauma, the acute 
inflammatory process should normally cease once the insult has been removed or 
eliminated. This switch from the inflammatory response to the normal 
homeostatic state is a highly controlled and regulated process that is 
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characterised by the change from the production of pro-inflammatory 
prostaglandins to anti-inflammatory chemicals, including resolution-inducing 
lipotoxins. Recruitment of neutrophils is reduced in favour of phagocytic 
monocytes to promote clearance of cellular debris and repair of damaged tissue. 
(Serhan and Savill, 2005). If this resolution of acute infection does not occur, 
then a persistent state of chronic inflammation follows. Such a state can be 
caused by chronic infections, foreign bodies, or unrepaired trauma (Kumar et 
al., 2003).  
The inflammatory and neuroendocrine response (Griffin, 1989) to trauma and 
disease are complex, and the full detrimental and beneficial effects of these 
physiological responses are yet to be fully understood. Nevertheless, there is 
widespread acceptance that a better understanding of inflammation holds the 
key to successful treatment and management of a number of traumatic and 
other disease states in humans and veterinary species. 
1.3.4 Benefits of inflammation and stress 
Clearly, the stress response is a normal physiological reaction to a variety of 
stimuli and, as such, it has a number of benefits to the “stressed” individual. 
The most notable and immediate effects are increased perfusion to a number of 
key viscera and therefore increased delivery of oxygen and nutrients to these 
tissues. This “extra fuel” is maintained through catabolism until the individual is 
able to resume normal food intake (Griffin, 1989).  
Inflammation occurs to restore tissue integrity and re-establish homeostasis, 
although it should be noted that the response to trauma serves a different 
purpose than that of the response to infection or immune stimuli. In the case of 
trauma the primary purpose of the inflammatory response is to remove damaged 
tissue and promote repair, whereas the response to pathological organisms is 
primarily protective and important in the induction of adaptive immunity 
(Medzhitov, 2010) 
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1.3.5 Methods used to identify stress and inflammation, and 
associated haematological and biochemical changes  
A variety of methods can be used to assess whether an individual animal is 
stressed. Clearly, clinical examination is of primary importance in assessing 
inflammation and disease. Changes in behaviour, feeding patterns, weight 
change, socialisation and performance have all been used. Quantification and 
identification of stressors can be extremely difficult and this has led previous 
investigators to examine a variety of haematological, biochemical and other 
chemical changes that may be associated with stress (Holbrook et al., 2010). 
The recent interest in pain scores for both humans and animals provides some 
quantification for stress and inflammation, but these do not provide a direct 
measure of the inflammatory response (Furr et al., 1995; Hunt et al., 2004). 
A number of markers have traditionally been used to identify and quantify the 
degree of inflammation. Classically, such changes have been used in the 
diagnosis of clinical and subclinical disease, to measure the stress of certain 
activities such as exercise and training, and as a guide to the assessment of 
fitness in racehorses. Significant increases in red blood cell numbers, packed red 
cell volume and haemoglobin concentrations are well documented in response to 
exercise and training (Snow and Mackenzie, 1977; Kedzierski and Bergero, 2006). 
These changes are thought to be due, in part, to splenic contraction (Person, 
1967; Person, 1975; Snow et al., 1983). Increases in serum protein 
concentrations have also been recorded in racehorses and in humans in response 
to exercise (Astrad et al., 1977; Keenan, 1979). Initially, the plasma protein 
fibrinogen, but more recently a number of interleukins (IL-6) and the acute 
phase protein C-reactive protein (CRP) have been shown to increase their 
concentration in response to exercise (Libardi et al., 2012). It is not understood 
whether this increase is a response to the development of muscle pathology, 
however, the fact that increased CRP concentrations can be associated with an 
increased risk of myocardial infarction in humans (Lindahl et al., 2000) suggests 
that these acute phase proteins could be used as markers of disease in horses. 
In humans, erythrocyte sedimentation rate (ESR) or the Biernacki Reaction, is 
used as a non-specific measure of inflammation (Westergren, 1957). The ESR is 
really a measurement of fibrinogen concentration as increased concentrations of 
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fibrinogen result in the formation of red cell stacks called rouleaux. For that 
reason, ESR can be considered to be an indirect indicator of the acute phase 
response (Van Leeuwen and van Rijswijk, 1994). Unfortunately, ESR is of limited 
use in veterinary species as rouleaux formation can be normal in horses, pigs and 
cats (Weng et al., 1996). 
1.4 Evaluating diagnostic tests 
A great variety of tests are used in clinical veterinary medicine, for diagnosis, 
screening and research. Tests can be evaluated using a number of criteria, 
including how well they classify the subjects that are tested, their practicality or 
cost. A diagnostic test is used to determine the presence or absence of disease 
in the presence of clinical signs, whereas a screening test identifies individuals 
without clinical signs. Many commonly used tests have a continuous scale and 
this may complicate the separation of diseased from healthy individuals 
(Thrusfield, 2007). 
The ability of a test to indicate whether or not the individual has the disease is 
referred to as the validity. Sensitivity describes the ability of the test to 
correctly identify which individuals have the disease, whereas specificity 
describes the ability of the test to correctly identify individuals who do not have 
the disease.  
With the introduction of a new test, a gold standard test can be used to evaluate 
the new test using a 2x2 table to compare the performance of the new test 
against the currently accepted test. This type of evaluation may also be used to 
determine the cut points used when the test is applied to potentially diseased 
individuals. Different cut points will influence the sensitivity and specificity of 
the test. In daily clinical practice very few tests are used in isolation; instead, 
multiple tests are performed sequentially or simultaneously and interpreted 
collectively in order to maximise the chance of the correct diagnosis. 
Predictive values can be used to evaluate the performance of a test. The 
positive predictive value (PPV) is the proportion of individuals that test positive 
and actually have the disease. The negative predictive value (NPV) is the 
proportion of individuals who test negative and are actually free of the disease. 
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The positive predictive value is influenced by the prevalence of the disease in 
the population tested and on the sensitivity and specificity of the test. The PPV 
or the NPV can be calculated using a formula or Bayes theorem (Dohoo, 2003). 
Finally, all diagnostic tests are evaluated for reproducibility, repeatability and 
reliability. The ideal test will yield a similar result each time it is conducted. 
Variations in laboratory practice, testing procedure, and within the subject of 
the test may affect the ability of the test to consistently yield the same result. 
For each test the overall percent agreement and percent positive agreement are 
calculated (Thrusfield, 2007). 
Acute phase protein testing is by its very nature non-specific, and such tests are 
never diagnostic in their own right. In human medicine, acute phase protein 
tests are interpreted at the bedside alongside clinical findings and the results of 
other tests. In the same way as the measurement of temperature is universal in 
medical and veterinary settings, the measurement of acute phase proteins is of 
great clinical utility (Pepys and Hirschfield, 2003) 
1.5 Choosing horses and clinical syndromes in which to evaluate 
acute phase proteins 
A number of disease states and syndromes and their effect on the concentration 
of acute phase proteins were investigated and are presented in the subsequent 
chapters. Although opportunistic in nature, the clinical conditions have been 
chosen because they represent a selection of relatively common ailments / 
syndromes in relation to which, for various reasons, it would be useful for the 
attending clinicians and the owners to have more precise indicators of status to 
inform clinical decision-making.  
The horses selected for inclusion in the project were chosen to represent both 
the professional and leisure horse industry in Northern Europe and with the 
recognition that in a great many instances in equine practice, clinical cases are 
available for examination and sampling on a single occasion.  
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1.6 Measuring the response to surgery and the effect of disease in 
the horse 
Historically, the response to surgery in the horse has been measured based upon 
surgical success, resolution of the disease and / or various performance indices 
in competition animals (Cheetham et al., 2008). While many of these measures 
provide useful data, it could be argued that, to date, none provide information 
on the general health status of the horse. There are numerous examples of 
instances in which the presence or degree of subclinical disease and economic 
output have been used as a general marker of herd health in populations of 
production animals (Gerardi et al., 2009) but again, no such study has been 
performed in the horse. 
A number of individuals and organisations have attempted to define health 
(Callahan, 1973; Gunnarsson, 2006) in all species, and there has been a gradual 
recognition that health is more than just an absence of overt disease or injury. 
Nevertheless, medical and veterinary professionals alike continue to struggle 
with the identification of disease states that are not readily apparent or 
subclinical. In humans, it is widely accepted that measures of disease status 
alone are insufficient to describe the burden of illness (Muldoon et al., 1998); 
consequently quality of life measurements have been widely adopted in human 
clinical practice (Thomas et al., 1994). Many of these definitions of health have 
been subject to extensive study and validation and are generally divided into 
measures of objective function and subjective wellbeing (Muldoon et al., 1998). 
In the veterinary species some of these measures are much more difficult to 
quantify and assess. Nevertheless it is still quite possible to simply record 
measures of general health. 
1.7 Equine surgical and non-surgical gastrointestinal disease (colic) 
There can be few diseases that have a greater emotional effect, or that 
engender such anxiety amongst horse owners, carers and trainers than 
gastrointestinal disease or colic. Producing a range of clinical signs from 
relatively mild and transient, to severe debilitating disease with high rates of 
morbidity and mortality, horse owner and veterinary led surveys in the UK and 
the USA suggest that colic is the second most common cause of death in horses 
after musculoskeletal disease (USDA, 2005; Andrews, 2009). The purpose of this 
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review is broadly to outline the type of pathology encountered by veterinary 
surgeons treating horses affected by colic that require surgical intervention, and 
to demonstrate the need for rapid decision making in such cases.  
Rather than a specific disease, the term colic refers to clinical signs associated 
with dysfunction or derangement of the gastrointestinal tract. These clinical 
signs vary in severity and include, but are not limited to, sweating, flank 
watching, rolling or lying down for longer than usual, dog sitting, groaning, 
pawing, stretching, yawning, alterations in intestinal borborygmi, spontaneous 
nasogastric reflux, extreme restlessness and violent rolling (Mair, 2002). An array 
of conditions can lead to the clinical signs described and range from 
derangements in intestinal motility, impactions, intestinal displacements, 
structural and functional obstructions, parasitic infestation, neoplastic and 
inflammatory conditions (Cohen, 2002). Unfortunately, in many instances the 
cause of colic is not identified and, even when it is, prognostication and 
determination of the likely outcome of the disease can be extremely difficult 
(Dukti and White, 2009). 
Colic is thought to affect between 4-10 cases per 100 horses presented to 
veterinary surgeons in first opinion practice (Tinker et al., 1997). Of these 
horses, the vast majority (80-85%) respond to medical management with an 
excellent prognosis for resolution and return to normal activity (Proudman, 
1992). Strangulating and non-strangulating diseases that lead to rapid 
development of clinical signs and necessitate surgical intervention are thought 
to represent 2-10% of colic cases (Hillyer et al., 1997).  
1.7.1 Making the decision for intervention and determining outcome 
in horses affected with colic 
A number of workers have developed models in an attempt to better determine 
the prognosis for horses affected by colic. These models are based on a variety 
of variables that include, but are not limited to, heart rate, total plasma protein 
concentration and packed red cell volume, plasma lactate concentration, 
peritoneal fluid evaluation, capillary refill time and mucous membrane 
appearance, and the presence of self-inflicted trauma (Orsini et al., 1989; 
Pascoe et al., 1990; Furr et al., 1995). Although a number of these models 
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performed well in the hospital environment in which they were developed, with 
high positive predicative values on the model data sets, they did not perform so 
well when evaluated using data sets outwith the hospital horse population 
(Reeves et al., 1989). 
Due to the potentially high financial and emotional costs to horse owners of 
horses affected by, and treated for colic, further work to allow an accurate 
prognosis to be given at the time of presentation is critical. Human doctors and 
veterinary surgeons are under increased pressure to practice evidence-based 
medicine (Freeman and Curtis, 2015). Consequently it is no longer acceptable in 
terms of animal, and indeed owner welfare to operate on a horse, affected by 
colic, with a hopeless prognosis (Mair et al., 2007). Objective survival data, 
mapped onto clinical parameters gathered at the time of presentation are 
critical to inform policy in equine hospitals (Proudman et al., 2002a, 2002b). The 
ideal test to determine whether a horse should be subjected to surgery or not, 
does not exist. Such a test would require to be run quickly, cheaply and if 
possible “horse-side”. Critically, and in contrast to the myriad of tests and 
clinical parameters that are currently available to measure, the test would need 
to be able to take a global view of the state of the horse. In a colicking animal, 
that would mean the test would assess the degree of gastrointestinal tissue 
damage, endotoxaemia, sepsis, and provide a global measure of the 
“inflammatory-state” of the animal, perhaps even the level of stress the animal 
was experiencing. At its most basic function, the test would determine the 
likelihood of survival for the patient following successful surgery, but secondary 
functions might extend to assessing fitness for surgery in the first place. 
1.8 The equine athlete-training in horses 
It is widely accepted that horses in race training are subject to a certain level of 
physiological stress (Cayado et al., 2006; Scoppetta et al., 2012; von Lewinski et 
al., 2013).  Strenuous exercise modulates both the autonomic nervous system 
and the hypothalamic-pituitary-adrenal axis (Galbo, 1986). The activity of these 
two stress-activated systems can be demonstrated by increases in cortisol, 
ACTH, adrenaline and noradrenaline concentrations. These endocrine responses 
to exercise have been extensively studied in horses (Church et al., 1987; Jiminez 
et al., 1998; Nagata et al., 1999).  
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Various physiological changes are associated with overtraining in human and 
equine athletes. Overtraining is a general term for any chronic condition in 
which there is imbalance between training and recovery resulting in fatigue. A 
drop in performance is necessary for a diagnosis of overtraining (Hamlin et al., 
2002) and the measurement of these reductions in performance is fraught with 
difficulty. Changes in humans and horses associated with overtraining include; 
decreased maximal heart rate, changes in muscle composition, modified 
responses to catecholamines, blunted responses to cortisol, and reduced weight 
(Hamlin et al., 2002). Perkins et al., (2004) described the effect of duration of 
training on subsequent performance in racehorses in New Zealand and a number 
of authors have examined the response of specific body systems and tissues to 
training (Price et al., 1995) However, to date, very little work has been 
performed investigating the use of inflammatory markers or acute phase 
reactants as a measure of general health or “normality” in apparently normal 
horses in training. 
1.9 Gastric ulceration in the horse 
Equine peptic disorders are conditions in which hydrochloric acid (HCl) and 
pepsin, secreted by the cells in the stomach, damage the mucosal lining of the 
oesophagus, stomach and duodenum. One such condition, which has recently 
received increased interest amongst clinicians and research workers, is gastric 
ulceration (Luthersson et al., 2009a, 2009b). Gastric ulceration is common in 
both adult horses and foals, with a reported prevalence of 25 – 50 % in foals 
(Wilson, 1986; Murray, 1988; Murray et al., 1990) and 60 – 90 % in adult horses 
(Hammond et al., 1986; Murray, 1988; McAllister et al., 1992; Vatistas et al., 
1994). Indeed two distinct age related syndromes, affecting different anatomical 
locations within the stomach, have been described. These syndromes may 
present with different aetiologies and clinical signs, but share a common 
pathogenesis. Definitive diagnosis relies on visualisation of the lesions with the 
aid of gastric endoscopy (gastroscopy). Due to the array of clinical 
presentations, pathophysiological mechanisms for their development and variety 
of different types of animals affected, the term equine gastric ulcer syndrome 
(EGUS) has been coined for this disease (Andrews et al., 1999). 
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1.9.1 Anatomy of the equine stomach 
The equine stomach is divided into two distinct regions anatomically, both 
grossly and histologically, the non-glandular or oesophageal region and the 
glandular region. The non-glandular region accounts for one third of the 
stomach, and like the oesophagus, is white in colour and lined by a thick 
stratified squamous epithelium (Murray et al., 1989). Separated from the 
remaining two thirds of the stomach by a raised ridge of tissue, known as the 
margo plicatus, or cuticular ridge, the glandular portion of the stomach is lined 
by glandular epithelium and is physiologically and histologically similar to the 
human stomach and that of some of the other domestic animals (Sisson, 1975). 
The glandular portion contains cells responsible for the production of 
hydrochloric acid, pepsin, mucus and bicarbonate (Sisson, 1975). The glandular 
portion of the stomach is protected from damage by hydrochloric acid (HCL) and 
pepsin by a number of mechanisms including: a mucus/bicarbonate layer which 
repels HCl and leads to a gradient of increasing pH towards the surface cells, 
excellent mucosal blood flow, allowing transport of H+ ions away from the 
mucosa and providing a source of oxygen and nutrients. Blood flow is mediated 
through the production of nitric oxide and prostaglandins E1 and E2. 
Prostaglandins also have a role to play in protection of the mucosa by 
stimulating the production of surface-active protective phospholipid and mucosal 
repair, and by preventing cell swelling by stimulating sodium transport (Lees and 
Higgins, 1985). In stark contrast, the non-glandular squamous epithelium of the 
equine stomach and oesophagus are poorly protected against the development 
of peptic ulcers (Orlando, 1991). The major barriers to HCl are the intercellular 
tight junctions and secretion of bicarbonate by the cells themselves. The 
oesophagus is protected by the flow of saliva distally, mucus and the integrity of 
the gastro-oesophageal sphincter.  
1.9.2 Ulceration in the equine stomach 
Gastric ulcers have been reported in both the glandular and non-glandular 
regions of the stomach and damage to the surface of the stomach can be 
classified as inflammation, erosion (superfical mucosa disrupted) or ulceration 
(penetration of the submucosa) (Rebhun et al., 1982; Roberts, 1990; Andrews et 
al., 1999; Lutherson et al., 2009a,b) 
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1.9.3 Prevalence and aeitiology of gastric ulceration 
The prevalence of gastric ulceration has been reported to range from 10.3% at 
necropsy to as much as 100% when limited to animals in full race training 
(Murray et al., 1989; Sandin et al., 2000). Gastric ulceration is a condition of 
multi-factorial aeitiology and, as a result, a variety of factors have been 
implicated in its development. Mucosal protective factors are more developed in 
the glandular portion of the equine stomach, compared to the squamous region, 
and different mechanisms are probably responsible for the development of 
ulcerative lesions in different regions (Sanchez, 2004). Ulcers in the non-
glandular, squamous region are primarily the result of increased exposure to 
hydrochloric acid and, as such, are similar to gastro-oesophageal reflux disease 
syndrome (GERDS) noted in humans (Collier and Stoneham, 1997). In contrast, 
ulcers in the glandular mucosa result from interruptions to blood flow and 
decreased mucus and bicarbonate secretion. This leads to back diffusion of 
hydrogen ions and resultant damage to the submucosa (Andrews et al., 1999). 
Hydrochloric acid is secreted continuously by equine parietal cells within the 
gastric glands and, as a result, equine gastric pH can range from 2 to 6 
depending on the fasted state of the horse (Campbell-Thompson and Merritt, 
1990: Murray et al., 1993). Anything interfering with HCl concentration or 
volume, within the stomach, or that prolongs HCl contact with the mucosa, or 
that interferes with mucosal blood flow and mucus production, may lead to 
gastric ulceration.  
In humans and horses, stress has been implicated as a potential cause of 
ulceration. The mechanism is not well understood but may be related to 
increased production of endogenous corticosteroid, which can inhibit 
prostaglandin synthesis. In foals, parturition and hospitalisation, and in adults, 
confinement and training, have been suggested as possible stressors (Andrews et 
al., 1999). 
1.9.4 Diagnosis of gastric ulceration 
In yearlings and adult horses, diagnosis of EGUS is based upon clinical signs and 
the response to treatment. Definitive diagnosis of gastric ulceration requires 
endoscopic evaluation of the stomach in fasted horses. Gastroscopy is simple to 
perform in the standing horse and is the current gold standard for identification 
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of pathology (Murray et al., 1990; MacAllister et al., 1997).  Clinical signs are 
variable, and erosions and ulcers are usually categorised as clinical or subclinical 
and may be associated with poor appetite, reduced body condition, recurrent 
colic, diarrhoea, poor performance and changes in demeanour (Sanchez, 2004). 
The presence of gastric ulceration is often overlooked in adult horses, although 
the syndrome may, in fact, be of greater clinical and economic significance in 
mature rather than young animals (Sanchez, 2004).   
A number of scoring systems have been used to describe lesions in the glandular 
and squamous regions of the equine stomach (Murray et al., 1996; MacAllister et 
al., 1997; Andrews et al., 1999; Bell et al., 2007). The scoring system used in 
the studies presented in this thesis was the accepted system during the study 
period (Murray et al., 1996). 
1.9.5 Treatment of gastric ulceration 
A number of treatment options are available, including histamine H2 receptor 
antagonists (cimetidine and ranitidine), mucosal protectants, such as sucralfate, 
and, more recently, and so far most effectively, the proton pump inhibitor, 
omeprazole. Omeprazole works by irreversibly binding to the H+,K+-ATPase 
proton pump of the parietal cells. The drug has shown excellent efficacy against 
gastric ulceration (MacAllister, 1999) and, additionally, continued low dose 
therapy is protective against the re-development of erosions and ulceration 
(Murray et al., 1997). Treatment with omerprazole has also been shown to 
reduce the severity, and even eliminate, ulceration in horses in full race training 
(Vatistas et al., 1999). Nevertheless, treatment is expensive and can be 
protracted.  
1.9.6 Acute phase proteins and gastric ulceration 
If the concentration of an acute phase protein or proteins were noted to change 
in response to the presence of clinically significant gastric ulceration, testing for 
this marker or markers could be added to the panel of biochemical analytes 
commonly examined during investigations for poor performance or as part of a 
routine screening regimen for performance horses. 
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1.10 Rhodococcus equi in Thoroughbred foals 
Rhodococcus equi, formerly know as Corynebacterium equi, was first described 
as a cause of purulent bronchopneumonia in foals in Sweden by Magnusson 
(1923). This gram-positive pleomorphic coccobacillus is frequently found in V 
and L shaped groups that are referred to as “Chinese character formations” 
(Wilkins 2004). Since its isolation, it has become a well-known pathogen in 
horses and, more recently, it has been identified as an opportunistic pathogen in 
immunocompromised humans (Drancourt et al., 1992). A facultative intracellular 
organism, many species of Rodococcus, including R. equi, can be isolated from 
the soil and the air in accommodation used to house horses (Woolcock et al., 
1980; Takai et al., 1987). The organism has also been isolated from the faeces of 
foals, from the first week of life onwards, and adult horses (Takai et al., 1986). 
The welfare and financial consequences for farms producing foals affected by R. 
equi are significant and, as such, a great deal of research has been conducted 
into the epidemiology, diagnosis and treatment of this disease. The result of 
infection with R. equi is a severe bronchopneumonia with granulomatous abscess 
formation and, in approximately half of all infected animals, the disease 
progresses to involve other body systems (Zink et al., 1986). 
1.10.1 Pathogenesis and virulence of Rhodococcus equi 
Rhodococcus equi inhabits, and replicates within, alveolar macrophages, where 
it can resist the innate immune system and can prevent phagosome lysosome 
function in infected animals and humans (Hietala and Ardans, 1987). Within the 
macrophage, the bacterium is also protected from neutrophil mediated killing. 
Ability to replicate within a macrophage is dependent on virulence and this, in 
turn, is dependent upon the capsular polysaccharide, the exoenzyme cholesterol 
oxidase, cell wall mycolic acids and, most importantly, the possession of a large 
plasmid, which encodes for a surface expressed lipoprotein, VapA. All strains of 
R equi isolated from horses with clinical disease possess the large plasmid and 
express VapA antigens (Hondulas, 1997). Plasmid-cured Rhodococcus equi are 
unable to produce infection and are cleared from the lung of foals within two 
weeks (Giguere et al., 1999). 
The consequences of infection with R. equi in all species is the development of a 
pyogranulomatous pneumonia, which is due to the presence of mycolic acid in 
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the R. equi cell wall which promotes granuloma formation (Wilkins, 2004).  Early 
lesions are characterised by a cellular influx of macrophages and multinucleate 
giant cells into the alveolar spaces. 
1.10.2 Development of disease and clinical signs 
Although infection with R. equi is reported in adult horses (Lavoie et al., 1994), 
the majority of clinical cases are reported in foals less than three months of age. 
Foals are exposed to infection by inhalation of the pathogen, although the 
alimentary and genital systems are other potential routes of infection. 
Characteristically, clinical disease is insidious in onset and clinical signs may be 
dependent upon the route of infection (Yager, 1987). Respiratory infection leads 
to an extensive bronchopneumonia and the development of large abscesses, 
which may coalesce (Hondalus, 1997). A proportion of infected individuals 
develop ulcerative colitis and / or mesenteric lymphadenitis (Zink et al., 1986). 
The intestinal form originates in the Peyer’s patches, which become ulcerated; 
with time, infection extends to involve the local mesenteric lymph nodes. 
Dissemination of infection from the lung to other sites leading to a variety of 
clinical syndromes has been described, including: septic arthritis, septic physitis, 
discospondylitis, serosistis, and cutaneous ulcerative lymphangitis (Hondulas, 
1997; Wilkins, 2004). 
1.10.3 Susceptibility of the foal compared to other species 
Although infection with R. equi has been reported in cattle, pigs, sheep, goats, 
deer, buffalo, cats, and dogs (Soedarmanto et al., 1997; Passamonti et al., 
2011), disease in species other than the horse, and more recently 
immunocompromised humans (Drancourt et al., 1992), is rare and generally 
confined to local lymph node abscessation or wound infections. The clinical 
syndrome of suppurative bronchopneumonia is almost entirely confined to young 
horses (Wilkins 2004). Furthermore, while experimental studies have readily 
induced the condition in foals, similar results have not been demonstrated in 
other animal species following inoculation with R. equi. Breed predispositions 
have been reported, but these differ according to geographical location (Taki et 
al., 1987); for example, despite an extensive study, no virulent strains of R. equi 
have ever been isolated from Prezwalski's horses in Mongolia (Taki et al., 2005). 
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Provided foals are exposed to a sufficient challenge dose, experimental studies 
have demonstrated that all foals are similarly susceptible (Yager, 1987). 
1.10.4 Diagnosis and treatment of Rhodococcus equi 
Diagnosis of R. equi is based upon the identification of the organism in direct 
smears or culture of tracheobronchal washes or faecal samples (Wilkins, 2004). 
Radiographs of the thorax may demonstrate the presence of multiple abscesses 
(Bertone, 1998) and thoracic ultrasound is very sensitive, particularly in foals 
with disease involving the peripheral sections of the lungs (Wilkins, 2004). 
Haematological examination may indicate the presence of a neutrophilia, 
increased fibrinogen concentration and thrombocytophilia. A number of 
serological tests have been described, although results can be difficult to 
interpret as young foals that become exposed to the organism may produce 
antibodies in the absence of clinical disease. Recently, a polymerase chain 
reaction (PCR) test has been validated for the identification of R. equi and 
results of two clinical trials suggest that this method is likely to be effective in 
the diagnosis of the disease (Sellon et al., 2001), although, again, this technique 
may only confirm the presence of the organism, and not necessarily clinical 
disease. Treatment can be difficult, and protracted, due to the intracellular 
nature of the pathogen and the fact that the disease may be extensive prior to 
the onset of clinical signs. The most common treatment is the combined oral use 
of erythromycin (25mg/kg tid) and rifampicin (5mg/kg bid). However, recently 
there has been a move to the use of azithromycin (10mg/kg sid PO or 
clarithromycin (7.5mg/kg bid PO) in combination with rifampicin (Wilkins 2004).  
1.10.5 Why do we need to do better with early identification of 
infected foals? 
The prognosis for survival of foals, following successful treatment, is particularly 
good for those individuals that are mildly or subclinically affected. Additionally, 
these animals are more likely to have an athletic career. However, despite this, 
diagnosis continues to rely heavily on the recognition of clinical signs by which 
time significant tissue damage may have occurred (Bertone, 1998; Johns, 2013). 
To this end, the development of a cheap, reliable test, which could form part of 
the routine biochemical screening panel utilised by many equine commercial 
breeding operations, is much needed.  
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1.11 Patient side acute phase protein testing 
Since the work described in this thesis was undertaken, patient side SAA testing 
has become available to equine veterinary surgeons. Although not yet widely 
used, the tests, performed on whole blood, provide two options for results; 
either, a binary result which simply tells the operator whether the SAA 
concentration is within the normal range or not; or a numerical value. The 
emphasis is on the identification of individuals who may be abnormal before the 
onset of overt clinical signs. The manufacturers advocate serial testing of 
individuals to develop an acute phase profile for each horse, as well as one off 
testing if disease is suspected. To date the tests have been used to successfully 
identify individuals, which with further screening have been diagnosed, with 
infectious airway disease, exercise induced pulmonary haemorrhage, 
gastrointestinal disease and surgical site infection. 
1.12 Summary, objectives and hypothesis 
The various traumatic interventions, inflammatory stimuli, acute and chronic 
disease states described in this introduction and literature review represent 
some of the conditions, affecting horses, in which the use of APP markers to 
diagnose, monitor response to interventions and treatment and prognosticate 
disease and injury, might be more generally adopted. The purpose of the work 
presented in the chapters that follow was to attempt to bridge the present gap 
between demonstrating that these markers are present following injury or 
disease, and their effective clinical use in everyday equine veterinary medicine. 
The specific objectives of this project were to answer the following questions; 
(1) to define differences, if any,  in the serum concentration of the acute
phase proteins, serum amyloid A and haptoglobin in clinically normal
horses.
(2) to determine if surgical stress is a significant factor in the serum
concentration of serum amyloid A and haptoglobin in the horse.
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(3) to determine if the serum concentrations of the acute phase proteins
serum amyloid A and haptoglobin are associated with the severity and
eventual outcome in horses with acute gastrointestinal compromise.
(4) to determine if differences in training regimens are a significant factor in
the serum concentration of serum amyloid A and haptoglobin within a
group of Thoroughbred racehorses.
(5) to determine if gastric ulceration has a significant association with the
serum concentration of serum amyloid A and haptoglobin, and if these
acute phase proteins are useful markers for identification of different
grades of ulceration within a group of Thoroughbred racehorses in
training.
(6) to determine if the concentrations of serum amyloid A and haptoglobin
are significantly increased in foals subclinically infected with Rodococcus
equi, but lacking clinical signs.
(7) to determine if serum amyloid A and other acute phase proteins have a
role to play as indicators of normal health in horses.
Overall, the work explored the extent to which the acute phase proteins, serum 
amyloid A and haptoglobin, can be used as non-specific tests in horses for: 
• the presence of inflammation,
• tissue injury,
• training stress and
• the presence of subclinical pathology,
• the diagnosis and prognostication of disease.
• as a general measure of health.
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Chapter 2 
General Materials and Methods 
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2.1 Introduction 
The clinical studies presented in this thesis were undertaken between 2003 and 
2007. Full details of the animals used, specific testing regimens and statistical 
methods are given in the subsequent relevant chapters. The general section 
details procedures common to all groups and provides an overview of the 
investigations outlined in the subsequent chapters.  
2.2 Animals 
Two hundred and forty six horses were used in this project. The majority of 
these horses (221) where Thoroughbreds. These horses could be separated into a 
number of groups. All were examined and sampled with permission from the 
owners, keepers or trainers. In the groups presented with evidence of disease, 
all of the findings from the project were made available to the owners/keepers 
or trainers during treatment planning. Sample size calculations to evaluate the 
power of the studies to detect biologically meaningful effects were performed 
retrospectively and are included in the subsequent chapters where relevant.  
2.2.1 Group One - 50 Clinically normal, Thoroughbred horses 
Fifty horses from a stud farm were blood sampled in August 2003. These horses 
were selected to be representative of the population of animals available. Each 
horse was subjected to a full clinical examination, including temperature, pulse, 
respiration and palpation of superficial lymph nodes. In addition, a thorough 
history was taken in an attempt to ensure that there was no evidence of disease. 
Clinical examination was carried out following blood sampling to reduce the 
effects of the stress of handling on the various haematological and biochemical 
parameters. This group of apparently normal horses was further subdivided into 
foals (n=16), young adults (n=28), and adults (6). For the purpose of this study an 
animal was considered to be a foal between birth and eight months of age, a 
young adult between 9 months and 4 years and an adult if it was 4 years or 
older. These subdivisions were created for the purpose of this study as there is 
no generally accepted definition in the literature. The young horses sampled, 
bred for sale, were all weaned, housed individually at night and mixed at 
pasture during the day. All brood mares had foals at foot, were housed 
individually during the night and mixed with other brood mares and foals 
throughout the day. All of the “in training” group had begun initial (pre) training 
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and were managed by full time stall confinement when not exercising. Full 
details of the horses in Group 1 can be found in Appendix 1. 
2.2.2 Group 2 - 25 horses presented for a variety of surgical 
procedures 
Twenty-five horses admitted to the University Veterinary Hospital, University 
College Dublin, Ireland were sampled in one month in 2003. These horses were 
further subdivided into two groups. The first group (n=18) (the elective group) 
included horses presented for elective surgical procedures, that is animals with 
no active inflammation or concurrent disease. The second group included 7 
horses with on-going disease presented for non-elective surgery. 
2.2.3 Group 3 - 59 horses presented for the investigation and 
treatment of colic 
Fifty nine horses were presented to one of three university veterinary hospitals, 
including University College Dublin, Ireland, The University of Copenhagen, and 
The University of Glasgow for the investigation and treatment of colic. The 
selection for this group was as follows; any horse presented to the equine 
emergency service at any one of the above three clinics between 2004 and 2006 
which was determined to have a lesion which required surgical intervention and 
was thereafter subjected to surgery no matter the surgical outcome. 
This group was further subdivided into one of two categories: (1) Horses 
recovered from surgery and subsequently discharged from the hospital, (2) 
Horses that were either euthanised or died were consequently not discharged 
from the hospital.  
Further details of these animals including reason for admission and details of 
treatment and outcome are given in Chapter 4. 
2.2.4 Group 4 - 100 racehorses in training 
One hundred Thoroughbred racehorses from nine separate training premises 
were blood sampled on three separate occasions between May 2003 and 
September 2003. This number was chosen due to numbers available, and based 
on geographical location of the training premises and the numbers that could be 
reasonably sampled on individual occasions. These horses were selected 
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randomly using a random number generator system based on stable door 
number, from eight national hunt and one flat training yard. History, including 
concurrent illness, past and present performance and current level of exercise, 
if any, was recorded for all individuals included in this group. Each horse was 
subjected to a full clinical examination, including temperature, pulse, 
respiration and palpation of superficial lymph nodes. Clinical examination was 
carried out following blood sampling to reduce the effects of the stress of 
handling on the results. 
Following sampling, these horses were subjected to gastroscopic examination. 
The degree of gastric ulceration, if present was scaled using the grading system 
described in 2.5 below. At the time of the research, it was accepted practice to 
use the grading system described to give a global score for ulceration across 
both regions of the stomach, rather than a separate score for squamous and 
mucosal ulceration as is common practice today (Murray et al., 1996) Full details 
of the horses in Group 4 can be found in Appendix 2.  
2.2.5 Group 5 - Thoroughbred foals exposed to, and subsequently 
naturally infected with Rodococcus equi 
Twelve Thoroughbred foals from the same commercial stud operation from 
which normal horses were collected in 2.2.1, but from another premises, were 
blood sampled on one occasion. These foals were part of a larger group of foals 
sampled as part of an on-going disease surveillance regimen on this part of the 
farm. The selected foals were between the ages of 3 and 6 months and clinically 
normal at the time of blood sampling, but subsequently developed clinical signs 
of infection with R. equi, confirmed by bronchoalveolar lavage and culture of 
the organism, within 4 weeks of the sampling date. All 12 foals were subjected 
to a clinical examination, including temperature, pulse, respiration and 
palpation of superficial lymph nodes at the time of sampling (i.e. before they 
became infected). 
2.3 Anaesthetic Protocol 
The horses in Groups 2 and 3 were subjected to general anaesthesia. All of the 
horses were anaesthetised using a standard protocol which consisted of sedation 
with 0.05mg/kg acepromazine maleate (ACP-Novartis), 1.1mg/kg xylazine HCL 
(Chanazine; Chanelle) and 0.05mg/kg diazepam (Valium; Roche). Anaeasthesia 
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was induced with 2.2mg/kg ketamine HCL (Narketan 10; Vetoquinol) and 
maintained with halothane or Isoflurane (Halothane-Vet; Merial or Isofane-
Novartis) in oxygen delivered in a circle system. All the horses received 22,000 
iu/kg procaine benzyl penicillin (Depocillin; Intervet) tetanus antitoxin (Intervet) 
and 4.4 mg/kg phenylbutazone (Phenylarthrite; Vetoquinol) before anaesthesia 
was induced. Recovery from anaesthesia was not assisted for Group 2 but was 
assisted for Group 3. 
2.4 Techniques 
2.4.1 Blood sampling 
Blood was obtained from each horse by jugular venopuncture using a vacutainer 
system and a 21g 1.5inch needle. Samples were obtained to determine full 
haematology, selected biochemical analysis and concentration of the acute 
phase proteins, fibrinogen, haptoglobin and SAA. Blood samples were collected 
into a plain tube, a tube containing lithium heparin, and a tube containing 
ethylenediaminetetracetic acid (EDTA). Clinical examination was carried out 
following blood sampling and gastroscopy (in Group 4) to reduce any effect of 
the stress of examination and handling on the concentration of the analytes. All 
of the horses were restrained by their regular handler where appropriate. 
Blood samples preserved in EDTA and lithium heparin were analysed immediately 
for routine haemtological and biochemical anayltes and fibrinogen, at the 
diagnostic laboratory of the School of Veterinary Medicine, University College 
Dublin (Groups 1, 2, 4 and 5) and the diagnostic laboratories of the School of 
Veterinary Medicine, in Dublin, Copenhagen or Glasgow (Group 3). Quality 
assurance testing was in place for each of the clinical laboratories and identical 
analysers were used for automated analysis.  
Blood in the plain tube was centrifuged at 5000rpm for five minutes, and the 
serum separated into three, 1.5mL aliquots. These samples were stored at –80oC 
until they were analysed for concentration of SAA and Haptoglobin. 
While it would certainly have been desirable to run all of these samples in one 
laboratory over a short time frame, due to the nature of the project this was 
simply not possible and, had this been attempted, the effects of transport and 
storage on samples could well have introduced discrepancies in any comparisons 
that were subsequently made. All of the laboratories conformed to ISO standard 
15189 and hade been approved by the ECVCP laboratory standards committee.  
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2.4.2 Sampling Details 
Information regarding timing of samples and details of testing are given in the 
subsequent chapters were relevant.  
2.4.3 Routine haematology and biochemical analysis 
Haemaglobin concentration (Hb), packed cell volume (PCV), erythrocyte count 
(RBC), mean corpuscular haemaglobin concentration (MCHC), mean corpuscular 
volume (MCV), mean corpuscular haemoglobin(MCH), were determined using an 
Abbot Cell-dyn 3500 analyser. The differential white blood cell count and 
platelet counts were determined using a manual blood smear technique, using a 
Giemsa stain.  
Clinical biochemistry analytes were measured using a Bayer Opera Automated 
Analyser.  Analysis of groups 1, 2, 4 and 5 were all carried out in the same 
laboratory at the School of Veterinary Medicine, University College Dublin. 
Analysis of Group 3 bloods were performed at the Schools of Veterinary 
Medicine, in Dublin, Glasgow and Copenhagen. The same analysers were used, 
operated by similarly qualified individuals and while there were minor 
differences in references ranges, these were small. Each of the laboratories in 
which the samples were run was subjected to national/international 
accreditation programmes as discussed. 
2.4.4 Acute phase protein assays 
All of the SAA and haptoglobin tests were performed in the biochemistry 
laboratory at the Irish Equine Centre. Where possible sample groups were mixed 
for analysis. Mixing of sample groups was performed in order to reduce any 
effects of changes in reagents, sample kits and operator on the results. 
2.4.4.1 Serum Amyloid A Assay 
Serum amyloid A concentration was determined using a commercial, enzyme-
linked immunosorbent assay (ELISA) (Tridelta Phase series) and a Multiscan 
Multisoft photometer plate reader. The detection limit for SAA was 0.5µg/mL. 
Six standards and 90 samples were added to 96 well plates coated with 
monoclonal antibody specific for SAA. Biotinylated anti-SAA monoclonal antibody 
was then added. Any SAA present in the well was both captured on the plate by 
the immobilised antibody and labelled with conjugate antibody in a one-step 
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procedure. After washing off any unbound material, streptavidin-horse radish 
peroxidase conjugate was added to the well and incubated. Following a second 
incubation, Tetramethylbenzidine (TMB) substrate solution was added. The 
intensity of the colour produced was proportional to the concentration of SAA 
present in the original sample. 
The intra-assay coefficient of variation was 7·7% and the inter-assay coefficient 
of variation was 10·8% at mean concentrations of 74 µg/ml and 81 µg/ml, 
respectively. The coefficients of variation were determined by screening three 
samples 16 times in three consecutive batches.  
Detailed Procedure 
(1). Each serum sample was diluted 1: 500 in diluent buffer prior to analysis. 
This amounted to 5ul of sample in 2.5ml of diluent buffer. Following dilution 
samples were vortexed vigorously to ensure mixing. 
(2). SAA standards were prepared using the standard provided and diluent 
buffer. This provided the working standards shown in the table 1 below along 
with the values for the horse. 
(3). 50ul of diluted (50ul in 5mls of diluent buffer) biotinylated anti-SAA was 
added to each well 
(4). Vortexed diluted samples were then added to each well and the plate was 
tapped gently to mix the well contents. The plate was then covered and 
incubated at 37oC for one hour. 
(5). Following incubation the plate was washed four times with diluted wash 
buffer, before drying the plate by tapping on absorbent paper. 
(6). 100ul of streptavidin peroxidase was then added to each well. The plate was 
then recovered and incubated at room temperature for 30 minutes in the dark. 
(7). The plate was then re-washed as described in step 5.  
(8). 100ul of TMB substrate was then added to each well. The plate was then 
recovered and incubated at room temperature for 13minutes in the dark. 
(9). Finally 50ul of stop solution was added to each well. 
(10). Absorbances were measured and results calculated using a Multiscan 
Multisoft photometer plate reader. Absorbance of each well was read at 450nm. 
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2.4.4.2 Haptoglobin assay 
Tridelta Phase range kits were used to determine haptoglobin concentrations in 
each sample. The principle of the assay uses the peroxidase-like activity 
exhibited by free haemoglobin, this activity is inhibited at low pH. Haptoglobin 
present in the sample combines with haemoglobin and at low pH preserves the 
peroxidase activity of the bound haemoglobin. Preservation of the peroxidase 
activity of haemoglobin is directly proportional to the amount of haptoglobin 
present in the sample. Although the assay can be performed manually, all 
samples were processed using an automated method on a Cobas Mira analyser. 
Reagent one (premixed haemoglobin), chromogen and substrate (stabilised 
hydrogen peroxide) were placed in the required storage vessels on the 
instrument. Single point calibration was carried out using the 2.0mg/ml 
standard, provided in the kit, diluted 1:1 to give a 1mg/ml calibrator. The 
standard was then run on the instrument as a quality control. Samples were 
placed on the instrument and results produced. The Cobas Mira instrument was 
set to the protocols provided by the Tridelta company for haptoglobin 
measurement. The intraassay coefficient of variation was 1.36%, and the 
interassay coefficient of variation was 11%. The analytical sensitivity was 
determined as 0.05mg/mL. 
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Table 2.1 Working Standards and Volume of Diluent used in the SAA 
Assay 
Tube 
Number 
Volume of 
Callibrator (ul) 
Volume of  
Diluent (ul) 
Serial 
Dilution 
Equine  
Standards (ng/ml 
T1  60 240 - 20 
T2 - 150 150 T1 10 
T3 - 150 150 T2 5 
T4 - 150 150 T3 2.5 
T5 - 150 150 T4 1.25 
T6 - 150 - 0.625 
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2.4.4.3 Fibrinogen Assay 
The concentration of fibrinogen was determined using the heat precipitation 
method (Millar et al., 1971) and was carried out in the diagnostic laboratory of 
the School of Veterinary Medicine, University College Dublin (Groups 1, 2, 4 and 
5) and the diagnostic laboratories of the School of Veterinary Medicine, in
Dublin, Copenhagen or Glasgow (Groups 3).
A potential source of error with the heat precipitation method for fibrinogen 
concentration determination is localisation of the interfaces of the pale brown 
buffy coat and the white later of packed fibrinogen. Occasionally these are not 
at right angles to each other in which case the test should be repeated. Precise 
vernier reading is essential. Using 20 randomly selected blood samples at each 
laboratory, two separate aliquots were taken and estimations of fibrinogen 
concentration were made on each of these. The mean difference was 
0.124mL/100mL (SD ± 0.114). Ninety-three per cent of the estimations had a 
test/retest difference of less than 0.3ml/100ml. Any test showing a difference 
of more than 0.3mL/100mL was repeated: this difference was equivalent to 30 
mg/100 ml, i.e., about 10% in the normal plasma fibrinogen range.  
The intraassay coefficient of variation was 3 -7%, and the interassay coefficient 
of variation was 6-9%. The analytical detection limit was set at 0.5g/dL.  
Procedure 
(1). Two microhaematocrit tubes with freshly drawn and anticoagulated 
(EDTA) whole blood were centrifuged as for measurement of the standard 
microhematocrit. 
(2). The first tube was broken just above the RBC/plasma interface. The plasma 
was dropped onto the prism of the refractometer and the total protein 
concentration (g/L) was read and recorded. 
(3). The second tube was incubated for 3 minutes in a 58° C water bath. The 
fibrinogen precipitates as a white ring above the RBC. 
(4). At the completion of the 3-minute incubation, the second tube was re-
centrifuged and then broken above the plasma/fibrinogen interface. Total 
protein of this remaining plasma was measured as previously described. 
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(5). The fibrinogen concentration was determined to be the difference in the 
total protein measurement of the first microhematocrit tube minus the 
incubated and recentrifuged second microhematocrit tube.  
2.5 Gastric endoscopy 
The trainers were instructed to starve each horse for at least 24 hours prior to 
examination, muzzles were provided for this purpose.  
Using a three metre, 12.8mm diameter video endosope (VES, UK) passed naso-
oesophageally, each horses stomach was examined on three separate occasions. 
The entire stomach was examined and the scope was then retroflexed to allow 
examination of the cardia and fundus (Figure 2.3a and 2.3b). Each examination 
was video recorded. 
47 
Figure 2.1a Schematic showing the technique for examination of the stomach 
Figure 2.1b Gastroscopic image showing the endoscope retroflexed in the 
stomach in order to image the cardia region 
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Table 2.2 Scoring System for Gastric Ulceration Used in the 100 Thoroughbred 
Horses in Training (after Murray et al., 1988) 
Score Squamous mucosa Glandular mucosa 
0 Normal Normal 
1 Mild hyperkeratosis, hyperaemia Focal areas of hyperaemia 
2 Moderate hyperkeratosis, hyperaemia, 1-2 
small erosions 
Multifocal hyperaemia, up to 
3 small lesions 
3 Multifocal small erosions, with hyperaemia +/- 
hyperkeratosis 
Multifocal hyperaemia, up to 
three small lesions 
4 1-4 small ulcers, minimal thickening at margin, +/- small
erosions
> 3 small lesions, multifocal
hyperaemia
5 Deeper appearing ulceration, mild to moderate 
thickening of margins, +/- bleeding 
1-2 moderate sized lesions,
hyperaemia
6 Multifocal ulceration, mild to moderate thickening of 
margins, +/- bleeding 
1-2 large lesions, hyperaemia
7 More extensive, deep-appearing ulceration, +/- bleeding 1-2 large lesions, + smaller
lesions, hyperaemia
8 Focal large, deep-appearing ulceration, +/- multifocal 
erosions/ulcers, +/- bleeding. More extensive and with 
more changes in surrounding tissue than for 7 
1-2 large, deep-appearing
lesions, +/- smaller lesions,
hyperaemia
9 Extensive, deep ulceration with bleeding, covering larger 
area than for 8 
3-4 large, deep-appearing
lesions, +/- smaller lesions,
hyperaemia
10 Most severe, most extensive, deepest-appearing 
ulceration. Active bleeding or evidence of recent 
bleeding. Majority of mucosa ulcerated 
5 or more large, deep-
appearing lesions, +/- small 
lesions, hyperaemia 
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Figure 2.2 Gastroscopic image of a normal stomach showing the margo plicatus, 
glandular and squamous regions 
Figure 2.3a and b. Gastroscopic images of a stomach with Grade 4 ulceration 
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Figure 2.4 Gastroscopic image showing moderate ulceration (Grade 6) 
Figure 2.5a and b. Gastroscopic images showing severe ulceration around the 
cardia (Grade 8) 
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2.6 Rhodococcus equi Diagnostics 
2.6.1 Bronchoalveloar lavage technique 
1. All foals were manually restrained and a nose or ear twitch applied for
restraint. A number of fractious individuals were sedated with a combination of
xylazine hydrochloride (0.3-1mg/Kg) and butorphanol tartrate (0.1mg/Kg).
2. A standard coiled, guarded, bronchoalveolar (BAL Cook) lavage tube, with a
sterile sample tube, was lubricated with KY-jelly and passed into the ventral
meatus of the right or left nostril. As the tube reached the pharynx the neck was
extended to facilitate passage of the tube through the rima glottis (a
combination of lack of resistance, and coughing confirmed correct placement).
The tube through which the sample is obtained is contained within an outer tube
to prevent contamination from the upper portion of the respiratory tract. A new
sterile tube was used for each foal.
3. The BAL tube was advanced until resistance was encountered; some coughing
was usually encountered at the level of the carina. 5-10mL of sterile fluid was
used to inflate the BAL tube cuff in order to maintain the tube in the correct
position and 10mL of lidocaine hydrochloride was instilled into the tube at this
point.
4. 40mL of sterile saline was instilled through the BAL tube into the lungs and
immediately aspirated. The aspiration was repeated 2-3 times until at least
20mL was retrieved. The fluid was split between sterile plain and EDTA filled
containers. Finally samples were submitted for culture and sensitivity,
differential cell counts and qualitative cell morphology.
2.6.2 Cytology and culture of Rhodococcus equi 
Samples were prepared for cytological examination using the following 
technique. 
1. Samples preserved in EDTA were centrifuged in order to concentrate cellular
material and smears were made and allowed to air dry.
2. Air dried smears were stained with H&E stain and allowed to air dry.
3. The slides were examined at high power and >500 cells were typically
examined.
4. A diagnosis of R. equi was confirmed based on the presence of multiple gram
positive coccobacilli during cytological examination of the BAL fluid (Figure 2.8).
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The fluid contained in the plain BAL tube was subjected to microbial culture. R. 
equi colonies form at 30oC on sheep blood agar, they are characteristically small 
smooth and shiny at 24 hours becoming salmon pink in colour and mucoid by 72 
hours (Figure 2.9). The organism is catalase and urease positive and CAMP + with 
a characteristic shovel shaped zone of hemolysis 
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Figure 2.6 BAL cytology showing macrophages containing multiple cocci-shaped 
bacteria. (H&E x 400) 
Figure 2.7 Agar plate showing growth on sheep blood agar at 72 hours 
R. equi colonies are typically smooth, mucoid and salmon pink.
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2.7 Statistical Analysis 
These data were manipulated using Excel (Microsoft Office for Mac, Versions 
2007 -2011). Statistical analysis was performed using STATA Version 8, Minitab 
Version 16 and SPSS version 12. Graphs and tables were produced using Excel 
and Minitab. The following tests where used evaluate statistical significance in 
the studies presented in the Chapters that follow. 
2.7.1 One-way analysis of variance (ANOVA) (Chapter 3) 
Analysis of variance is a technique to determine whether the mean of a variable 
is influenced by different types and combinations of factors. One way analysis of 
variance is an extension of the independent t-test and was used to compare any 
number of groups or treatments. The reason ANOVA is used instead of multiple t-
tests is to reduce the chance of a type 1 error. That is incorrectly rejecting the 
null hypothesis and incorrectly concluding that a difference did not occur by 
chance. In ANOVA calculations variances are used rather than standard 
deviations to measure variability (Bland 2001; Bewick, Cheek, Ball 2004). ANOVA 
testing was completed using the statistical package STATA V8. 
2.7.2 Logistic regression (Chapters 5 and 6) 
During analysis of much of the data presented there were multiple explanatory 
variables examined; consequently, methods to facilitate multivariable analysis 
and account for potential confounding were used. In most cases, the outcomes 
of interest were binary in nature, e.g. presence or absence of gastric ulceration, 
survival or death following colic surgery; as a result, logistic regression 
modelling was utilised. Logistic regression models the natural logarithm (ln) of 
the odds of an outcome for a given value of explanatory variable(s). The odds 
are defined as the probability of having an outcome (e.g. ulceration) divided by 
the probability of not having the outcome (e.g. no ulceration). A major 
advantage of performing multivariable logistic regression is that multiple 
explanatory variables can be considered at once. 
A logistic regression model can be represented using the following equation: 
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In the above equation:                 the log transformation of the odds of 
outcome, where p = probability of outcome 
α = the intercept term, which represents the value of y when x=0  
βi = the regression coefficients, which represent the change in y for a unit 
change in xi, whilst the values of the other explanatory variables remain 
constant  
xi = the explanatory variables. 
(a) Univariable logistic regression
Logistic regression was used to develop models to determine whether any of the
variables measured during the studies presented here could be used to predict
the outcome. In logistic regression the relationship between the variables is
asymmetric, in that the value of one variable is caused or can be predicted by
the value or state of another variable or variables (Dohoo et al., 2003). Each
potential predictor variable was examined with respect to its association with
the relevant outcome variable one at a time. Predictor variables were
considered for inclusion in multivariable models where the likelihood ratio p-
value during univariable analysis was less than 0.25. Continuous explanatory
variables were examined in their original continuous form (assuming a linear
relationship between explanatory variable and outcome) and in their quartiles in
order to identify any deviations from linearity. Where continuous variables fitted
the model best in a categorical form and two or more levels of that variable
were not significantly different from each other, category levels were collapsed
together in order to include categorical variables with the fewest possible
levels, without compromising model fit. Model fit was assessed by examination
of likelihood ratio statistic and models were compared using the LRTEST
command in STATA.
(b) Multivariable logistic regression
A forward stepwise process was used to build multivariable models. Variables
were selected in turn, based on log likelihood values, biological
relevance/plausibility and P values. In the models developed for this work,
which generally had relatively few potential explanatory variables available, all
variables not otherwise included in final multivariable models, were forced into
models to examine potential confounding. Confounding was regarded as
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significant if the values of coefficients altered by more than 30% (Dohoo et al., 
2002). Final multivariable models were compared using the LRTEST command in 
STATA and decisions over the best fit model were made by examination of 
Akaike Information Criterion (AIC).  Hosmer–Lemeshow tests were performed to 
identify any lack of fit of the final multivariable models. 
2.7.2.1 Clustering of data 
The structure of data in a number of the studies presented here represents 
populations in which there is a hierarchical relationship between some of the 
variables, that is to say that one variable affects and may be dependent on 
another (Goldstein, 2003; Rahaman et al., 2011).  In addition, in a number of 
the studies presented, repeated measurements were taken from individual 
horses and these horses may have had further relationships (managed in the 
same way, on the same yard etc.). Repetition of analysis following these types 
of relationships between horses violates some of the assumptions made 
regarding the independence of the logistic regression model. The consequence 
of this is that failure to account for clustering may lead to artificially small 
standard errors, resulting in narrower confidence intervals, P-values that are too 
small and therefore incorrect inferences (Dohoo et al., 2010) i.e. identifying 
associations that do not exist. To account for this, multi-level models were also 
developed where appropriate to allow for these relationships which particularly 
related to clustering of data due to animals being kept together or managed in a 
similar way. 
2.7.3 ROC curves and predictive ability (Chapters 5 and 6) 
A receiver operating characteristic (ROC) curve is a plot of the sensitivity of a 
test against the false positive rate of the test. The purpose of the ROC curve is 
to determine the optimal cut point for distinguishing between affected and non-
affected individuals. The shape/angle of the line provides information on the 
discriminating ability of the test with a 45 degree angled line describing a test 
that is no better at predicating than chance alone. As the ROC curve moves 
towards the top left hand corner, the better the ability of the test, described by 
the plot, to predict outcome the outcome in question it becomes. 
The area under the curve can be used to predict the percentage of animals 
which will be correctly classified by the test. The advantage of using ROC curves 
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to determine a cut point for sensitivity and specificity is that it describes the 
overall ability of the test to discriminate affected from non-affected animals 
over a range of cut points (Dohoo et al., 2003). 
2.7.4 Mann Whitney u Test (Chapters 4, 6 and 7) 
The Mann Whitney u Test is a test used to compare groups when the dependent 
variable is either ordinal or continuous but not normally distributed (Dohoo et 
al., 2010). 
The Mann-Whitney U test is a non-parametric test, hence it does not make any 
assumptions related to the distribution, although the following assumptions are 
made; 
1. The sample drawn from the population is random.
2. Independence within the samples and mutual independence is assumed.
3. Ordinal measurement scale is assumed.
The calculation is as follows, where:
U=Mann-Whitney U test 
N1 = sample size one 
N2= Sample size two 
Ri = Rank of the sample size 
2.7.5 Post Hoc Power Calculations  - 2 Sample t test 
There are two approaches to power analysis, the first is to calculate the 
necessary sample size for a specific power, the second is to calculate the power 
for a given sample size. Sample sizes were based on available data and post hoc 
power calculations were conducted for all of these studies.  
STATA version 8.0 was used to conduct the power calculations and perform the 
two-sample t tests. 
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2.7.6 Kruskall wallis (Chapter 3) 
The Kruskal-Wallis test is non-parametric, rank-based test used to determine 
whether there are statistically significant differences between two or more 
groups of an independent variable on a continuous or ordinal dependent 
variable. 
The calculation is as follows, where: 
Ni is the number of observations in group i 
Rij  is the rank (among all observations) of observation j from group i 
N = is the total number of observations across all groups 
ŕi =  is the average rank of all observations in group i 
ŕ =1/2(ni/N+1) is the average of all the Rij
2.7.7 Wilcoxon signed-rank test (Chapter 4, 6) 
 A Wilcoxon signed-rank test was used to compare the pre-surgery 
concentrations of SAA, haptoglobin and fibrinogen between the horses 
undergoing elective and non-elective surgery because these data were not 
normally distributed. The test is a non-parametric statistical hypothesis test 
which can be used to compare to related samples, matched samples or repeated 
measurements from a single individual. The test is used as an alternative to the 
paired t test for data that is not normally distributed. 
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Chapter 3 
Acute Phase Proteins, Haematological and Clinical 
Biochemistry in Thoroughbred Horses, a “Snapshot” of the 
Normal Horse 
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3.1 Introduction 
The aims of this chapter were as follows: 
1. To determine the serum concentrations of Serum Amyloid A (SAA),
haptoglobin and fibrinogen amongst a representative group of horses, judged to
be clinically normal, from a well-maintained equine breeding and training
establishment.
2. To test the hypothesis that the chosen acute phase proteins are simple to
measure in the Thoroughbred and that normal values of SAA are associated with
currently accepted indices of clinical normality in both sexes and across a range
of ages.
In chapters 1 and 2 acute phase proteins were introduced and the case made for 
their quantification in the horse in a variety of circumstances some with known 
overt pathology and others more concerned with particular circumstances, often 
associated with competition, in which the animals involved are in various ways 
subject to stress. It was important that before embarking on this study 
experience was gleaned of the values and range of values of the chosen acute 
phase proteins in normal healthy animals. The results obtained were intended to 
serve as an independent set of base line values and to explore in outline the 
extent to which gender and age were associated with the average values 
observed. Initially 50 horses were chosen at random, as indicated in chapter 2, 
in a premises with approximately 250 available horses.  It was considered 
necessary to perform this investigation because, at the time the study was 
performed, the measurement of SAA was not routine in equine clinical practice. 
Reference ranges (0-200µg/mL) had been described based on serial examination 
of small groups of horses (Lumsden and Mullen, 1978; Husebekk et al., 1986; 
Pepys et al., 1989; Nunokawa et al., 1993; Hulten et al., 1999), and it was 
generally accepted that serum concentration of SAA could be expected to 
increase up to 1000-fold following inflammation, infection, tissue injury and cell 
necrosis and decline rapidly following recovery in horses (Pepys et al., 1989; 
Hulten et al 1999). However this had never been tested in a group of 
thoroughbreds and never in the geographical location in which the study was 
performed. 
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The acute phase protein concentrations were determined by the methods 
already given. In addition, to serve as more usual indicators of health, standard 
haematological and clinical biochemical measurements, again determined as 
outlined previously, were derived. These measurements are given in Appendix 1. 
Initially no power calculations were attempted with the intention being to see 
what was found and from the results to determine whether greater numbers of 
animals needed to be recruited. Post hoc power calculations were then 
performed and are presented. The animals available were of three age groups, 
foals, young adults and adults. As indicated in Chapter 2 horses were defined as 
foals if they were aged between birth and eight months of age, young adults if 
they were between nine months and four years, and adults if they were aged 
from four years or more. It should be noted that these were based on actual 
time since birth and not the conventional ageing system used for all 
Thoroughbreds that assumes the 1st January as day one of life. The young horses 
sampled, bred for sale, were all weaned, housed individually at night and mixed 
with other individuals of a similar age at pasture during the day. All brood mares 
had foals at foot, were housed individually during the night and mixed with 
other brood mares and foals throughout the day. All of the “in training” group 
had begun pre-training, which involved lunging exercise, with full tack, and 
were managed, from a housing point of view, in the same way as the other 
horses. The details of the horses sampled are given in Appendix 1. This group of 
horses, from an internationally recognised breeding and training establishment, 
was considered to be representative of the typical thoroughbred common to 
Europe, the Americas and Australasia.  
3.1.1 Variation in SAA measurement 
There are a number of potential sources of variation in APP concentration in 
normal horses. These include, but are not limited to, variation between 
individuals, different age groups, sex, breed, and variation based on 
management system, use of the horse, storage and handling of samples, assay 
used and geography. Some of these potential variables are difficult, if not 
impossible to test, and are not tested by the investigation described here. The 
effect of age, sex (Hulten et al., 1999), storage (Hillström et al., 2010), and to 
some extent breed (Pepys et al., 1989) have been described by previous studies, 
albeit based on small numbers of horses, and only age has been consistently 
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shown to result in a small variation in SAA concentration (Hulten et al., 1999) 
Critically all of the previous work investigating SAA concentration in horses 
suggests that an increase in serum concentration of 1000 times or more can be 
expected in response to inflammation, infection, necrosis and trauma  (Pepys et 
al., 1989; Hulten et al., 1999; Pollock et al., 2005; Jacobsen and Andersen, 
2007) and therefore in the clinical setting, a small variability between groups of 
horses based on the variables described are likely to be of little biological 
significance in the detection of abnormal horses. 
3.2 Materials and methods 
3.2.1 Ethics 
Ethical approval for this study was granted by the Ethics and Welfare 
committee, School of Veterinary Medicine, University College Dublin. This 
particular equine premises was chosen due to the numbers of horses available 
and the fact that a routine sampling regimen was already in place, allowing 
surplus samples to be collected for the purpose of this study with minimal 
disruption to the animals and to the routine. The numbers of animals were 
selected based roughly on the proportions of each age group in the general 
population. Within these age groups individual animals were selected randomly 
by placing their stable door number on a card in a box and selecting these by 
yard (i.e mare and foal yard, brood mare yard, young adult yards). 
3.2.2 Experimental design 
This was a prospective analytic cross sectional study, 50 horses of mixed age and 
sex were selected randomly from a population of approximately 250 horses. This 
number was chosen initially as it was the number of horses that could reasonably 
be sampled by one person in one morning while causing minimal disruption to 
the monthly sampling regimen in place on the premises.  
3.2.3 Sample collection 
Full details of the sampling methods, haematology, biochemistry and acute 
phase protein assays are given in Chapter 2-General Materials and Methods.  
Samples were obtained on one occasion in August 2003. 
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3.2.3.1 Acute phase proteins 
The acute phase proteins SAA, haptoglobin and fibrinogen were measured using 
the assays outlined in Chapter 2.  
3.2.3.2 Haematological and clinical biochemistry examination 
Haematological examination included determination of haemaglobin 
concentration (Hb), packed cell volume (PCV), erythrocyte count (RBC), mean 
corpuscular haemaglobin concentration (MCHC), mean corpuscular volume 
(MCV), mean corpuscular haemoglobin (MCH), and a differential white blood cell 
count.  
The following biochemical analytes were also measured: gamma glutamyl 
transferase, alkaline phosphatase, creatinine, urea, total protein, albumin, and 
globulin. These biochemical and haematological analytes were chosen in an 
effort to determine whether any of the horses sampled had evidence of 
infectious or inflammatory disease. 
3.2.4 Clinical examination 
Each horse was observed from a distance (usually over the stable door) for a 
period of not less than one minute; thereafter the animals were caught and 
restrained by the regular handler. A full clinical examination including 
measurement of heart and respiratory rate, rectal temperature, and palpation 
of superficial lymph nodes was performed. In addition, a history was obtained to 
determine whether there had been any evidence of disease in the previous 
month or if veterinary intervention had been sought.  
3.2.5 Data processing and statistical methods 
3.2.5.1 Data processing 
All data were entered into a Microsoft Excel spread sheet (Microsoft Excel for 
mac). Data were checked for errors, consistency and validity using Excel’s 
standard functions. The data were separated into groups based on age, and sex 
and, once a final database was produced, it was imported into SPSS, version 8.0, 
for analysis. Minitab, version 16, and Microsoft Excel for mac, were used to 
produce graphical summaries of the data. 
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3.2.5.2 Statistical methods 
The results were analysed using the statistical package SPSS version 8.0. The 
results from all of the horses sampled were analysed using one-way analysis of 
variance tests.  
3.2.5.2.1 Analysis of variance (ANOVA) 
Analysis of variance (ANOVA) was used to analyse the differences between group 
means and variation among and between groups for SAA and haptoglobin. The 
variance observed in a group of data is partitioned into components attributable 
to different sources of variation. In this study ANOVA was used to assess whether 
or not the means of several groups were equal, and therefore generalizes the t-
test to more than two groups. This is important as performing multiple two 
sample t-tests can lead to an increased likelihood a type 1 error. A t-test was 
also used to analyse the differences between age and sex. 
3.2.5.2.2 Kruskal-Wallis analysis 
The Kruskal-Wallis test (or One-way ANOVA by ranks) is a non-parametric 
equivalent of the ANOVA. The test does not assume normal distribution, unlike 
the one-way analysis of variance. In this test, the null hypothesis is that the 
medians of all groups are equal, and the alternative hypothesis is that at least 
one population median of one group is different from the population median of 
at least one other group. This test was used to analyse the differences between 
age and sex for fibrinogen concentration. 
3.2.5.2.3 Normality testing 
These data were tested for normal distribution using Minitab, version 16 
standard functions. This software uses an Anderson-Darling test of normality to 
assess whether the data are normally distributed. A p-value of greater than 0.05 
suggests that the data are normally distributed.  
3.2.5.2.4 Power calculations 
Post hoc power calculations were performed following data collection to 
determine what change in the concentration of SAA could be detected by the 
test.  Minitab, version 16, standard power calculation functions, were used to 
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perform this analysis. This uses a one sided t-test with a statistical power of 
80%. 
3.3 Results 
Of the 50 animals identified, there were 16 foals (32% of group), 28 young adults 
56% of group) and 6 adults (12% of group). The foals ranged in age from 5 to 8 
months, the young adults from 2 to 3 years, and the adults from 7 to 16 years. 
Of the foals, there were 8 males and 8 females. Amongst the young adults there 
were 17 males and 11 females. All of the adults were female. Six of the foals 
sampled were with the adult mares sampled. Signalment details for the 50 
horses are given in Appendix 1. 
The results of the analysis for the APPs are presented in table 3.1, results for 
haematology and clinical biochemistry are given in Appendix 1. 
3.3.1 Initial Review of Data 
As a first step in examining the data, simple graphical representations of 
selected variables of interest, were produced (Figure 3.1). This was done for a 
number of reasons: firstly examining the data in this way facilitated 
identification of errors or missing values in the data; secondly it helped to guide 
further examination of the data. Of the 50 horses included in the study, a full 
set of data was available for all of them. 
Box plots were produced showing each of the APPs by age group and by sex; the 
concentration of the acute phase proteins, SAA, haptoglobin and fibrinogen are 
shown (Figures 3.2, 3.3, 3.4, 3.5, 3.6 and 3.7).  
3.3.1.1 Method 
Box plots were produced using Minitab, version 16 for each of the variables 
outlined above (Figures 3.2-3.7). A histogram (Figure 3.1), of mean results for 
the 3 acute phase proteins was produced using Excel for mac. These graphical 
representations suggested that the results were similar between the 3 age 
groups for all of the analytes examined except for haptoglobin and fibrinogen 
concentration for which the foals were noted to have a higher concentration 
than the young adult or adult groups (Figures 3.3 and 3.4).  
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Table 3.1. Acute Phase Protein Profile for the General Population, Foals, Young 
Adults and Adults in Group 1  
SAA Haptoglobin Fibrinogen 
(µg/mL) mg/mL (g/L) 
Mean (sd) Mean (sd) Median 
Range Range   Range 
General 
141.9  
(65.22)   1.8(0.58)   3.96  
Population 
n=50 16-­299.5   0.5-­2.7   2.0-­6.0  
Foals 
n=16 
144.92 
(45.27) 
2.21* 
(0.35) 
4.0 
53.5-196.1 1.0-2.7 4.0-6.0 
Young 
adults 
n=28 
149.52 
(73.63) 
1.7 
(0.50) 
3.6 
16-299.5 0.8-2.6 2.0-6.0 
Older 
adults 
n=6 
98.68 
(45.27) 
1.11 
(0.70) 
4.0 
42.5-194.8 0.5-2.4 2.0-4.0 
* Significantly greater concentration than the two older groups, (P=0.01)
The results for fibrinogen were not normally distributed and thus are presented as 
medians with a range. 
67	  
Histogram showing the concentrations of the three APPs for the general population, and 
for the three age groups. Error bars show 95% C.I. for SAA and haptoglobin and 2.5% and 
97.5% percentiles for fibrinogen.
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3.3.2 Normality testing 
The data obtained for each of the acute phase proteins were assessed for 
whether they satisfied the conditions for normal distribution. Minitab, version 16 
was used to produce scatterplots comparing the data to values that would be 
attained by numbers drawn independently from a standard Normal distribution. 
When the points plotted are close to the line along the diagonal, they are close 
to normal; horizontal departures (along the data axis) indicate departures from 
normality. The scatter plots produced demonstrated that the results for SAA and 
haptoglobin were normally distributed; however, the results for Fibrinogen 
concentration were not. 
3.3.3 Statistical analysis and summary 
Haematology and clinical biochemistry results, including the acute phase 
proteins, haptoglobin and fibrinogen, were all within previously reported 
reference ranges described for the domestic equid, Equus caballus. All of the 
results for SAA were within the reference ranges described except for three of 
the young adults. (Lumsden and Mullen, 1978; Taylor-MacAllister et al., 1997; 
Tyler-McGowan et al., 1999). Close inspection of the results including 
haematological, clinical biochemical and clinical examination findings from all of 
the animals included, revealed no analyte or clinical finding, or combination of 
findings, that would lead an experienced clinician to suspect any of these 
animals to be anything other than healthy and normal. The yard manager 
reported that the three young adults with mild increases in SAA concentration 
developed evidence of an upper respiratory tract infection between 5 and 10 
days after sampling. 
There were no significant differences in the concentration of serum amyloid A 
between horses of different ages and sexes (compared using ANOVA), but the 
concentration of haptoglobin was significantly higher in the foals than in the two 
adult groups (P<0·001). There were no significant differences in the 
concentration of fibrinogen between the groups (P=0.435) (these were compared 
using a Kruskal-Wallis analysis as the fibrinogen results were not normally 
distributed). There was no significant difference between the concentrations of 
haptoglobin or fibrinogen in the two adult groups. 
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Figure 3.2 Box plot of SAA concentration for the three groups of normal horses 
The box and whisker plot allows comparison of SAA concentration across the three age 
groups of horses and further shows the maximum, minimum, median and any outliers 
for each group. The horses that later developed an upper respiratory tract infection can 
be clearly seen in the young adult group. 
Figure 3.3 Box plot of Haptoglobin concentration for the three groups of normal 
horses 
The box and whisker plot allows comparison of Haptoglobin concentration across the 
three age groups of horses and further shows the maximum, minimum, median and any 
outliers for each group. 
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Figure 3.4 Box plot of Fibrinogen concentration for the three groups of normal 
horses 
The box and whisker plot allows comparison of SAA concentration across the three age 
groups of horses and further shows the maximum, minimum, median and any outliers 
for each group. 
Figure 3.5 Box plot for SAA concentration comparing females and males 
The box and whisker plot allows comparison of SAA concentration by sex and further 
shows the maximum, minimum, median and any outliers for each group. 
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Figure 3.6 Box plot for haptoglobin concentration comparing females and males 
The box and whisker plot allows comparison of haptoglobin concentration by sex and 
further shows the maximum, minimum, median and any outliers for each group. 
Figure 3.7 Box plot for fibrinogen concentration comparing females and males 
The box and whisker plot allows comparison of fibrinogen concentration by sex and 
further shows the maximum, minimum, median and any outliers for each group. 
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Post hoc power calculations performed using a one sided t-test suggested that 
with an 80% power and with the sample size of 50 animals, a difference in SAA 
concentration of greater than 26.36µg/mL would be identified as a statistically 
significant difference. Based on clinical use of SAA in horses, 1000 fold changes 
in concentration can be expected in abnormal individuals and therefore it was 
considered that from a biological perspective there was sufficient power in the 
study. 
3.4 Discussion 
A composite “snapshot” of the haematology and clinical biochemistry including 
acute phase proteins was carried out in a randomly selected group of clinically 
normal Thoroughbred horses. Haematology and clinical biochemistry results 
were all within previous references ranges described for the domestic equid, 
Equus caballus. The results for the acute phase proteins SAA, haptoglobin and 
fibrinogen were all within the normal range except for the SAA results in three 
horses, which were subsequently reported to have developed a respiratory tract 
infection (Lumsden and Mullen, 1978; Taylor-MacAllister et al., 1997; Tyler-
McGowan et al., 1999).  
There were no significant associations with age or sex for any of the parameters 
that were measured except for haptoglobin, for which were was a significantly 
higher mean concentration in the sub group of foals. However, as there were 
only six horses over the age of 4, these results need to be treated with caution. 
The results indicate that SAA concentration is normally distributed in horses and 
that there are no significant effects of age or sex based on this group of 
Thoroughbreds. This marker of tissue damage has a narrow normal range and 
previous work suggests that it is unaffected by normal handling, season, time of 
day and normal management practice (Pepys and Hirschfield, 2003). 
Investigations in other species support the fact that clinically normal animals can 
be expected to have SAA concentrations within the reference range no matter 
what time of day, season, sex or age they may be (Nunokawa et al., 1993; Satoh 
et al., 1999; Stoneham et al., 2001; Pollock et al., 2005; Hillstrom, 2010). To 
date, the majority of studies have been limited to the measurement of SAA in 
the diagnosis of specific infectious diseases in horses (Pepys et al., 1989; Hulten 
et al., 1999; Stoneham et al., 2001; Hulten 2002; Cohen et al., 2005; Copas et 
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al., 2013), with responsibility for defining the normal range left to individual 
commercial laboratories offering these assays. Definition of normal ranges can 
be complex and requires large groups of animals. They must be defined using 
only healthy individuals. However, in practice, exclusion of abnormal animals or 
those with subclinical disease can be difficult. Various techniques can be used to 
determine a normal range but all require removal of outliers, and determination 
of the distribution of the data and appropriate normalising transformations 
(Shine, 2008). For the purpose of this study, animals were considered to be 
normal if their behaviour upon observation was as expected by their usual 
handler, no abnormalities were identified during routine clinical examination 
and haematological and biochemical parameters were within the normal range. 
It is reasonable to question how representative this group of 50 Thoroughbred 
horses was in comparison to the general population. Every effort was made to 
identify individuals with evidence of disease through clinical examination and an 
extensive history; furthermore, the horses were selected from a management 
system typical of the standard breeding and training establishments across the 
UK and Ireland.  
The ELISA method for determining the concentration of SAA is relatively simple 
and allows for large numbers of samples to be analysed concurrently making the 
test potentially attractive for a commercial laboratory from a financial 
perspective, and to equine clinicians. In order to be an effective test in animals 
with acute disease, it is important that accurate results can be returned quickly. 
Since the work described here was carried out, a number of horse-side SAA tests 
have been developed, some of which provide a numerical result, others which 
simply indicate whether the SAA concentration is within the normal range or not 
(Stablelab, 2015) and these are becoming increasingly popular and useful in the 
identification of abnormal individuals. 
Post-hoc power analysis was performed on the results presented in this chapter. 
Post-hoc power calculations are conducted after a study has been completed, 
and utilise the obtained sample size and effect size to determine what the 
power was in the study, assuming the effect size in the sample is equal to the 
effect size in the population. Whereas the utility of prospective power analysis 
in experimental design is universally accepted, the usefulness of retrospective 
techniques can be controversial (Thomas, 1997). Falling for the temptation to 
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use the statistical analysis of the collected data to estimate the power could 
result in uninformative and misleading values. In particular, it has been shown 
(Hoenig and Heisey, 2001) that post-hoc power in its simplest form is a one-to-
one function of the p-value. In this work, Hoeing and Heisey suggest that that all 
post-hoc power analyses suffer from what is called the "power approach 
paradox" (PAP), in which a study with a null result is thought to show more 
evidence that the null hypothesis is actually true when the p-value is smaller, 
since the apparent power to detect an actual effect would be higher. 
Nevertheless the power calculations performed, interpreted in light of the 
biological relevance of changes in SAA concentration presented in the 
subsequent chapters, suggest that large changes in SAA concentration are to be 
expected in abnormal animals and therefore there is sufficient power in this 
study. 
There are a number of limiting factors when dealing with a group of horses, 
which are by definition non-experimental animals. Nevertheless, with the 
reservation that the relatively small number of horses sampled in this study 
means it is difficult to confirm that the results are normally distributed (despite 
normality testing), all of the results for the acute phase proteins fell within 
previously published reference ranges, except for three individuals with 
relatively small increases in SAA concentration which subsequently developed 
low grade respiratory tract disease (Nunokawa et al., 1993). The low number of 
older adults and adult males in the study group means that larger differences in 
the results from this group might not be statistically significant. This fact would 
be worth considering in any future study. It is also possible that the results were 
subject to an effect of environment common only to this establishment at this 
geographical location. However, it should be noted that the effect of 
environment, location, season and time of day on the concentration of APPs has 
been studied in humans and shown to be of no consequence (Pepys and 
Hirschfield, 2003). In respect of this, these premises were chosen as they 
contained a large population of horses kept extensively, that is to say that the 
majority of the horses sampled were not kept in close proximity to one another, 
nor were all of the horses sampled managed in the same manner, i.e. foals were 
at foot and kept at pasture during the day and housed at night, the young stock 
were housed and in pre-race training. The fact that the animals on the premises 
that were used were already subject to a regular blood-sampling regimen 
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allowed for surplus samples to be collected with minimal effects on animal 
welfare. As in all clinical studies, it would have been of interest to sample 
animals from other sources.  
Access to “real”, that is clinically normal, horses in a standard environment can 
be difficult; equine breeding premises are, by definition, commercial operations 
which rightly protect the welfare of their stock and are often keen to maintain a 
degree of confidentiality. Although the numbers used in this part of the thesis 
are small, they represent a group of “typical” Thoroughbreds bred for the racing 
industry from a well established and respected international operation. 
While it would be dangerous to draw too many conclusions based on the results 
presented in this initial “snapshot” of the serum concentration of SAA in the 
normal Thoroughbred, this pilot work indicates that SAA concentrations appear 
to be low in horses with no clinical, haematological or biochemical evidence of 
disease. SAA is simple to measure and if, as was noted in this group of horses, 
normal horses can be expected to have a low concentration of SAA, SAA could be 
used as a sensitive, although non specific indicator of health. As has been 
described during previous published work, and as will be shown in the 
subsequent chapters, the magnitude of increase in SAA concentration in 
clinically abnormal horses is greater than the observed differences between the 
groups presented here and therefore the measurement of SAA is potentially 
biologically and clinically useful.  These findings form the basis of the in depth 
studies presented subsequently in this thesis. 
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 Chapter 4 
The Effect of Surgery on the Acute Phase Response in Horses
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4.1 Introduction 
Operative surgery can be considered to be goal orientated violence towards 
tissue and a number of authors have demonstrated that surgical intervention 
leads to an acute phase response in horses which can be measured and which 
then reduces during the post operative period (Pollock et al., 2005; Jacobsen et 
al., 2005; Jacobsen et al., 2009; Hillstrom et al., 2010). Surgical trauma leads to 
inflammation that creates a wide range of physiological, biochemical, and 
behavioural changes in animals and in humans. Changes in haematological and 
biochemical parameters have been used to diagnose, monitor, and prognosticate 
the course of disease in horses. However, these analytes are relatively 
insensitive indicators of inflammation (Hillstrom et al., 2010). Changes in serum 
concentration of traditional markers of inflammation, such as fibrinogen and 
haptoglobin, unfortunately, occur relatively slowly in the presence of disease 
and these analytes have a wide normal range (Allen et al., 1988, Pepys et al., 
1989). For this reason, these analytes, although fairly commonly used in 
veterinary clinical practice to diagnose, monitor and determine prognosis, have 
major limitations. 
4.1.1 Searching for the optimum biomarker 
Biological analytes used to indicate the presence of a disease or injury, or to 
prognosticate such pathology are referred to as biomarkers. Clearly the ideal 
biomarker has both high sensitivity and specificity for the disease or traumatic 
damage and for detecting a change in the status of the affected organism and 
for the outcome of the disease or injury (Hsu et al., 2014). However, the 
widespread use of CRP in human medicine as a highly sensitive, but non-specific, 
marker of most forms of inflammation, infection and tissue damage suggests 
that acute phase proteins, although rarely diagnostic in their own right, have a 
major role in the management of disease (Pepys and Hirschfield, 2003). 
Typically a panel of biomarkers is used, or individual biomarkers are used in 
conjunction with haematological and clinical biochemical analytes and / or 
clinical findings. In humans the use of a panel of biomarkers, including CRP, 
fibrinogen and matrix metalloproteinase 7, among others (La Framboise et al., 
2012), is widespread during diagnosis and prognostication of disease. When 
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choosing treatment modalities multiple logistic regression models and ROC 
curves have been used to evaluate the biomarker set (Hsu et al., 2014).  
4.1.2 Acute phase proteins as biomarkers 
Acute phase proteins have the potential to be included in an array of biomarkers 
due to the fact that they, by definition, increase in concentration following 
disease or injury. The acute phase proteins CRP and SAA are stable in blood 
samples obtained in field conditions, have a short half life in serum (Tape et al., 
1990) and are apparently not affected by differences in season, time of day, 
gender or age or general anaesthesia (Pepys and Hirschfield, 2003). In human 
medicine the use of CRP to monitor inflammation (Kordeluk et al., 2016), and to 
quantify the risk of complications following surgery, is well described (Palani 
Velu et al., 2016). CRP has been shown to predict postoperative morbidity 
following oesophageal, gastric and colorectal resections (Warschkow et al., 
2012; Platt et al., 2012). In humans, CRP concentration increases in response to 
infectious, allergic, and inflammatory disease; it is a sensitive marker of tissue 
necrosis, myocardial infarction, pancreatitis and for the presence of malignancy 
Furthermore, CRP concentration has been shown to increase rapidly in response 
to surgery, burns and bone fractures (Pepys and Hirschfield, 2003; Palani Velu et 
al., 2016). Consequently the use of APPs in human clinical practice is now the 
gold standard and routine method for the identification of tissue damage, 
disease and injury (Pepys and Hirschfield, 2003). Despite this, the use of these 
biomarkers has not become routine in veterinary medicine (Pepys and 
Hirschfield, 2003; Jacobsen et al., 2005).  
The Aims of this study were as follows: 
1. To investigate the effect of surgery on the serum concentrations of SAA,
haptoglobin and fibrinogen in horses undergoing surgery for a variety of reasons.
2. To compare the production of SAA and haptoglobin in horses, in response to
surgery, to that of another APP, fibrinogen, which is often regarded as a marker
for inflammation and is widely used in equine clinical practice.
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4.2 Materials and methods 
4.2.1 Study animals, case selection and experimental design 
This was a prospective clinical study in which 25 horses presented for surgery at 
the University Veterinary Hospital, University College Dublin, Dublin, Ireland 
were recruited. The horses were divided into two groups based on whether they 
were presented for Elective (n=18) or Non-elective (n=7) surgery. The numbers 
were entirely dictated by the numbers of animals presented to the University 
Veterinary Hospital during a period of one month in 2003. The surgery was 
considered elective if the horse presented without clinical evidence of 
inflammation and had no evidence of abnormalities during full blood counts and 
serum biochemistry, and non-elective if the horse had clinical evidence of 
substantial pre-existing disease prior to surgical intervention. 
4.2.2 Ethics 
Horses were included in the project with the informed consent of their owners 
and the project was approved by the Faculty of Veterinary Medicine, Ethics and 
Welfare Committee, University College Dublin, Ireland. 
4.2.3 Group 1 
Group 1 consisted of 18 horses subjected to elective surgical procedures. These 
included: closed castration (7), cryptorchidectomy (2), prosthetic laryngoplasty 
and ventriculocordectomy (3), staphylectomy (1), ovariectomy (2), transphyseal 
bridging (2), and a modified Forrsell‘s procedure (1) (Table 4.1.).  
4.2.4 Group 2 
Group two consisted of seven horses with significant pre-existing disease, 
subjected to non-elective surgery. These included: tooth repulsion (4), 
sinusotomy for removal of a sinus cyst (2), and an abscess excision (1) (Table 
4.2.). 
4.2.5 Surgical procedures and anaesthetic protocol 
Details of the general anaesthetic protocol are given in Chapter 2. 
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4.2.6 Sample collection 
Blood was obtained from each horse by jugular venepuncture using a vacutainer 
system. Each horse was restrained by an experienced handler and subjected to a 
clinical examination prior to jugular venepuncture. Clinical examination was 
carried out after blood sampling to reduce any effect of the stress of 
examination and handling on the concentration of the analytes. Each horse was 
sampled when it was admitted to the hospital, at the end of anaesthesia, and at 
12, 24, 48, and 72 hours following surgery. Further samples were not obtained as 
the majority of the animals were discharged from the hospital at this point. 
Samples were obtained to determine full haematology, selected biochemical 
analysis and concentration of the acute phase proteins; fibrinogen, haptoglobin 
and SAA. Blood samples preserved in EDTA and lithium heparin were analysed 
immediately for routine haematological and biochemical anayltes; blood in the 
plain tube was centrifuged at 5000rpm for five minutes, and the serum 
separated into three, 1.5mL aliquots. These samples were stored at –80oC until 
they were analysed for concentration of SAA and haptoglobin. Both acute phase 
proteins are known to be stable when stored at this temperature (Wilkins et al., 
1984) 
Full details of the sampling methods, haematology, biochemistry and acute 
phase protein assays are given in chapter 2.   
4.2.6.1 Acute phase proteins 
The concentration of the acute phase proteins SAA, haptoglobin and fibrinogen 
were determined using the storage protocol and methodology described in 
Chapter 2. 
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Table 4.1. 18 Horses presented for Elective Surgery 
Number Age Sex Breed 
Length of 
general 
anaesthetic 
Reason for 
admission and 
anaesthesia 
position (D or 
L)* 
1 1 year M  TB 34 mins Castration (D) 
2 2 years M  TB 43 mins Castration (D)(cryptorchid) 
3 5 years F  TB 27 mins Castration (D) 
4 4 years M  TB 38 mins Castration (D) (cryptorchid) 
5 4 years M  TB 63 mins Arthroscopy(L) 
9 2 years  TB 25 mins Castration(D) 
10 6 years F  Warmblood 83 mins Crib Bitter(D) 
12 3 years F  TB 75 mins 
Intermittent 
dorsal 
displacement of 
the soft 
palate(D) 
14 4 years F  TB 22 mins Castration(D) 
17 11 years M  TB 91 mins 
Recurrent 
laryngeal 
neuropathy(L) 
18 3 years F  TB cross 98 mins Ovariectomy(D) 
19 6 months M  TB 49 mins 
Angular limb 
deformity(L) 
20 6 months M  TB 59 mins Angular limb deformity(L) 
21 2 years M  TB 36 mins Castration(D) 
22 5 years M 
 Irish 
Draught 106 mins 
Recurrent 
laryngeal 
neuropathy(L) 
23 7 years F  TB 22 mins Castration(D) 
24 2 years M  TB 87 mins 
Recurrent 
laryngeal 
neuropathy(L) 
25 1 year M  TB 32 mins Castration(D) 
* D=dorsal recumbency, L= lateral recumbency
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Table 4.2. Seven Horses Presented for Non-elective Surgery 
Number Age Sex Breed 
Length of 
general 
anaesthetic 
Reason for 
admission 
and 
anaesthesia 
position (D 
or L)* 
6 4 years M  TB cross 45 mins Sinus cyst (L) 
7 4 years M  Highland 108 mins Dental problem (L) 
8 6 years M  TB 124 mins 
Dental 
problem (L) 
11 6 years F  TB cross 62 mins Dental problem (L) 
13 6 years M  TB 75 mins Dental Problem (L) 
15 4 years M  TB 43 mins 
Sinus cyst 
(L) 
16 3 years M  TB 117 mins Neck Abscess (D) 
* D=dorsal recumbency, L= lateral recumbency
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4.2.6.2 Haematological and clinical biochemical examination 
Haematological examination included determination of haemaglobin 
concentration (Hb), packed cell volume (PCV), erythrocyte count (RBC), mean 
corpuscular haemaglobin concentration (MCHC), mean corpuscular volume 
(MCV), mean corpuscular haemoglobin (MCH), and a differential white blood cell 
count. The following biochemical analytes were measured: gamma glutamyl 
transferase, alkaline phosphatase, creatinine, urea, total protein, albumin, and 
globulin.  Total protein concentration was measured at every time point; 
however, the following biochemical analytes were only measured at time point 
one; gamma glutamyl transferase, alkaline phosphatase, creatinine, urea, 
albumin, and globulin. This was in part due to the resources available for the 
project and also because the purpose of performing these tests was to 
determine whether there were any underlying problems not related to the 
presenting disease (non-elective, group 2) or the surgical intervention. Finally, 
SAA, haptoglobin and fibrinogen concentration were also determined at every 
time point. 
4.2.7 Clinical examination 
Each horse was observed from a distance (usually over the stable door) for a 
period of not less than one minute to confirm that the horse was behaving in a 
normal manner, and that there was no external evidence of disease; thereafter 
the animals were caught and restrained by an experienced handler. A full 
clinical examination including measurement of heart and respiratory rate, rectal 
temperature, and palpation of superficial lymph nodes was performed. In 
addition, the surgical sites were closely examined for the presence of 
complications, signs of wound infection or any other abnormalities at least twice 
per day. 
4.2.8 Data processing and statistical methods 
All data were entered into a Microsoft Excel spread sheet (Microsoft Excel for 
Mac 2011). Data were checked for errors, consistency and validity using Excels’ 
standard functions. The data were separated by groups (elective and non 
elective), and once a final database was produced it was imported into Minitab, 
version 16, for analysis. Microsoft Excel for mac 2011 and Minitab, Version 16 
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were used to produce graphical summaries of the data. Exploratory data 
analyses included the production of line graphs and box and whisker plots for 
each of the analytes in order to determine which variables were of interest and 
to determine the distribution of these data.  
Exploratory analyses were conducted to determine whether the data were 
normally distributed and a Mann-Whitney U test was used to compare the 
concentrations of SAA, haptoglobin and fibrinogen between the horses within 
each group. Wilcoxin signed rank tests (for paired analyses) were used to 
compare the differences between horses over time (elective and non-elective 
surgery at selected time points). These tests were chosen because the data were 
not normally distributed. The following time points were selected for analysis 
and are included in the results: SAA, admission and 12 hours after surgery; 
haptoglobin, admission and 24, and 48 hours after surgery; fibrinogen, admission 
and 12 hours after surgery. 
Post hoc power calculations were performed using a 2 sample t-test. 
4.3 Results
4.3.1 Acute phase proteins 
There were measureable increases in the concentrations of all 3 acute phase 
proteins in both the non-elective and the elective surgery groups. However, 
there was considerable variation between each of the three acute phase 
proteins and between individual horses.  Of the three APPs, only SAA 
concentration was noted to increase and decrease during the sampling period, 
although this was not the case for two individuals in the elective group and 
three individuals in the non-elective group. Median acute phase protein results 
for each time point are given in Table 4.3. 
4.3.1.1 Group 1. Elective surgery 
a. Serum Amyloid A
There was a significant increase in the median concentration of SAA within 12 
hours after surgery (P<0·05) in the horses that underwent elective surgery (Table 
4.3). The concentration of SAA reached its peak 24 hours after surgery and 
began to decline after 48 hours in 23 of the horses. For the remaining two horses 
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SAA concentration continued to increase. One of these horses experienced some 
wound drainage and local swelling following castration; the second had more 
incisional swelling and increased drainage around the site of the laryngotomy 
than would normally be expected.  
b. Haptoglobin
The concentration of haptoglobin increased between 24 and 48 hours after 
surgery and began decline in 10 of the horses during the sampling period, but did 
not decline in the remaining 15. A significant difference in median haptoglobin 
concentration was noted after 48 hours (P<0·05). 
c. Fibrinogen
The concentration of fibrinogen increased between 24 and 48 hours after surgery 
in all of the horses in the elective group. The concentration remained elevated 
or continued to rise in 22 of the 25 horses. There was no significant difference in 
median Fibrinogen concentration at any time point (Mann Whitney U test). 
4.3.1.2 Group 2. Non-elective surgery 
a. Serum Amyloid A
In the non-elective surgery group, basal SAA concentrations were all outwith the 
reference range; however, there were significant variations in the values with 
some only mildly increased and others 100 times greater than normal values. 
There was an increase in SAA concentration in all seven horses after surgery with 
a statistically significant increase in the median concentration of SAA after 12 
hours (P<0·05). In four of the horses in the non elective group, SAA 
concentration began to decline during the sampling period; in the remaining 
three horses, a dental extraction, an infected sinus cyst and a neck abscess as a 
result of an infected microchip site, SAA concentration continued to increase. 
Each of these three horses experienced significant complications, and all three 
required further surgical therapy.  
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Table 4.3. Group 1-Elective Surgery. Median results for Acute Phase Protein 
Concentrations at each time point 
SAA 
(µg/mL) 
Haptoglobin 
 (mg/mL) 
Fibrinogen 
(g/L) 
Admission 133(66.5) 2.45(0.75) 4.0(2.0) 
End of anaesthesia 453(668) 2.3(0.75) 4.0(2.5) 
12 Hours 9800(13500) 1.9(0.95) 4.0(2.5) 
24 Hours 19802(7777) 2.1(1.05) 4.0(3.0) 
48 Hours 19220(14530) 2.45(0.75) 4.0(2.0) 
72 Hours 11585(16884) 2.30(0.75) 4.0(1.5) 
Figure 4.1 Box plot showing SAA concentration in the elective surgery group at 
each time point 
SAA concentration was within the reference range for all horses prior to surgery, although there 
was considerable variation in response, a significant increase (P<0.05) was noted within 12 hours 
of surgery. Two horses continued to show increases in SAA concentration during the sampling 
period, both of which experienced complications of surgery. 
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Figure 4.2 Box plot showing haptoglobin concentration in the elective surgery 
group at each time point 
A significant difference in mean haptoglobin concentration was noted after 48 hours (P<0·05), 
however, haptoglobin concentration was quite variable between individual horses and no clear 
pattern of response was observed. 
Figure 4.3 Box plot showing Fibrinogen concentration in the elective surgery 
group at each time point  
The concentration of fibrinogen increased between 24 and 48 hours after surgery in all of the 
horses in the elective group. The concentration remained elevated or continued to rise in 22 of 
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the 25 horses. There was no significant difference in median fibrinogen concentration (P<0·05) 
until 48 hours after surgery. The number of individual values was limited.
b. Haptoglobin
The concentration of haptoglobin was highly variable amongst the elective 
surgery group; however, all of the horses experienced an increased 
concentration between 24 and 48 hours after surgery. There was a significant 
increase in the median concentration of haptoglobin after 48 hours (P<0.05). In 
four of the seven horses, haptoglobin concentration began to decline during the 
sampling period. 
c. Fibrinogen
The concentration of fibrinogen increased in all of the horses following surgery, 
but took between 24 and 48 hours to do so and did not begin to decline during 
the sampling period for any of the horses. There was a statistically significant 
difference in fibrinogen concentration after 48 hours (P<0.05). 
4.3.1.3 Comparison between elective and non-elective surgery 
A Wilcoxin signed rank test was used to compare the concentration of the 3 
acute phase proteins for the elective and non-elective groups at each time 
point. There was a significant difference between the concentration of SAA 
between the two groups but not for haptoglobin or fibrinogen. 
4.3.1.4 Acute phase protein kinetics - Summary 
There was considerable variation in the response to surgery between the two 
groups of horses, and between horses in the same group. However surgery led to 
an increase in SAA, haptoglobin and fibrinogen concentration in all of the horses. 
A pattern of an increase to a peak, followed by a reduction, or a peak followed 
by a reduction and then a further rise were noted for SAA concentration. 
Haptoglobin concentration was too variable to discern a pattern and fibrinogen 
concentration simply increased and remained high throughout the sampling 
period. 
For SAA concentration, the peak response to surgery was particularly variable in 
terms of the time of the peak and whether there was a single peak. However, in 
all of the horses that underwent a decrease and then increase in SAA 
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concentration, or in which SAA concentration continued to increase beyond the 
sampling period (elective group n=2, non elective group n=3) evidence of a 
complication or surgical site infection was noted. 
SAA concentration increased for every horse that underwent surgery, all of the 
horses in the elective group started with normal SAA concentrations and all of 
the horses in the non-elective group had increased SAA concentrations, although 
some of these values were only mildly increased. In general, the magnitude of 
the increase in SAA concentration for the non-elective group was not as great as 
for the elective group suggesting that there may be a peak total response for 
SAA. Based on the small numbers of horses in this study, it could be suggested 
that increased concentrations of SAA always indicate the presence of 
inflammation, or injury and that continued high concentrations in the post 
operative period may be suggestive of a complication. However, based on the 
group with significant pre-existing disease (non-elective group), some of which 
only had very mild increases in SAA concentration, despite the presence of 
disease, normal or near normal SAA concentration does not always rule out the 
possibility of tissue injury. 
All of the horses undergoing non-elective procedures (Group 2), that is, the 
horses with significant pre-existing disease, had a significantly greater median 
concentration of SAA before, and after the surgery, than the horses in Group 1 
(8220µg/mL compared with 133µg/mL) (P<0·05).  
Although basic descriptive statistical analysis was carried out as described, the 
variation in SAA concentration between the groups and between individuals 
within groups made these analyses of limited value. To that end, graphical 
representation of two horses from each group where produced to illustrate the 
SAA response to surgery in horses with and without complications (4.7-4.10). 
4.3.1.5 Haematology 
A range of blood dyscrasias consistent with inflammatory and infectious disease 
were noted in the horses presented for non-elective surgery, these included 
increases in total white blood cell count and neutrophilia. Similarly, alterations 
in mean PCV, total protein and haemoglobin concentration, consistent with 
minor haemorrhage during surgery and the dilution effect of intraoperative fluid 
therapy were noted in both elective and non-elective surgery cases.  
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4.3.1.6 Clinical biochemistry 
Clinical biochemistry results for all of the parameters were measured at 
admission only, as part of a pre-anaesthetic screen. Plasma protein was 
measured at every time point. There were no significant differences from 
reference ranges for any of the biochemical parameters assessed.  
4.3.2 Post hoc power calculations 
Post hoc power calculations were performed in Minitab, version 16 using a 2-
sample t-test. These indicated that with the numbers of animals included in this 
study a difference in SAA concentration of 179 µg/mL or greater could be 
detected with an 80% power as significant at p ≤ 0.05. The biological significance 
of this, based on previously published results and the results of this study 
suggest that changes in SAA concentration in response to disease or injury are 
likely to be of a magnitude much greater than this value. 
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Table 4.4. Group 2- Non-Elective Surgery. Median results for Acute Phase Protein 
Concentrations at each time point 
SAA 
(µg/mL) 
Haptoglobin 
 (mg/mL) 
Fibrinogen 
(g/L) 
Admission 8220(18923) 1.9(1.40) 2.0(0) 
End of anaesthesia 8097(18343) 1.65(0.70) 2.0(0) 
12 Hours 21177(22415) 2.45(1.55) 4.0(1) 
24 Hours 26097(13787) 2.25(1.75) 4.0(1) 
48 Hours 20377(15475) 2.90(0.45) 4.0(2.5) 
72 Hours 21770(11465) 2.50(1.20) 4.0(4) 
Figure 4.4 Box plot showing SAA concentration in the non-elective surgery group 
at each time point  
Surgery resulted in an increase in SAA concentration in all seven horses with a statistically 
significant increase in the median concentration of SAA after 12 hours (P<0·05) 
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Figure 4.5 Box plot showing haptoglobin concentration in the non-elective 
surgery group at each time point 
There was a significant increase in the median concentration of haptoglobin after 48 hours 
(P<0.05). However between individual animals there was considerable variation and it was 
difficult to discern a clear pattern of response 
Figure 4.6 Box plot showing Fibrinogen concentration in the non-elective surgery 
group at each time point  
There was a statistically significant difference in fibrinogen concentration after 48 hours 
(P<0.05). Fibrinogen concentration remained elevated beyond the end of the sampling period for 
all of the horses. 
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Figure	  4.7	  Graph	  showing	  SAA	  concentration	  in	  a	  horse	  subjected	  to	  elective	  surgery	  without	  complications.	  The	  response	  occurred	  within	  12	  hours	  of	  surgery	  and	  began	  to	  decline	  during	  the	  sampling	  period.	  
Figure	  4.8	  Graph	  showing	  SAA	  concentration	  in	  a	  horse	  subjected	  to	  elective	  surgery	  with	  complications.	  The	  response	  occurred	  within	  12	  hours	  of	  surgery	  and	  began	  to	  decline	  before	  rising	  to	  a	  second	  peak,	  then	  declining	  and	  rising	  again	  during	  the	  sampling	  period.	  This	  horse	  experienced	  incisional	  drainage	  and	  swelling	  post	  castration.	  
Figure	  4.9	  Graph	  showing	  SAA	  concentration	  in	  a	  horse	  subjected	  to	  non-­‐‑elective	  surgery	  without	  complications.	  The	  response	  occurred	  within	  12	  hours	  of	  surgery	  and	  began	  to	  decline	  during	  the	  sampling	  period.	  
Figure	  4.10	  Graph	  showing	  SAA	  concentration	  in	  a	  horse	  subjected	  to	  non-­‐‑elective	  surgery	  with	  complications.	  The	  response	  occurred	  within	  12	  hours	  of	  surgery	  and	  SAA	  concentration	  continued	  to	  rise	  during	  the	  sampling	  period.	  This	  horse	  subsequently	  required	  further	  surgery	  for	  a	  neck	  abscess.	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4.4 Discussion  
4.4.1 Introduction 
The results of this study suggest that surgical trauma produces a measurable 
response in SAA concentration in both normal individuals and in those with pre-
existing disease. Following surgery, SAA concentration increased significantly 
within 12 hours and reached peak concentration within 24 hours after which 
point it began to decline in horses without complications, but continued to rise, 
or dropped and then rose again, in horses with complications. Although baseline 
SAA concentration was significantly greater in horses with pre-existing disease, 
the effect of surgical intervention in these animals led to an increase in SAA 
concentration, although not of the same magnitude as that noted in the elective 
group. Thus, horses undergoing surgery with significant pre-existing disease 
(non-elective group) had a much greater median concentration of SAA 
(8220µg/mL) before surgery than the elective surgery horses (133µg/mL). 
Haptoglobin and fibrinogen concentration also responded to surgery and began 
to increase within 24 hours. Haptoglobin concentration was highly variable 
between groups and between horses within groups and no clear pattern was 
apparent. Fibrinogen concentration remained increased without a significant 
decline in serum concentration for at least 72 hours after surgery. Fibrinogen 
concentration results did not vary greatly and relatively few values were 
observed; changes in fibrinogen concentration occurred more slowly when 
compared to the other APPs suggesting this analyte may be of limited value in 
the clinical setting despite its common usage. 
Based on the small numbers of horses in this study, it could be suggested that 
increased concentrations of SAA always indicate the presence of inflammation, 
or injury and that continued high concentrations in the post operative period 
may be indicative of a complication. However, based on the non-elective group, 
some of which only had very mild increases in SAA concentration, despite the 
presence of significant disease, normal or near normal SAA concentration does 
not always rule out the possibility of tissue injury. 
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The use of SAA concentration to diagnose and monitor disease in horses is 
gradually gaining momentum with a number of authors describing the use of 
these analytes (Pepys et al., 1989; Vandenplas et al., 2005; Pollock et al., 2005; 
Jacobsen et al., 2005; Jacobsen et al., 2009; Andersen et al., 2012; Copas et 
al., 2013; Belgrave et al., 2013). However, to date it has not gained the 
widespread acceptance noted in a number of other animal species, including 
cattle, sheep, pigs and dogs, or people (Pepys et al., 1983, Hind and Pepys, 
1987; Hulten et al., 1999; Eckersall et al., 1999b; Stoneham et al., 2001; Hulten 
and Demmers, 2001; Hulten et al., 2002; Cohen et al., 2005; Vandenplas 2005; 
Jacobsen et al., 2005; Jacobsen et al., 2006; Duggen et al., 2007; Jacobsen et 
al., 2009; Eckersall and Bell, 2010).  
The serum concentrations of fibrinogen and haptoglobin have also been used to 
diagnose and monitor disease in horses (Allen et al., 1988), and both are 
sensitive markers that increase in concentration in response to surgical trauma 
(Allen et al., 1988, Auer et al., 1989, Eurell et al., 1993). However, their 
concentrations respond relatively slowly following disease, trauma or infection 
and vary widely in normal horses (Hillstrom et al., 2010).  
The concentration of SAA has been shown to increase in horses with septic 
arthritis, infectious respiratory disease, after castration, and after surgery of 
variable intensity (Hulten et al., 2002, Jacobsen et al., 2005; Jacobsen et al., 
2009), but the distinction between the effects of elective and non-elective 
surgery had not previously been investigated. The results of this study agree 
with previous work indicating that surgical trauma produces an acute phase 
response but that the scale of response varies on the markers used and between 
animals (Allen et al., 1988, Pepys et al., 1989; Ellis and Humphreys, 1992; 
Hulten et al., 1999; Jacobsen et al., 2005; Jacobsen et al., 2009) and, at least 
speculatively, on the presence of, and maybe, duration of, pre existing disease 
or inflammation.  
4.4.2 Developing the test, using SAA concentration in surgical 
practice  
The value of the measurement of SAA concentration to a surgeon in clinical 
practice would be in determining which horses were clearly in the recovery 
phase and not affected by complications such as surgical site infection. In this 
96	  
initial study, SAA concentration rose sharply and quickly following surgery and 
began to reduce by 24 hours after the conclusion of the surgical procedure in 
horses without complications. The clinical signs of early surgical site infection 
can be subtle and are typically only apparent after the infection is well 
established. The ability to identify these animals prior to the development of 
fulminant infection, allowing rapid instigation of treatment, could significantly 
reduce morbidity and in some instances mortality (Rodriguez et al., 2009). 
Unfortunately none of the horses in this study were sampled after 72 following 
surgery, and it would have been very interesting to follow the changes in APP 
concentration further into the recovery period, particularly in the horses that 
suffered complications.   
Other studies, performed subsequent to the work presented here, have 
suggested that SAA is the most sensitive method for identifying inflammation in 
horses (Hillstrom et al., 2010). Based on the findings presented in Chapter 3 and 
in this chapter, one could conclude that clinically normal horses have very low 
SAA concentrations and that SAA concentration increases rapidly, sometimes by 
a factor of at least 10 times normal, in response to an inflammatory stimulus  
A number of specific questions arise, which are not resolved by the present 
study, with respect to the clinical use of SAA concentration; 
1. Are there differences in SAA concentration, including speed of response and
magnitude, based on different surgical procedures?
2. What effect does the presence of surgical complications, including surgical
site infection, have on SAA concentration?
3. Given that it is known that individual differences exist in SAA responses, are
there any particular SAA profiles that can be associated with the development of
a particular complication?
4.4.3 Limitations and further investigation 
This part of the study was very much limited by the type and number of horses 
available for sampling, and by the types of pathologies represented in the non-
elective surgery horses and the limited number of elective procedures. It could 
be of value to extend these studies with larger numbers of animals presented for 
different procedures or perhaps grouped according to the affected body system. 
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In humans CRP concentration is frequently measured in the post-operative 
period in order to identify individuals with complications and to inform 
therapeutic interventions (Palani Velu et al., 2016). From a clinical perspective 
it may be that the magnitude and intensity of the acute phase response is 
affected by the nature of the surgical procedure (Jacobsen et al., 2009). Thus, 
in view of the drive to develop the use of minimally invasive surgery in 
veterinary medicine, it may be that SAA concentration could be used to 
determine the degree of tissue trauma caused by a particular intervention or as 
an aid to identification of post-operative complications such as wound infection 
(Busk et al., 2010). The decline in SAA concentration, noted in some of the 
animals in this study, following surgical trauma suggest that this analyte could 
form part of a minimum database during postoperative monitoring.  In human 
medicine, panels of biomarkers are frequently used to produce a single 
diagnostic or predictive paradigm for a particular disease or surgical outcome 
(Hsu et al., 2014; Palani Velu et al., 2016). However, in human medicine, 
relatively specific surgical specialist groups means that large numbers of similar 
cases can be accumulated quickly, which is in stark contrast to the situation in 
equine veterinary hospitals, in which the case load tends to be more seasonal 
and diverse.  
During examination and statistical analyses of the results, it became apparent 
that the variation in APP response between individuals and between groups led 
to major limitations when using standard statistical comparisons and to that end 
examples of individual horse responses are included alongside a description of 
the response. 
It will be important to investigate a number of specific uses for the 
measurement of SAA concentration. These include, but are not limited to, 
monitoring response to treatment of septic arthritis. In such cases, repeated 
synoviocentesis, to monitor intra-articular inflammation, can be detrimental. 
However, plasma SAA concentration could be monitored and correlated to the 
degree of lameness with relative ease. The use of antimicrobials is a topic that 
has received a great deal of interest, and public scrutiny, since the emergence 
of a number of multi-resistant, and often nosocomial organisms (Boerlin et al., 
2001; O’Mahony et al., 2005). A horse with an increasing plasma SAA 
concentration in the postoperative period should be considered for closer 
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scrutiny or further perioperative antimicrobial therapy whereas perhaps a 
declining profile may inform a prompter cessation of antimicrobial treatment. 
It could be postulated that induction and recovery from anaesthesia and surgical 
positioning could lead to an acute phase response (Ellis et al., 1992). In humans 
and animas the effect of anaesthesia on the acute phase response is believed to 
be negligible (Pepys et al., 1989; Pepys and Hirschfield 2003). Allen et al., 
(1988) demonstrated that anaesthesia had no significant effect on fibrinogen 
production; its’ potential effects on SAA were not investigated, however in the 
study by Pepys et al., (1989) general anaesthesia without surgery had no effect 
on SAA concentration. In the study described here, both groups of horses were 
subjected to the same anaesthetic protocol to minimise any potential effects on 
the results and to at least make any effect uniform across the horses in the 
study. In both groups, it was not possible to distinguish any discernable evidence 
of an effect of general anaesthesia on the acute phase protein concentrations.  
An obvious next step might include the measurement of acute phase protein 
concentration in horses subjected to anaesthesia without surgery, i.e., during 
advanced imaging techniques such as MRI in which horses are routinely 
anaesthetised for long periods without surgical intervention. Unfortunately, 
these types of imaging modalities were not yet widely available at the time 
when the study presented above was performed. Nevertheless, even positioning 
in dorsal or lateral recumbency for short periods of time during anaesthesia can 
lead to increased concentrations of enzymes indicative of muscle damage 
(creatinine kinase and alkaline phosphatase), (Smith et al., 1996). It is 
reasonable to assume that an inflammatory response, and therefore an acute 
phase response, could accompany these types of changes. Similarly, the possible 
dilution effect of the intravenous fluids given during the surgery on the 
concentration of the acute phase proteins was not investigated. However, there 
was a decrease in the mean haemoglobin concentration of the horses undergoing 
elective surgery, probably as a result of haemodilution.  
There are clearly many other factors, common to equine medicine and surgery, 
that could potentially influence the acute phase response, for example, the use 
of antimicrobials, non-steroidal anti-inflammatory drugs, invasive versus non-
invasive surgical procedures and experience of the surgeon. In conclusion, 
separating the effects of anaesthesia, positioning and recovery, and the use of 
99	  
different pharmacological agents from the effect of surgical intervention is likely 
to be extremely challenging. 
No attempt was made to evaluate the prognostic value of the various acute 
phase reactants; this was due to the diverse range of surgical conditions 
affecting the horses presented and the relatively small numbers of animals in 
each group during the study period.  
There is evidence that a specific combination of cytokines is required to induce 
increases or decreases in acute phase reactants (Ramadori et al., 1985; 
Perlmutter et al., 1986; Gauldie et al., 1987; Bauman et al., 1987). The 
significance of this is that particular pathological conditions which lead to the 
production of a unique combination of cytokines may in turn have a unique 
acute phase profile (Ganapathi et al., 1991). As the activity of SAA in diseased 
horses is further characterised and perhaps other equine acute phase markers 
identified, it may become possible to identify an acute phase signature for 
particular pathological conditions and to further use these markers to make 
decisions regarding treatment and prognosis.  
Having established that SAA is an effective indicator of inflammation in horses 
with surgical and therefore acute trauma, the next phase of this work has 
focused on other causes of inflammation, low grade inflammatory conditions and 
infectious disease, and investigates the use of SAA and other acute phase 
reactants as prognostic indicators in horses (Chapters 5, 6 and 7). 
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CHAPTER 5 
Surgical colic and the acute phase response in horses 
Can we improve clinical decision making at admission? 
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5.1 Introduction 
Few clinical syndromes affecting equidae engender as much concern, anxiety 
and fear amongst horse owners, trainers and keepers as colic. The term colic 
refers to any syndrome which includes clinical signs attributable to dysfunction 
or derangement of the gastrointestinal tract and therefore refers to a group of 
diseases with a variety of aetiologies, and with a wide spectrum of severity and 
outcome (Mair, 2002; Marshall and Blikslager, 2012). Fortunately, the majority 
of horses affected by colic have low-grade transient abdominal pain that is self-
limiting or is rapidly ameliorated following the administration of medical 
therapy by a veterinary surgeon (Proudman, 1992). However, a small, but 
significant, minority of horses affected with colic require rapid surgical 
intervention (Hillyer et al., 1997).  
The purpose of surgery in the colicking horse is three fold: 1. Initially to obtain 
or confirm the diagnosis of a lesion requiring surgical intervention; 2. To 
determine the prognosis following treatment; and, finally, 3. To correct, if it 
seems feasible, the abnormality or determine that euthanasia is the most 
appropriate course of action.  
Clinical signs of colic are attributable to varying degrees of intestinal injury, 
which, although principally associated with intestinal ischemia and obstruction, 
can also occur when the intestinal lumen remains patent (Cohen, 2002). A 
spectrum of lesions with variable amounts of vascular compromise and intestinal 
patency are regularly encountered. It is widely recognised that determination of 
the degree of intestinal injury (Snyder, 1989), which occurs prior to and 
following surgical correction of a lesion is critical when attempting to decide 
which horses should be treated, and in turn deciding their prognosis. Surgical 
intervention in horses with gastrointestinal disease is a major undertaking 
financially (Hillyer et al., 1997), in terms of the personnel required and surgical 
skill and experience. Additionally, performing surgery on horses, which 
subsequently perish as a result of intestinal injury and its consequences, has 
significant implications for equine welfare.  
As previously discussed in Chapter 1, a number of groups have focused on the 
identification of a range of laboratory analytes that might provide useful 
information on survival rates at the time of presentation. However, to date, no 
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single variable, or group of variables have been shown to be any more effective 
than measurement of heart rate at presentation alone (Orsini et al., 1989; 
Freden et al., 1989; Pascoe et al., 1990; Reeves et al., 1990; Furr, et al., 1995; 
Blikslager and Roberts, 1995; Thoefner et al., 2000; Senior et al., 2011). This is 
in stark contrast to the situation in a number of clinical syndromes in humans, 
e.g., myocardial disease, gastrointestinal and pancreatic surgery in which the
measurement of a number of acute phase reactants is routinely used to help
determine which treatment modality is most appropriate (Waleczek et al., 1991;
Schillinger et al., 2002; Dhankhar et al., 2011; Palani Velu et al., 2016).
Following on from Chapters 3 and 4, in which it was established that the resting
concentration of the acute phase proteins Serum Amyloid A (SAA), haptoglobin
and fibrinogen are measureable and not highly variable in clinically normal
horses, and that these analytes respond rapidly following disease and surgical
intervention (Pollock et al., 2005), it seems reasonable to speculate that
measurement of these particular APPs could be used to determine the degree of
tissue damage, and therefore likelihood of survival, of horses presented with
surgical colic. Identification of individuals with widespread intestinal ischaemia,
necrosis, and therefore severe systemic compromise, with its associated grave or
hopeless prognosis for survival, prior to the onset of treatment would have
considerable implications during decision making by veterinary surgeons, and
horse owners/keepers and trainers alike. Perhaps most importantly, the ability
to identify these horses without the need for invasive and often pointless
surgical intervention would be of unquestionable value.
5.1.1 Developing a clinical test 
The focus of the work presented in this thesis was to explore whether acute 
phase protein measurements, specifically SAA, should be adopted from a 
position of sporadic use as part of a general panel of biochemical analytes, 
without specific purpose, to a position whereby it could be used as part of a 
targeted panel of biomarkers and clinical parameters to inform decision making 
in a clinical setting for a specific disease or syndrome.  
In order for a test to function clinically, it is critical to define the parameters for 
which the test is intended. In the case of surgical colic these could include: 
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1. Ability rapidly to differentiate between horses with a poor or hopeless
prognosis and those that are likely to respond to treatment
2. Ability to differentiate between horses with medical and surgical colic
3. A test in which results could be available quickly and “horse-side”
5.1.2 Summary and aims 
The Aims of this chapter were as follows: 
1. To determine at intervals, and analyse serum concentration of SAA,
haptoglobin and fibrinogen in horses with surgical colic at the point of
presentation to specialist referral centres to resolution of clinical signs,
euthanasia or death following evaluation and treatment in the centres
concerned.
2. To explore whether APPs, specifically SAA and haptoglobin, can be used
accurately to predict the outcome and likelihood of survival following surgical
intervention in horses with colic and could be used during decision making at the
time of initial presentation.
5.2 Materials and methods 
5.2.1 Experimental design 
This was a prospective clinical study in which horses were recruited at three 
university based equine clinics, The Faculty of Veterinary Medicine, University 
College Dublin, Ireland, The Large Animal Hospital, Royal Veterinary and 
Agricultural University, Copenhagen, Denmark and the School of Veterinary 
Medicine, University of Glasgow. 
5.2.2 Ethics 
The project was approved by the ethics and welfare committees at each 
institution. Owners and keepers, or their agents, were asked to give written 
consent, in the form of a consent form which was clearly explained and signed 
by both the lead clinician and owner, keeper or their agent, prior to collection 
of these clinical data.  
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5.2.3 Study animals 
The animals studied in this Chapter represented a wide range of equine breeds, 
types, and uses. Detailed information on these animals relevant to their 
outcome is given in Tables 5.1 and 5.2.  
5.2.3.1 Case selection 
The selection criteria were as follows: Any horse presented to the equine 
emergency service at any one of the above three clinics between 2003 and 2006 
which was determined to have a lesion which required surgical intervention and 
was thereafter subjected to surgery no matter the surgical outcome and in 
which the author, was either principal or assistant surgeon. During the study 
period, animals presented for the investigation of colic that did not require a 
surgical consultation or subsequent surgical intervention were not included. In 
addition, animals presented and subsequently subjected to euthanasia on 
financial grounds were not included.  
5.2.4 Sampling procedures 
Signalment, historical data, initial examination, surgical findings including the 
position and type of lesion and procedure performed, results of routine ancillary 
diagnostics and outcome were recorded. Blood samples for the acute phase 
reactants SAA, haptoglobin and fibrinogen, total protein (TP) concentration, 
packed red cell volume (PCV) where collected using the methods described in 
Chapter 2, at the following time intervals: presentation, at the end of the 
anaesthetic period or the point of euthanasia, and then at 12, 24, 48 and 72 
hours post surgery assuming the horse survived to each time point. Heart rate 
was also recorded at each time point.  
5.2.5 Anaesthesia 
All of the horses described in this chapter were subjected to general 
anaesthesia. Broadly similar protocols for general anaesthesia were used in all 
three institutions, these represented the standard operating procedure at the 
time of sampling. Details of the protocols are given in Chapter 2. The broad lack 
of effect of anaesthesia, viewed against the perspective of an increase in values 
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due to the surgical procedure itself, on the acute phase response has been 
documented and was discussed briefly in Chapter 4.  
5.2.6 Data processing 
All data were entered into a Microsoft Excel spread sheet (Microsoft Excel for 
mac). Data were checked for errors, consistency and validity using Excel’s 
standard functions. The data were separated into groups based on the outcome 
and once a final database was produced it was imported into STATA, version 
12.1, for analysis. Minitab, version 16, and Microsoft Excel for mac, were used to 
produce graphical summaries of the data. Simple line graphs were initially 
produced to explore variables of interest. Thereafter, box plots were produced 
to further scrutinise these data, these are included. 
5.2.7 Statistical methods 
Full details of the statistical tests performed are given in Chapter 2. 
The relationship between each explanatory variable and each of the two 
possible outcomes 1). surgical survival and discharge, 2). Death or euthanasia 
during anaesthesia or during the post operative period without discharge from 
the hospital, was examined using univariable logistic regression in order to 
identify variables for inclusion in multivariable model(s).  
Comparisons were made between each variable in each of the two outcome 
groups for the values of each analyte or clinical variable obtained at the point of 
admission. The reason for choosing the point of admission was that this is the 
key decision making time when dealing with an animal affected by a surgical 
colic. Restricting analysis to one time point also minimised the risk of Type I 
error by reducing the number of comparisons made.  
5.2.7.1 Univariable analysis 
Examination of Explanatory Variables 
The relationship between the following explanatory variables and the outcome 
variable, euthanasia/death or survival to discharge, were examined: SAA 
concentration, haptoglobin concentration, fibrinogen concentration, total 
protein concentration (TP), Packed red cell volume (PVC), heart rate (HR) in 
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beats per minute, and age. All continuous variables were categorised into 
quartiles in order to examine whether this form of the variable produced a 
better fit in the univariable logistic regression model. The categorical or 
continuous form of each variable that fitted the model best was taken forward 
to the multivariable modelling stage. Where appropriate, 4-level categorical 
forms of variables were collapsed to either 3- or 2-level (binary) variables. Wald 
P values were used to summarise the fit of categorical variables. 
5.2.7.2 Multivariable analysis and model building 
Potential explanatory variables were ordered based on a combination of factors: 
those with the lowest p value and highest odds ratio, biological importance and 
log likelihood value. A manual forward stepwise process was used to build the 
optimal multivariable model(s). Variables were retained within the models if 
their associated p-value was below 0.05.  
Any confounding effect of non-significant variables was examined by forcing 
each into the final multivariable model(s) one at a time. Significant confounding 
was regarded as an alteration in the odds ratio of variables retained within the 
multivariable model(s) of more than 20% (Dohoo et al., 2010). Assessment of 
correlation was an automated feature of model building. Manual assessment of 
correlation was not done as there was no indication from any of the models that 
there was any significant correlation between the variables included in the final 
models. 
5.2.7.3 Receiver operating characteristic curves (ROC) 
ROC analysis is one of the most popular graphical tools for evaluating the 
diagnostic power of a biomarker. It can be used to determine the ability of a 
test to discriminate between animals that are likely to survive a disease or 
syndrome and those that will not. The strength of the ROC analysis is that it 
provides the clinician with ability to view the trend of sensitivity over all values 
of the variable, and thus provides information about the relationship between 
the sensitivity and the specificity of a biomarker at all possible values. ROC 
analysis assesses the “performance” of the diagnostic test in terms of the 
sensitivity and 1-specificity (1-Sp) and therefore allows the user to determine 
the proportion of animals that are correctly classified by the test; this is 
summarised using the area under the curve (Greiner et al., 2000). Receiver 
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operating characteristic (ROC) curves were created to estimate the predictive 
ability of multivariable models and the RocTab function in STATA was used to 
identify the optimal cut-off in different APPs which best differentiated between 
horses that were discharged or not. 
5.2.7.4 Goodness of fit testing 
Goodness of fit testing was performed on the final models using an Homer-
Lemeshow goodness of fit test in STATA version 12.1  
5.2.7.5 Post hoc sample size calculations 
Post hoc power calculations were performed using a 2 sample t-test in Minitab V 
16.
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Table 5.1. Signalment, diagnosis, surgical procedure performed and clinic for the 
21 horses in group 1 
Horse ID 
D=dublin 
C=Copenhagen 
G=Glasgow 
Surgical diagnosis Procedure Age Sex 
23 (D) 
Epiploic foramen 
entrapment 
Resection and 
anastomosis 
15 M 
24 (D) 
Strangulating 
Lipoma 
Resection and 
anastomosis 
17 M 
25 (D) 
Strangulating 
Lipoma 
Resection and 
anastomosis 
25 F 
26 (D) 
Right Dorsal 
Displacement 
Correct 
displacement, 
colon dump 
5 M 
27 (D) 
Right Dorsal 
Displacement 
Correct 
displacement, 
colon dump 
4 M 
28 (D) 
Right Dorsal 
Displacement 
Correct 
displacement, 
colon dump 
2 M 
29 (D) 
Strangulating 
Lipoma 
Resection and 
anastomosis 
16 F 
30 (D) Large Colon Torsion 
Correct 
displacement 
8 F 
31 (D) 
Small intestinal 
volvulus 
Decompress 
lesion 
4 F 
32 (C) 
Left dorsal 
displacement 
Correct 
displacement, 
colon dump 
11 M 
33 (C) 
Right Dorsal 
Displacement 
Correct 
displacement, 
colon dump 
3 F 
34 (C) Ileal impaction 
Decompress 
lesion 
0.5 M 
35 (C) Ceacal impaction Typhlotomy 5 M 
36 (C) 
Small intestinal 
eventration 
Resection and 
anastomosis 
2 M 
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Horse ID 
D=dublin 
C=Copenhagen 
G=Glasgow 
Surgical diagnosis Procedure Age Sex 
38 (C) 
Entrapping 
mesodiverticular 
band 
Decompress 
lesion 
3 F 
39 (G) Peritonitis Open lavage 2 M 
40 (G) 
Right Dorsal 
Displacement 
Correct 
displacement, 
colon dump 
11 M 
41 (G) Strangulating lipoma 
Resection and 
anastomosis 
7 F 
42 (G) Ascarid impaction 
Soften and 
decompress via 
enterotomy 
0.5 M 
43 (G) 
Strangulating 
inguinal hernia 
Resection and 
anastomosis 
18 M 
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Table 5.2. Signalment, diagnosis, clinic and reason for euthanasia for the 38 
horses in group 2 
Horse ID 
D=Dublin Diagnosis Reason for 
Euthanasia 
Age Sex 
1 (D) 
Small intestinal 
volvulus 
Extensive 
lesion 12 F 
2 (D) Large colon torsion 
Severe 
intestinal 
compromise, 
beyond 
boundaries in 
which 
resection 
possible 
16 F 
3 (D) Strangulated 
inguinal hernia 
Severe 
compromise of 
terminal 
iliuem, not 
amenable to 
ressection 
7 months F 
4 (D) Small intestinal 
volvulus 
Extensive 
lesion 
9 M 
5 (D) 
Peritonitis - 
ruptured 
stomach 
Severe 
abdominal 
contamination 
-prognosis 
hopeless
22 M 
6 (D) 
Strangulating 
lipoma 
Extensive 
lesion 26 F 
7 (C) Enterocolitis 
Extensive 
lesion, 
evidence of 
peritonitis 
4 M 
8 (C) Pelvic flexure 
rupture 
Severe 
abdominal 
contamination 
-prognosis 
hopeless
8 F 
9 (C) 
Epiploic 
foramen 
entrapment - 
jejunum 
Extensive 
lesion 7 M 
10 (C) Strangulating lipoma 
Extensive 
lesion 10 F 
11 (C) Strangulating lipoma 
Extensive 
lesion 13 F 
12 (C) Small intestinal volvulus 
Extensive 
lesion aged M 
13 (C) Jejunojenuo intussusception 
Extensive 
lesion 2 months M 
14 (C) 
Ruptured 
stomach 
Severe 
abdominal 
contamination 
-prognosis 
hopeless
3 M 
15 (C) 
Epiploic 
foramen 
entrapment - 
jejunum 
Extensive 
lesion 
7 M 
16 (G) 
Entraping 
mesenteric rent 
- Jejunum
Extensive 
lesion 11 M 
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Horse ID 
D=Dublin Diagnosis Reason for 
Euthanasia 
Age Sex 
17 (G) 
Strangulating 
lipoma 
Extensive 
lesion 17 F 
18 (G) 
Small colon 
enterolith and 
rupture 
Severe 
abdominal 
contamination 
- prognosis
hopeless
5 M 
19 (G) 
Epiploic 
foramen 
entrapment - 
jejunum 
Extensive 
lesion 10 F 
20 (G) Large colon 
torsion 
Severe 
intestinal 
compromise, 
beyond 
boundaries in 
which 
resection 
possible 
13 F 
21 (G) Strangulating lipoma 
Extensive 
lesion 20 M 
22 (G) Strangulating lipoma 
Extensive 
lesion 19 F 
44 (D) 
Colon torsion - 
Resection 
Ileus, severe 
cardiovascular 
compromise 
(24 hours after 
surgery) 
12 F 
45 (D) 
Epiploic 
formamen 
entrapment - 
Ressection and 
anastomosis 
Ileus, severe 
cardiovascular 
compromise 
(48 hours after 
surgery) 
4 M 
46 (D) 
Focal 
eosinophilic 
bands - 
Decompression 
Ileus, severe 
cardiovascular 
compromise 
(12 hours after 
surgery) 
1.5 M 
47 (D) 
Small intestinal 
volvulus - 
Ressection and 
anastomosis 
DIed in 
recovery 
2 M 
48 (C) 
Peritonitis - 
ruptured 
stomach 
Severe ileus 
(48 hours) 5 F 
49 (C) 
Colon torsion - 
Resection 
Ileus, severe 
cardiovascular 
compromise 
(48 hours after 
surgery) 
10 F 
50 (C) 
Epiploic 
formamen 
entrapment - 
Ressection and 
anastomosis 
Ileus, severe 
cardiovascular 
compromise 
(12 hours after 
surgery) 
6 F 
51 (C) 
Right dorsal 
displacement of 
the large colon 
and caecal 
torsion - correct 
displacement, 
tylphlotomy 
Caecal rupture 
(48 hours after 
surgery) 
17 F 
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Horse ID 
D=Dublin Diagnosis Reason for Euthanasia Age Sex 
52 (G) 
Small intestinal 
volvulus - 
Ressection and 
anastomosis 
Rectal tear 
((24 hours 
after surgery) 
6 M 
53 (G) Colon torsion - 
Resection 
Ileus, severe 
cardiovascular 
compromise 
(12 hours after 
surgery) 
14 F 
54 (G) 
Small intestinal 
intussusception 
- Resection and
anastomosis 
Ileus, severe 
cardiovascular 
compromise 
(24 hours after 
surgery) 
6 months F 
55 (G) 
Small intestinal 
volvulus - 
jejunocecal 
anastomosis 
Severe ileus 
(48 hours after 
surgery) 
6 M 
56 (G) 
Epiploic 
formamen 
entrapment - 
Ressection and 
anastomosis 
Ileus, severe 
cardiovascular 
compromise 
(24 hours after 
surgery) 
3 M 
57 (G) 
Right dorsal 
displacement - 
Correct 
displacement, 
colon dump 
Died in 
recovery 19 F 
58 (G) 
Entrapping 
mesodiverticular 
band - jejunum- 
resection and 
anastomosis 
Ileus, severe 
cardiovascular 
compromise 
(12 hours after 
surgery) 
7 M 
59 (G) 
Large colon 
torsion 
Peritonitis (48 
hours after 
surgery) 
13 F 
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5.3 Results 
Fifty nine cases, ranging in age from two months to 26 years were identified. 
There were 25 females and 34 males. Based upon outcome, two groups 
emerged; 
(1) Horses that underwent surgery and survived to be discharged from the
clinic at various time intervals after treatment (n=21)
(2) Horses that died or were euthanised either during general anaesthesia
or during the postoperative period prior to discharge (n=38)
5.3.1 Group 1. Horses subjected to surgery which were subsequently 
discharged from the hospital  
Twenty-one horses, presented for investigation of clinical signs of colic and 
subsequently subjected to exploratory abdominal celiotomy, survived to be 
discharged from one of the three hospitals. The signalment of these animals, 
surgical diagnosis, procedure performed and in which clinic, is given in Table 
5.1. Results for the three APPs and for HR, PCV and TP at admission are given in 
Table 5.3 
There was considerable variation in the concentration of SAA at admission, 
which ranged from 113 µg/mL to 10876 µg/mL, however, 10 of the 21 horses had 
an SAA concentration within the normal reference range (0-22 µg/mL). There 
were three outliers with an SAA concentration more than 100 times normal, each 
of these horses was subsequently noted to have intraoperative evidence of 
significant tissue damage (typhlitis, peritonitis and necrosis of the jejunum). The 
remaining horses had mild increases in SAA concentration (203µg/mL-
547µg/mL). In all 21 horses, changes in SAA concentration followed a broadly 
similar pattern whereby it increased during the initial 12-24 hours before 
beginning to decline. Consequently, mean SAA concentration increased from the 
point of admission, reached peak concentration 24 hours after admission after 
which point it began to decline (Figure 5.1). Haptoglobin concentration was 
within the reference range for 18 of the 21 horses at admission; thereafter the 
concentration increased from the end of anaesthesia and began to decline after 
48 hours (Figure 5.2). The same three outlying horses identified as a result of a 
considerably increased SAA concentration, also had an increased haptoglobin 
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concentration. Fibrinogen concentration was within the reference range for 18 
of the 21 horses at admission and began to increase from the end of anaesthesia 
but did not decline during the sampling period (Figure 5.3). The three outlying 
horses, noted as a result of increased concentration of SAA and haptoglobin, also 
had a fibrinogen concentration outwith the reference range. Heart rate and 
total protein concentration followed a general pattern of reducing from a high 
at admission for all of the horses (Figures 5.4 and 5.5). Total protein 
concentration was variable without evidence of a pattern (Figure 5.6). 
5.3.2 Group 2 horses that died or were euthanised  
Thirty eight horses, presented for investigation of clinical signs of colic and 
subsequently subjected to exploratory abdominal celiotomy, were determined, 
by a European or Royal College of Veterinary Surgeons Recognised Specialist 
surgeon (the author), to have lesions which were not amenable to surgical 
intervention and were therefore subjected to euthanasia during general 
anaesthesia (n=22) or, were considered to have a lesion amenable to treatment 
and were therefore recovered from anaesthesia but subsequently died or were 
euthanised in one of the three hospitals (n=16) (these two groups were 
combined because they had the same outcome and it was therefore considered 
appropriate to analyse them as one group). The signalment of these animals, 
surgical diagnosis and details of which clinic they presented to, is given in Table 
5.2. Results for the three APPs and for HR, PCV and TP are given in table 5.4. 
The concentration of SAA at admission was outwith the reference range for all of 
the horses in group 2. In the subgroup of horses not recovered from anaesthesia, 
the concentration of SAA was increased by a factor of 100 times for a number of 
the horses. 
5.3.3 Graphical comparisons between groups 
Box plots were produced using Minitab, version 16 for each of the explanatory 
variables, at admission, for the two groups of horses. These variables were the 
acute phase proteins, SAA, haptoglobin and fibrinogen, and the clinical and 
haematological analytes, HR, PCV and TP. The purpose of these plots was to 
assess which variable or variables were likely to be of most interest when 
producing models to predict survival. 
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Table 5.3 Results of analytes collected at admission for horses in Group 1 
(survivors) 
Horse ID HR SAA (µg/mL) Haptoglobin (mg/mL) Fibrinogen (g/L) PCV TP 
23 64 346 2 2 46 78 
24 76 178 1.3 2 58 70 
25 68 123 1.4 2 31 69 
26 58 184 1 2 31 58 
27 62 547 1 2 45 62 
28 72 139 2.2 2 35 * 
29 68 370 1.1 1 54 55 
30 86 127 2 2 65 46 
31 76 356 1 2 32 83 
32 52 129 1.2 2 35 78 
33 52 113.5 1.5 2 37 52 
34 84 124 1.5 2 37 41 
35 48 10876 3.2 6 49 52 
36 62 176 1.1 2 45 69 
37 68 203 1.3 2 48 * 
38 80 183 1.6 2 45 62 
39 92 3765 3.9 7 46 54 
40 58 1275 1 2 35 79 
41 76 234 1.6 2 25 62 
42 48 282 0.9 2 26 64 
43 68 645 2.9 4 25 79 
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Table 5.4 Results of analytes collected at admission for horses in Group 2 (non-
survivors) 
Horse ID HR SAA (µg/mL) Haptoglobin (mg/mL) Fibrinogen (g/L) PCV TP 
1 98 2441 2.5 2 48 73 
2 112 3247 2.7 2 52 83 
3 68 2999 3 2 39 66 
4 88 2172 2.4 3 54 54 
5 120 41364 4.5 6 58 72 
6 60 3245 2.9 4 51 70 
7 120 45375 3.4 4 34 69 
8 64 1958 2.4 4 39 67 
9 44 1260 3.2 4 43 58 
10 80 3739 3 4 61 63 
11 68 3136 2.9 3 55 64 
12 82 1953 2.4 3 57 77 
13 80 4273 2.8 2 53 80 
14 32 52568 2.8 6 47 93 
15 52 7150 2.7 2 49 97 
16 102 3484 3.2 3 54 54 
17 28 63790 4.2 6 48 52 
18 64 3055 3 4 43 81 
19 48 1582 2.9 4 55 58 
20 100 3940 2.1 5 67 72 
21 80 2638 2 3 42 57 
22 92 2463 1.8 2 37 85 
44 88 658 2 2 55 89 
45 68 453 1.8 2 62 77 
46 76 3290 2.1 2 48 74 
47 80 789 2.4 2 48 72 
48 80 4573 2.6 2 58 77 
49 108 936 3.3 2 62 85 
50 40 1228 2 2 34 50 
51 52 783 1.4 2 30 61 
52 78 933 3.6 2 48 70 
53 100 952 2.7 2 57 85 
54 88 765 3 2 37 52 
55 58 367 2 2 41 54 
56 78 402 2.4 2 30 49 
57 60 347 2 2 30 58 
58 88 983 1.8 2 48 57 
59 88 8761 2 2 55 74 
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Figure 5.1 Box plot showing SAA Concentration at each time point for the group  
1 horses that survived to discharge 
 
 
 
 
 
 
 
 
There were three outliers, nevertheless SAA concentration followed a broadly similar pattern in 
all of the horses, increasing for 24 hours before beginning to decline. 
Figure 5.2 Box plot showing haptoglobin concentration at each time point for the 
group 1 horses that survived to discharge  
 
 
 
 
 
 
 
 
There was considerable variation in haptoglobin concentration and the same outliers were noted 
as with SAA concentration.   
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Figure 5.3 Box plot showing Fibrinogen Concentration at each time point for the 
Group 1 horses that survived to discharge  
 
 
 
 
 
 
 
 
Fibrinogen concentration was within the reference range for 18 of the 21 horses at admission and 
began to increase from the end of anaesthesia but did not decline during the sampling period. 
Three outliers were noted at admission. 
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As previously noted in the literature, heart rate                                                                          
is commonly noted to decline from the point of                                                             
presentation in surviving horses. 
 
 
 
 
 
 
 
As also previously noted in the literature, PCV also                                                              
declined from the point of presentation in the surviving horses. 
 
 
 
 
 
 
The TP results were difficult to relate directly to the clinical           
findings. 
 
Figure 5.4 Box plot showing 
HR at each time point for the 
Group 1 horses that survived 
to discharge.	  
Figure 5.5 Box plot showing 
PCV at each time point for the 
Group 1 horses that survived 
to discharge.  	  
Figure 5.6 Box plot showing 
TP Concentration at each time 
point for the Group 1 horses 
that survived to discharge. 	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Figure 5.7 Box plot showing SAA concentration for the horses in group 1 and 
group 2 
 
 
 
 
 
 
 
Samples for SAA concentration at admission only were compared. In group 1, a number of 
outliers were identified in horses with particular evidence of tissue necrosis. In group 2, a wide 
range of SAA concentrations were identified at admission reflecting the variety of surgical lesions 
identified and considerable tissue necrosis and inflammation. 
Figure 5.8 Box plot showing haptoglobin concentration for the horses in group 1 
and group 2 
 
 
 
 
 
 
 
 
Samples for haptoglobin concentration at admission only were compared. In group 1, the same 
outliers were identified as with SAA concentration. There was considerable variation amongst 
the group 2 samples; however, these were generally of a greater concentration than those in 
group 1.  
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Figure 5.9 Box plot showing fibrinogen concentration for the horses in group 1 
and group 2 
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Heart rate at admission was generally higher for the non-survivors.  
 
 
 
 
PCV at admission was generally higher for the non-survivors.  
 
 
 
TP concentration was broadly similar for both groups. 
 
Figure 5.10 Box plot showing 
heart rate for the horses in 
group 1 and group 2. 	  
Figure 5.11 Box plot showing 
PCV for the horses in group 1 
and group 2. 	  
Figure 5.12 Box plot showing 
total protein concentration 
for the horses in group 1 and 
group 2. 	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5.3.4 Statistical modelling 
In this study, horses presented for evaluation of clinical signs of colic that were 
subsequently subjected to an emergency abdominal celiotomy were divided into 
two groups based on outcome. A number of alternative statistical analyses were 
performed using multivariable logistic regression models and receiver operating 
characteristic curves (ROC) in order to assess which variables were most strongly 
associated with the outcome, in this case death or survival to discharge. For all 
models, clinical data at admission were used, given that the purpose of this 
study was to determine whether this information could be used to decide 
whether an individual horse should be subjected to surgical exploration. 
The following statistical models were produced in order to determine which 
explanatory variable or variables were associated with the outcome and could 
therefore have potential to predict which horses would not survive. 
5.3.4.1 Horses which survived to be discharged versus horses which 
died or where euthanised (59 observations). 
a. Univariable analysis 
Seven explanatory variables were screened at the univariable level, both as 
continuous variables and as categorical variables. Details of confidence 
intervals, odds ratios and P values are given in Table 5.5. SAA and haptoglobin 
concentration and PCV were found to be significantly associated with death (SAA 
concentration, p=0.03, haptoglobin concentration p<0.001, PCV p=0.01). 
Fibrinogen concentration, age, sex, heart rate, and total protein were not 
significantly associated with outcome (Table 5.5). 
b. Multivariable analyses  
SAA, haptoglobin and fibrinogen concentration were included in a final 
multivariable model (Table 5.6). In this model, Category 2 SAA concentration 
(>350µg/mL) at admission remained a statistically significant predictor for 
survival of horses presented for the investigation of colic with a surgical lesion (P 
= 0.001) haptoglobin (P=0.003) and fibrinogen (P=0.008) concentration were also 
significantly associated with the outcome variable (Table 5.5).  
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Table 5.5 Results for the univariable analyses for each of the seven explanatory 
variables. 
Variable	   OR	   CI	   P	  value	   Dead	   Alive	  
SAA	  (μg/mL)	  
(CONT)	   1.0005	  
1.00005-­‐
1.0009	   0.03	  
38	   21	  
SAA(CAT)	   	  	   	  	   	  <0.001	   	   	  
	  	  	  	  	  	  	  	  113.5-­‐347	   1	   *	   *	   1	   14	  
	  	  	  	  	  	  	  	  356-­‐983	   38.5	   3.75-­‐395.41	   0.002	   11	   4	  
	  	  	  	  	  	  	  1228-­‐8247	   196	   11.12-­‐3453.722	   <0.001	  	  	  	  	  	  
14	   1	  
	  	  	  	  	  	  	  >63790	   84	   6.76-­‐1045.31	   0.001	   12	   2	  	  	   	  	   	  	   	  	   	   	  
Haptoglobin	  
(mg/mL)	  (CONT)	   7.59	   2.59-­‐22.27	   <0.001	  
38	   21	  
Haptoglobin	  (CAT)	   	  	   	  <0.001	   	   	  
	  	  	  	  	  	  	  0.9-­‐1.6	   1	   *	   *	   1	   15	  
	  	  	  	  	  	  	  1.8-­‐2.4	   80	   7.48-­‐856.01	   <0.001	   16	   	  3	  
	  	  	  	  	  	  	  2.5-­‐2.9	   150	   8.38-­‐2685.50	   0.001	   10	   1	  
	  	  	  	  	  	  	  >3	   82.5	   6.62-­‐1028.84	   0.001	   11	   2	  	  	   	  	   	  	   	  	   	   	  
Fibrinogen	  
(g/L)(CONT)	   1.31	   0.82-­‐2.09	   0.255	  
38	   21	  
Fibringen	  (CAT)	   	  	   	  0.1	   	   	  
	  	  	  	  	  	  1.0-­‐2.0	   1	   *	   *	   22	   18	  
	  	  	  	  	  	  3.0-­‐3.0	   3	   0.72-­‐12.42	   0.13	   5	   0	  
	  	  	  	  	  	  >4	   1.22	   0.65-­‐2.28	   0.53	   11	   3	  	  	   	  	   	  	   	  	   	   	  
HR	  (bpm)(Cont)	   1.02	   0.99-­‐1.05	   0.10	   38	   21	  
HR	  (CAT)	   	  	   	  	   	  	  0.009	   	   	  
	  	  	  	  	  	  28-­‐60	   1	   *	   *	   10	   6	  
	  	  	  	  	  	  64-­‐68	   0.33	   0.8-­‐1.54	   0.12	   	  	  	  6	   11	  
	  	  	  	  	  	  79-­‐92	   2.6	   0.52-­‐13.0	   0.25	   13	   3	  
	  	  	  	  	  	  >92	   5.4	   0.54-­‐53.0	   0.15	   	  	  	  	  9	   1	  	  	   	  	   	  	   	  	   	   	  
PCV	  (%)(CONT)	   1.08	   1.02-­‐1.14	   0.01	   38	   21	  
PCV	  (CAT)	   	  	   	  	   	  	  0.02	   	   	  
	  	  	  	  	  	  25-­‐37	   1	   *	   *	   7	   11	  
	  	  	  	  	  	  39-­‐47	   2.2	   0.50-­‐9.75	   0.3	   7	   5	  
	  	  	  	  	  	  48-­‐54	   6.29	   1.30-­‐30.54	   0.02	   12	   3	  
	  	  	  	  	  	  >55	   9.43	   1.60-­‐55.45	   0.01	   12	   2	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Variable	   OR	   CI	   P	  value	   Dead	   Alive	  
TP	  (g/L)(CONT)	   1.04	   0.99-­‐1.08	   0.14	   38	   21	  
TP	  (CAT)	   	  	   	  	   	  	  0.15	   	   	  
	  	  	  	  	  	  41-­‐57	   1	   *	   *	   9	   6	  
58-­‐59	   0.86	   0.21-­‐3.58	   0.83	   9	   7	  
	  	  	  	  	  	  70-­‐77	   7.33	   0.74-­‐72.63	   0.09	   11	   1	  
	  	  	  	  	  	  >78	   1.2	   0.27-­‐5.40	   0.81	   9	   5	  
Age	  in	  years	  
(CONT)	   1.05	   0.41-­‐8.01	   0.25	  
38	   21	  
Age	  in	  years	  	  (CAT)	   	  	   	  	   	  	  0.48	   	   	  
	  	  	  	  	  0.2-­‐4	   1	   *	   *	   10	   9	  
	  	  	  	  	  5.0-­‐7.0	   1.8	   0.40-­‐8.07	   0.44	   8	   4	  
	  	  	  	  8.0-­‐14.0	   3.3	   0.69-­‐15.74	   0.69	   11	   3	  
	  	  	  	  >15	   1.62	   0.39-­‐6.68	   0.39	   9	   5	  
Wald p-values for categorical variables are in bold 
 
Table 5.6 Results for the multivariable analysis including SAA, haptoglobin and 
fibrinogen 
Variable	   OR	   CI	   P	  value	   Dead	   Alive	  
SAACAT2	  (ref	  
<350ng/ml)	  
>350ng/ml	   1	  
60.73	  
*	  
4.97-­‐742.63	  
*	  
0.001	  
	  
	  
1	  
37	  
	  
	  
14	  
7	  
Haptoglobin	   20.28	   0.09-­‐0.70	   0.003	   38	   21	  
Fibrinogen	   0.25	   0.08-­‐0.17	   0.008	   38	   21	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c. Receiver operating characteristic curves  
Receiver operating characteristic curves (ROC) were produced for the final 
multivariable model, (with and without fibrinogen) (Figures 5.13 and 5.14) and 
for SAA and haptoglobin concentration alone respectively, in order to estimate 
an appropriate cut point for optimal sensitivity and specificity when using SAA 
(Figure 5.15) and / or haptoglobin (Figure 5.16) to predict survival in horses with 
clinical signs of surgical colic.  
The area under the curve for SAA concentration was 0.89 and for Haptoglobin 
concentration was 0.84. This suggests that when using these tests one could 
expect 89% and 84% of horses to be classified correctly. 
ROCtab results for SAA concentration suggested that a range of SAA 
concentrations between 347 µg/mL and 453 µg/mL would result in the correct 
classification of approximately 88% of animals, with a sensitivity of 
approximately 97% and a specificity of between 66 and 77%. A range is given 
because in this range sensitivity and specificity vary by very small amounts. For 
haptoglobin a concentration greater than 1.8 mg/mL would result in the correct 
classification of 88% of cases with a sensitivity of 97.37% and a specificity of 
71.43%. A fibrinogen concentration greater than 3 g/L was associated with the 
correct classification of 57.63% of cases with a sensitivity of 42.11% and a 
specificity of 85.71%. 
5.3.5 Goodness of fit testing 
Hosmer–Lemeshow goodness of fit testing was performed on the final model. 
Hosmer-Lemeshow goodness of fit tests failed to identify any evidence of a lack 
of fit of the final model (P-value =0.98). 
5.3.6 Post hoc sample size calculations 
Post hoc power calculations were performed in Minitab, version 16 using a 2-
sample t-test. These indicated that with the numbers of animals included in this 
study a difference of 107 µg/mL or greater in SAA concentration could be 
detected with an 80% power as significant at p<0.05. 
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Figure 5.13 ROC curve for the final model including fibrinogen concentration 	  	  	  	  	  	  	  
 
 
 
The ROC curve is a measure of performance of the test (in the final model including fibrinogen), 
with the area under the curve indicating the percentage of horses (95%) classified correctly (in 
this case animals which do not survive).  
Figure 5.14 ROC curve for the final model excluding fibrinogen concentration 
 
 
 
 
 
 
 
The ROC curve is a measure of performance of the test (in the final model excluding fibrinogen), 
with the area under the curve indicating the percentage of horses (88%) classified correctly (in 
this case animals which do not survive).  
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Figure 5.15 ROC curve for SAA concentration 
 
 
 
 
 
 
 
The ROC curve is a measure of performance of the test (in this case SAA concentration), with the 
area under the curve indicating the percentage of horses (98%) classified correctly (in this case 
animals which do not survive).  
Figure 5.16 ROC curve for haptoglobin concentration 
 
 
 
 
 
 
 
 
The ROC curve is a measure of performance of the test (in this case haptoglobin concentration), 
with the area under the curve indicating the percentage of horses (84%) classified correctly (in 
this case animals which do not survive).  
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5.4 Discussion 
5.4.1 Review of findings 
In the results of these studies, the ability of acute phase proteins, heart rate 
and two haematological parameters, packed red cell volume (PCV) and total 
protein (TP) measurement, to predict the outcome of horses presented for the 
investigation of surgical colic were assessed. These data were grouped according 
to the outcome; either the horses survived to be discharged, or were euthanised 
or died prior to discharge. All of the horses in the group that did not survive had 
an SAA concentration outwith the reference range, by a factor of between 2 and 
100 times, at admission. There was considerable variation in the concentration 
of SAA at admission in the group that did survive to be discharged; however, in 
this group, SAA concentration was considerably less than for those in the non-
surviving group (except for 3 outliers with evidence of marked tissue necrosis).  
In the horses in group 1, in which serial samples were obtained, the behaviour of 
SAA concentration followed the same general pattern of an increase over a 
period of 24 hours followed by a decrease. As described in chapter 4, these 
findings suggest that SAA is a good marker of tissue necrosis and of surgical 
trauma. Haptoglobin concentration was within the normal range for the majority 
of the horses in group 1 (those that survived), although there were several 
outliers. Amongst group 2, the non-surviving group, the majority of horses had a 
haptoglobin concentration outwith the reference range. Fibrinogen 
concentration was more similar across both groups than the other two APPs, 
although there were considerably more outliers.  
A multivariable model suggested that there were significant differences in the 
concentration of SAA, haptoglobin and fibrinogen between the two groups and 
that these markers therefore had the potential to be useful during the decision 
making process.  
ROC curves were produced for the final model, including and not including 
fibrinogen, and for SAA and haptoglobin. The areas under the ROC curves (AUC) 
represent a global summary of diagnostic accuracy. Guidelines suggest that a 
non-informative test has an AUC of 0.5, an accurate test has an AUC of 0.5 to 
0.7, a very accurate test has an AUC of 0.7 -0.9 and a highly accurate test has an 
AUC of 0.9 to 1. The area under the curve for SAA concentration was 0.89 and 
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for Haptoglobin concentration was 0.84. This suggests that when using these 
tests one could expect 89% and 84% of horses to be classified correctly. 
The original intention had been to compare serial APP samples from the 
surviving group with a sub group of horses which survived surgery but were not 
discharged from the hospital. These analyses were undertaken; however, due to 
small numbers in each set and the risks of multiple comparisons, these were left 
out of the thesis. 
5.4.2 Comparison of these findings with previous work 
Previous work to identify and assess variables that could be used to predict 
outcome, and therefore inform decision making in horses with surgical colic, 
have focused on a number of areas. Many of these are related to clinical 
parameters measured during initial clinical examination, including heart rate, 
presence or absence of gastrointestinal borbyrigmi (sounds), results of rectal 
examination, passage of a nasogastric tube, peritoneal fluid examination and the 
measurement of PCV and TP (Freden et al., 1989; Furr et al., 1995; Blikslager et 
al., 1995; Thoefner et al., 2000; Senior et al., 2011). 
There is very little specific work on the use of acute phase proteins to predict 
survival in horses affected by colic (Sandholm et al., 1995), although one study 
suggests that non-survivors had statistically greater concentrations of SAA than 
survivors in a large group of horses (Vandeplas et al., 2005). Recent work by Pihl 
et al., (2015) suggests that SAA and other clinical parameters could be used to 
differentiate between horses that could be treated medically from those which 
should be subjected to surgical intervention.  
5.4.3 Limitations and factors that may have influenced the results 
There are some significant limitations associated with the work presented in this 
Chapter. Principally these relate to the relatively small number of horses. In 
addition, the fact that these data were collected in three different university 
hospitals could have influenced the outcome for the horses based on local 
decision-making and treatment. A similar anaesthetic protocol and the fact that 
all of the procedures were undertaken by the same surgeon, either as principal 
or assistant, may have reduced the effect. Consideration was given to including 
centre as a random effect in the multivariable models, but given the size of the 
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databases and resultant statistical power it was not considered appropriate. In 
the recent similar multicenter study by Pihl et al, (2015), there was no effect of 
centre.  
The effect of anaesthesia on the acute phase response has often been cited as a 
potential problem when interpreting results from horses with inflammatory 
disease that have also been subjected to general anaesthesia. While the effect 
of anaesthesia on SAA concentration was not specifically investigated in our 
study, previous studies by Allen and Kold (1988) indicate that anaesthesia has no 
significant effect on fibrinogen production and on SAA production (Pepys and 
Hirschfield, 2003). The three groups of horses across the three hospitals were 
subjected to the same or a very similar anaesthesia protocol in an attempt to 
minimise any effects on the results.  
One of the aims of this study was to produce a model or models that could be 
used to inform decision making in horses presented for investigation and 
treatment of colic. As stated in the introduction, colic is not a disease in itself, 
but rather a term that describes a set of clinical signs associated with 
gastrointestinal dysfunction. It could be argued that there is considerable 
variation between the diagnosis, and therefore the pathological lesions, of some 
of the horses described in this study. There is no doubt that the power of this 
work could be increased through the inclusion of larger numbers of horses 
affected by the same or very similar lesions. Nevertheless, all of the horses 
described are unified by a common pathology: loss of gastrointestinal integrity 
leading to the urgent requirement for surgical exploration as the apparent 
option for treatment. 
In some of the analyses reported in this study, the explanatory variables which 
remained statistically significant in the final multivariable model had a cut point 
or range of cut points which would make them of limited biological value in the 
clinical situation. In most cases this was because the cut point value was very 
close to normal, or very abnormal, as to be a value which would not be 
commonly encountered in practice. The best example of this was haptoglobin 
concentration, with the model suggesting that a value greater than 1.8 mg/mL 
was associated with death.  
	   132	  
There were a considerable number of outlying results amongst the APPs, and this 
could have had an effect on the interpretation of mean results and in the 
comparisons. These outliers simply reflect the individual nature of the acute 
phase response in all species and of the underlying pathologies. For this reason, 
full results were included alongside a description of the behaviour or individual 
APPs in individual horses. As in human medicine, there is clearly an argument for 
assessing repeated APP results at the individual level (Pepys and Hirschfield, 
2003). 
The use of Kaplan-Meier survival analysis was considered, however, given the 
small numbers in each group and the fact that comparisons were made using the 
admission samples only, it was considered that as this test is a measure of the 
fraction of animals surviving for a certain amount of time after treatment it was 
less appropriate for this study than the models that were utalised. 
5.4.4 What the clinician requires – Statistical significance versus 
biological significance 
For any a test to be adopted and effective in the clinical setting, a number of 
criteria must be satisfied. These include but are not limited to: 
1. The test must be easy to perform and results must be available quickly; in the 
case of colic, decision making is typically measured in minutes (such an SAA test 
has recently become commercially available – StableLab ©). 
2. The test must be sensitive and specific, it is critical to identify as many 
animals that require intervention as possible. The costs in welfare and financial 
terms of operating on horses that do not require surgery are high. 
3. The test should be interpreted against a background of other clinical, 
haematological and biochemical examinations and tests. 
4. The test should be as binary in its output as possible; unfortunately horses 
with clinical signs of colic are difficult to categorise. 
5 The test should be necessary in strengthening clinical decisions in 
circumstances where there is some doubt on the basis of pre-existing tests.  
When attempting to define and validate a marker or markers for clinical 
decision-making, there is always a danger of assessing only one variable in 
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isolation. There is no doubt that, just as in human medicine, acute phase protein 
concentration should not be used in isolation. In many years of research into 
clinical decision making in equine colic, few clinical or haematological and 
biochemical analytes have been able to compete with the predictive value of 
heart rate at the time of admission. Perhaps this is related to the association 
between heart rate and endotoxamia (Senior et al., 2011). Surprisingly, HR did 
not feature strongly in many of the models produced during this study; perhaps 
this is because it is more labile than other markers of survival. 
In chapter 4 it was shown that SAA concentration in horses, just like CRP 
concentration in humans, is a non-specific, rapidly responding marker for tissue 
injury, necrosis and surgical trauma. The findings of this study, in horses with 
colic, confirm that this is the case. However, based on the findings presented 
here, it would be unwise to base a decision on whether to operate on a horse or 
subject it to euthanasia using APP concentration alone. Nevertheless, the 
measurement of APP concentration, and in particular SAA, is likely to be a very 
useful adjunct to other parameters during the investigation and treatment of 
colic.  
5.4.5 Future work 
Future work should concentrate on larger number of horses, grouped by 
diagnosis/surgical lesion or specific syndrome. The inclusion of horses from a 
variety of hospitals would also be of value and appropriate statistical modelling 
that accounts for clustering of horses would be appropriate. Given the myriad of 
objective and subjective measurements commonly recorded in a modern 
specialist veterinary clinic, it is certain that there are other appropriate 
explanatory variables that should be included in future models. In addition, 
proteomic and metabolomics methodology is likely to identify other acute phase 
proteins in the horse in the years ahead, some of which could be included in a 
testing regimen to develop an acute phase signature for predicting the outcome 
for horses with surgical colic. 
Across the field of medicine and veterinary medicine, models to predict survival 
are often generated from data such as those presented in this Chapter. These 
models may effectively describe the results for the data from which they have 
been generated, as is the case here. However, the true test comes when the 
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model continues to predict outcome effectively when used with a different data 
set from that from which it was produced (Berrisford et al., 2005; Zhang et al., 
2013). This is an obvious next step for the models described here.  
5.4.6 Conclusion 
In conclusion, the findings presented here suggest that the acute phase proteins 
SAA and haptoglobin could contribute to decision making in horses presented for 
the evaluation of surgical colic. These markers are likely to be most effective 
when used in combination with more traditional markers of severity such as PCV, 
TP and heart rate as well as a thorough historical and clinical assessment of the 
patient. The findings demonstrate that clinicians can and should combine 
statistically significant and biologically logical findings during acute clinical 
decision-making.  It may be that future work will identify particular colic 
syndromes with a particular acute phase profile or signature. The use of these 
acute phase markers to identify horses with a very poor or hopeless prognosis at 
the point of admission would be of considerable benefit to equine welfare.  
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Chapter 6 
The effect of gastric ulceration on the acute phase 
response- 
Chronicity and the acute phase response 
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6.1 Introduction 
Thoroughbred horses in race training are subject to a variety of stressors. 
These range from the training regimen itself, to frequent transport, mixing 
with unfamiliar individuals, different surroundings, and exposure to infectious 
agents (Cappelli et al., 2013). The presence of these stressors has a variety 
of effects, including sub-optimal performance (Morris and Seeherman, 1991), 
the development of clinical and subclinical disease, modelling of soft tissue 
and bone, that can lead to increased risk of injury, and ultimately, for some 
horses, retirement from racing (Verheyan and Wood, 2004; Smith and 
Goodship, 2008). Wastage from the thoroughbred industry, as a result of sub-
optimal performance, or the presence of disease or injury, overt or 
subclinical, is of significant concern to the industry itself and the public at 
large (Jeffcott et al., 1982; Wilsher et al., 2006; Parkin and Rossdale, 2006). 
Evidence for a link between race training and gastric ulceration has emerged 
in recent years with estimates of prevalence of gastric ulceration ranging 
from 66% (Hammond et al., 1986) to over 90% (Murray et al., 1989) in racing 
Thoroughbreds. Conversely, prevalence of ulceration is reported to be 
negligible in horses turned out to pasture and considerably lower in horses 
used for pleasure riding (37%), (Murray et al., 1989). The effects of moderate 
to severe grades of gastric ulceration appear to be variable. However, there 
is compelling evidence that treatment frequently leads to improved 
performance and amelioration of clinical signs such as poor appetite, loss of 
condition, and colic (Murray, 1988; Murray et al., 1989; Murray, 1992). At 
present, definitive diagnosis of gastric ulceration can only be achieved 
through examination of the stomach with an endoscope, with a minimum 
insertion tube length of 3 metres. In order to effectively evaluate the 
majority of the glandular and squamous portions of the equine stomach, 
horses need to be starved for 24 hours. Prior to the procedure, the 
requirement to withhold feed in horses under training, coupled with the 
necessity to use expensive equipment, has led to the practice of presumptive 
treatment as a means of diagnosis. Effective treatment involves the use of 
the proton pump inhibitor omeprazole (Murray et al., 1997), and although 
effective, there are significant financial implications. 
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The ability to identify horses that have a high probability of being affected by 
gastric ulceration without the need for endoscopic examination would be of 
considerable benefit. 
6.1.1 Pathophysiology of gastric ulceration 
Equine Gastric Ulcer Syndrome (EDUS) is thought to be due to an imbalance 
between inciting and protective factors in the equine stomach (Murray and 
Grodinsky, 1989). A myriad of inciting factors have been identified in horses 
and other species. These include; physiological stress, excessive acid 
production and exposure, diet and dietary management, volatile fatty acid, 
lactic acid and bile acid production, exercise, use of steroidal and non 
steroidal anti-inflammatory drugs, and perhaps infection. To date a firm link 
between gastric ulceration and Helicobacter spp. or other bacterial 
pathogens is yet to be firmly established. Nevertheless, these organisms may 
play a role in delayed gastric healing (Nord, 1988; Green et al., 1991; 
Sanchez, 2004; Nadeau and Andrews, 2009).  The pattern is complicated as 
inciting, as well as protective, factors may be different in the glandular 
versus squamous epithelial regions of the equine stomach (Argenzio, 1999). 
Protective factors include mucosal prostaglandin E2 and epidermal growth 
factor production, maintenance of gastric blood flow, the gastric 
mucous/bicarbonate layer production and gastrointestinal motility (Sanchez 
2004). It is known that horses secrete hydrochloric acid continuously and 
therefore, any mechanism that increases exposure of non-protected gastric 
wall to this acid is likely to lead to an increased risk for ulcerative damage. 
Ulceration of the squamous portion of the equine stomach has been 
compared to gastro-osophageal reflux disease (GERDS) in humans (Argenzio, 
1999). While a sphincter protects the distal portion of the human oesophagus, 
there is no such barrier between the squamous portion of the equine stomach 
and gastric acid. In part, this may account for the anatomical location of 
equine ulcers along the margo plicatus or boundary between glandular and 
squamous epithelial regions (Sanchez, 2004). Ulceration of the squamous 
portion of the equine stomach is more common than the glandular portion. 
Hydrochloric acid damages the outer cell layer and consequently diffuses into 
the stratum spinosum leading to the inhibition of sodium transport resulting 
in cellular swelling and ulceration (Nadeau et al., 2003). 
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6.1.2 Mechanisms of gastric healing 
The physiology of healing following gastric ulceration in horses, particularly 
within the gastric squamous epithelial area, is complex and poorly 
understood. However, healing is a dynamic process and appears to begin 
almost immediately after the onset of ulceration (Murray et al., 2001). 
Epithelial proliferation at the margin of ulcers is accompanied by vascular 
proliferation in the lamina propria and takes place in response to an 
increasing concentration of epidermal growth factor (EGF) (Jeffrey et al., 
2001). A considerable inflammatory response accompanies healing in equine 
gastric squamous epithelium. This includes influx of leucocytes, angiogenesis, 
hyperplasia, wound contracture and re-epithelialisation (Tarnawski et al., 
1990; Szabo et al., 1994) similar to healing in equine skin wounds. 
Upregulation of COX-2 has been noted in horses with experimentally induced 
ulcers in the gastric squamous epithelium (Morrisey et al., 2010); however, 
limited information is available on the types of inflammatory mediators 
present during ulcer healing.  
6.1.3 Summary and aims 
In summary, it is clear that a profound inflammatory response accompanies 
the development and subsequent healing of equine gastric ulcers. As a 
consequence, it seems reasonable to postulate that components of that 
response could be used as biological markers in horses affected by EGUS. 
In light of this the aims of this chapter were as follows: 
1. To test the hypothesis that the concentration of serum amyloid A (SAA), 
haptoglobin and fibrinogen increase in response to the presence of ulceration 
of the equine stomach such that these markers could be used to identify 
individuals that require further screening.  
2. To determine, with measurement of the APPs selected for examination in 
the present study, whether there were any associated changes in routine 
biochemistry or haematology associated with the subclinical disease 
presented by gastric ulceration. 
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6.2 Materials and methods 
6.2.1 Study animals 
This was a prospective clinical study in which 100 Thoroughbred racehorses in 
training were recruited. 100 horses were chosen for initial examination as 
this was the number that could logistically be subjected to serial gastroscopic 
examination in the period of time available for the project, and based on the 
number of trainers that responded to adverts in the lay press and following a 
direct approach. The aim was to make measurements on a representative 
population of Thoroughbred horses. The horses were selected from nine 
separate training establishments in County Kildare, Ireland. Six of these 
trained exclusively national hunt horses, two trained exclusively flat horses 
and one yard contained a mixture of flat and national hunt horses. Animals 
were randomly selected, within yards, using a random number generator 
system based on stable door number. The number of horses from each yard 
was limited to the number of animals that could be comfortably subjected to 
gastroscopy in one day. Details of signalment are given in Appendix 2. Of the 
100 Thoroughbred horses identified, there were 77 males (70 Geldings, 7 
colts) and 23 females. The ages of these horses ranged from 2 to 10 years. 
Each horse was subjected to clinical examination, jugular venopuncture, and 
gastroscopy on three separate occasions. Gastroscopy was performed three 
times in an attempt to determine whether there was variation, over time, in 
the appearance of gastric pathology, if present, and to asses any effect this 
might have on the concentration of the three acute phase proteins. The 
second examination took place four weeks after the first and the third and 
final examination took place six weeks after the second. These data were 
collected between May 2003 and September 2003. 
6.2.2 Ethics 
Ethical approval for this study was granted by the Ethics and Welfare 
Committee, School of Veterinary Medicine, University College Dublin. A 
member of the Health Research Board (undertakes a similar role as Home 
Office Inspector in UK) sat on the committee and oversaw ethical approval 
for the study. Racehorse trainers were contacted through the National 
Trainers Federation of Ireland, and asked to give written consent in the form 
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of a consent form that was clearly explained and signed prior to collection of 
these clinical data. Information regarding clinical findings was shared with 
the trainers following data collection. 
6.2.3 Sampling procedures 
Signalment, historical data, clinical examination, results of serial gastroscopy 
and performance data were recorded in an Excel spread sheet (Microsoft 
Excel for Mac). The level of work for each horse was recorded at each 
sampling point as; rest, light work, moderate work, or full work and coded as 
1, 2, 3, or 4, respectively. In addition, the official handicap for the horse was 
recorded as increasing, decreasing or unchanged and coded 1, 2 or 3, 
respectively.  
Full details of the sampling methods, haematology, biochemistry and acute 
phase protein assays are given in Chapter 2.   
6.2.4 Gastroscopy 
The trainers were instructed to starve each horse for at least 24 hours prior 
to examination, muzzles were provided for this purpose. In all but four 
horses, which required sedation, gastroscopy was performed with the aid of a 
nose twitch. The insertion tube of a three metre video endoscope was 
inserted via the ventral meatus of the right nostril and advanced into the 
pharynx. At this point, the head was flexed and the horse encouraged to 
swallow in order to facilitate passage of the insertion tube of the endoscope 
via the oesophagus to the stomach. The stomach was insufflated with room 
air to facilitate examination of as much of the interior surface as possible.  
Saline was flushed into the stomach, via a trans-endoscopic catheter, in a 
proportion of horses to remove any ingesta that were adherent to the gastric 
wall. The entire stomach was examined and the scope was then retroflexed 
to allow examination of the cardia and fundus. Where possible the pylorus 
was also imaged. During removal of the endoscope, air was insufflated to 
allow examination of the oesophagus. Each examination was recorded on a 
VHS video recorder and tapes were stored for future analysis.  The stomachs, 
or a video recording of the examination, were examined by two individuals 
experienced in the examination of the equine stomach, and the level of 
ulceration, if any, was scored using the system described by Murray et al., 
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(1996)(Table 6.1). Full details of the scoring technique including pictures of 
each grade are given in Chapter 2. For the purpose of this project horses with 
a score of 4 or above were considered to be positive for gastric ulceration. 
This decision was based on the fact that grade 4 on the scale described by 
Murray et al., (1996) is the first grade in which the integrity of the squamous 
epithelium or glandular mucosa is compromised and there is true ulceration. 
At the time the project was carried out, gastric ulceration had only recently 
been identified in horses ante mortem. Indeed the gastroscope used in this 
study was the only one in Ireland at the time. Furthermore, at the time it 
was accepted practice to conflate the scores for the squamous and glandular 
mucosa.  
6.2.5 Data processing 
All data were entered into a Microsoft Excel spread sheet (Microsoft Excel for 
mac). Data were checked for errors, consistency and validity using Excels’ 
standard functions. The data were separated into groups based on the 
outcome variable of interest, gastric ulceration score of 4 or above, and once 
a final data base was produced it was imported into Stata, version 12.1, for 
analysis. Minitab, version 16, was used to produce graphical summaries of the 
data. 
6.2.5.1 Statistical methods 
Full details of the statistical tests performed are given in Chapter 2. 
6.2.5.2 Mann Whitney U test 
A Mann Whitney U test was used to compare the concentration of SAA 
between the horses with and without clinically significant gastric ulceration 
(Score of 4 or more) for each time point because these data were not 
normally distributed. 
6.2.5.3 Wilcoxin signed rank test 
A Wilcoxin signed rank test was used to determine whether any of the 
differences between the median results for ulcer score and SAA 
concentration were statistically significant between time points (Figures 6.1 
and 6.2) 
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6.2.5.4 Univariable analysis logistic regression 
Examination of Explanatory Variables 
The relationships between the following explanatory variables and the 
outcome variable, gastric ulcer score of 4 or above, were examined: SAA 
concentration, haptoglobin concentration, fibrinogen concentration, age, 
sex, type of race (Flat and National Hunt), yard, and work level (rest, light 
work, moderate work, or full work). Analysis was undertaken based on horse- 
sampling episodes, such that each horse was entered more than once. Horse 
was then analysed as a random effect. 
6.2.5.5 Multivariable analysis and model building 
Potential explanatory variables were ordered based on a combination of 
factors: those with the lowest p-value and highest odds ratio, biological 
importance and log likelihood value. A manual forward stepwise process was 
used to build the optimal multivariable model(s). Variables were retained 
within the models if their associated p-value was below 0.05.  
Any confounding effect of non-significant variables was examined by forcing 
each into the final multivariable model(s) one at a time. Significant 
confounding was regarded as an alteration in the odds ratio of variables 
retained within the multivariable model(s) of more than 20% (Dohoo et al., 
2010). 
For the outcome variable, gastric ulceration score of 4 or more, single-level, 
two-level (examination within horse or yard) and three-level models 
(examination within horse and horse within yard) were created to identify 
the best fit for the models and to assess whether unexplained variance was 
still present at the level of horse and or yard. Multi-level analyses also 
allowed for the effect of any elements within yard or horse to be accounted 
for when coefficients for fixed effects were estimated. 
It was recognised that yard and race type overlap to a large extent, however 
these were included as yard was considered a proxy for management and 
race type as a proxy for exercise experience. It was acknowledged that these 
cannot be truly untangled, however, using yard as a random effect sought to 
compensate for variation at an inter-yard level. Race type was included as a 
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fixed effect to explore systematic differences in stress that was hypothesised 
to exist between the disciplines. 
6.2.5.6 Goodness of fit testing 
Goodness of fit testing was performed on the final single-level model using a 
Homer-Lemeshow goodness of fit test in STATA version 12.1.  
6.2.5.7 Receiver operating characteristic curves (ROC)  
ROC curves were produced for each of the three time points for the outcome 
variable gastric ulcer score 4 plus and the explanatory variable SAA 
concentration. Further information is contained in Chapter 2. 
6.2.5.8 Sample size calculation 
A post hoc power calculation with a sample size of 100 divided into 51 cases 
and 49 controls identified that the study would have sufficient power (>80%) 
to identify odds rations of 3.5 or more with 95% confidence, assuming 
prevalence of exposure in the control population between 18 and 55%. 
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Table 6.1. The Scoring System used for Gastric Ulceration in Horses 
Scoring system described by Murray et al., (1996). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Score Squamous mucosa Glandular mucosa 
0 Normal Normal 
1 Mild hyperkeratosis, hyperaemia Focal areas of hyperaemia 
2 
Moderate hyperkeratosis, 
hyperaemia, 1-2 small erosions 
Multifocal hyperaemia, up to 
3 small lesions 
 
3 
Multifocal small erosions, with 
hyperaemia +/- hyperkeratosis 
Multifocal hyperaemia, up to 
three small lesions 
4 
1-4 small ulcers, minimal thickening 
at margin, +/- small erosions 
> 3 small lesions, multifocal 
hyperaemia 
5 
Deeper appearing ulceration, mild 
to moderate thickening of margins, 
+/- bleeding 
1-2 moderate sized lesions, 
hyperaemia 
6 
Multifocal ulceration, mild to 
moderate thickening of margins, +/- 
bleeding 
1-2 large lesions, hyperaemia 
7 
More extensive, deep-appearing 
ulceration, +/- bleeding 
1-2 large lesions, + smaller 
lesions, hyperaemia 
8 
Focal large, deep-appearing 
ulceration, +/- multifocal 
erosions/ulcers, +/- bleeding. More 
extensive and with more changes in 
surrounding tissue than for 7 
1-2 large, deep-appearing 
lesions, +/- smaller lesions, 
hyperaemia 
9 
Extensive, deep ulceration with 
bleeding, covering larger area than 
for 8 
3-4 large, deep-appearing 
lesions, +/- smaller lesions, 
hyperaemia 
10 
Most severe, most extensive, 
deepest-appearing ulceration. 
Active bleeding or evidence of 
recent bleeding. Majority of mucosa 
ulcerated 
5 or more large, deep-
appearing lesions, +/- small 
lesions, hyperaemia 
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6.3 Results 
6.3.1 Overview of gastroscopic findings 
All 100 horses were available and amenable for gastroscopy at time point 1. 
At time point 2, three of the horses were either not available or refractory to 
endoscopy, and at time point 3, 21 of the horses were either not available or 
refractory to endoscopy. In the horses that were available, and in which 
gastroscopy could be performed, the technique was carried out with a 
minimum of three people, including a horse handler, one individual operating 
the endoscopic controls and a final individual passing the scope via the 
ventral nasal meatus of the right nares.  
The horses were separated into groups based on the presence or absence of 
gastric ulceration. A gastric ulcer score of 4 or above was used as the cut off 
point for a diagnosis of gastric ulceration. The results are shown in Table 6.2. 
Of the 100 horses, gastroscopy was accomplished in 76 horses on all 3 
occasions, and in 24 horses on only two occasions. This was either because 
the horse was refractory to endoscopy or had been declared to race and was 
subsequently not available. 15 horses had a gastric ulcer score of less than 4 
on all three occasions, 29 horses had a gastric ulcer score of 4 or more on 
only one occasion, 35 horses had a gastric ulcer score of 4 or more on two 
occasions and 21 horses had a gastric ulcer score of 4 or more on all three 
occasions. No oesophageal abnormalities were identified in any of the horses 
at any of the time points.  
No management changes were instituted in response to the diagnosis of 
gastric ulceration and no treatment was carried out. The reason for this was 
that, at the time the project was undertaken, the significance of gastric 
ulceration in performance horses was poorly understood and no effective 
treatment was available and licensed for use in the horse.  
6.3.2 Gastric pathology 
There was a high prevalence of gastric ulceration with 51-67% of horses 
affected at any one time. A full spectrum of gastric pathology affecting both 
the glandular and squamous epithelium of the stomachs was identified.  
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The lesions identified were predominantly within the squamous epithelium 
adjacent to the margo plicatus. Lesions ranged from mild hyperkeratosis, and 
hyperaemia of the mucosa through moderate ulceration to extensive, deep 
ulceration with active bleeding. In severe cases, lesions were noted 
extending dorsally towards the gastric fundus. In a number of individuals, 
there was evidence of a proliferative margin to the ulcer, indicating healing. 
6.3.3 Supplementary clinical examination results 
Each of the horses that were available for gastroscopy (numbers given 
above), were subjected to a full clinical examination prior to passage of the 
insertion tube of the endoscope. Clinical information, including heart and 
respiratory rate, rectal temperature, mucous membrane colour, capillary 
refill time (CRT), and results of palpation of superficial lymph nodes was 
recorded. As part of the standard history taking procedure, questions were 
asked regarding changes in amount and type of food consumption, 
appearance and regularity of faecal material, evidence of colic or a change 
of behaviour, resistance to tacking up and girthing or unwillingness/ 
resistance to work. In addition, the trainers were asked to provide a recent 
history of any veterinary treatment or the presence of any clinical signs of 
disease. Eleven horses had transient rises in heart rate during the 
examination, three horses had been noted to be lame in the previous month 
but had not been treated. In the remaining horses, all clinical parameters 
were within normal limits. 
6.3.4 Acute phase protein results 
There was a wide range of results for the acute phase proteins, particularly 
SAA which varied from low normal to abnormal results well outside the 
reference range. A considerable number of outliers were identified for each 
time point; based on the data available, no other reason or reasons, other 
than EGUS, for this range of results was identified. 
Median results and ranges for the acute phase proteins and ulcer scores for 
each time point are shown in Table 6.3.  
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Table 6.2.  Gastric Ulceration Findings Over Time 
  Time point 1  Time Point 2  Time Point 3 
Total Horses  100   79   75 
< 4   49   26   31 
≥ 4   51   53   44 
Table demonstrating that 51% (51 of 100 horses) of the horses at time point 1 had evidence 
of clinical gastric ulceration, 67% (53 of 97 horses) of the horses at time point 2 had evidence 
of clinical gastric ulceration and 58% (44 of 75 horses) of the horses at time point 3 had 
evidence of clinical gastric ulceration. 
 
Figure 6.1 Box plot of ulcer score at each time point 
 
 
 
 
 
 
A Wilcoxin signed rank test determined that there was no significant difference between the 
median results for ulcer score at each time point  (P=0.257). The range of ulcer scores was 
broadly similar for each group. 
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6.3.5 Initial review of data 
As a first step in examining the data, simple graphical representations of 
selected explanatory variables of potential interest versus the outcome 
variable, gastric ulcer score of 4 or more, were produced. This was done for a 
number of reasons: firstly, examining the data in this way facilitated 
identification of errors or missing values in the data; secondly it helped to 
guide further examination of the data by identifying patterns and generating 
potential hypotheses for links between possible explanatory variables of 
interest and the outcome variable, gastric ulcer score of 4 or more.  
Of the 100 horses included in the study, a full set of data, that is ulcer score, 
and APP concentration results were available for all of the horses at the 
initial examination. At the second examination, 79 horses had a full data set, 
and by the final examination 75 horses had a full data set. 
6.3.5.1 Method 
Box plots were produced using Minitab V. 16 for SAA, haptoglobin and 
fibrinogen against gastric ulcer score (Figures 6.3-6.11). Based on these 
graphical representations, it was apparent that the SAA concentration was 
the explanatory variable likely to be of interest in relation to the outcome 
variable, gastric ulceration. Box plots were also produced for ulcer score and 
SAA concentration across the three time points (Figures 6.1 and 6.2). 
Following this, the results for SAA concentration at each time point were 
separated based on ulcer of 0-3 or 4 -9 (Table 6.4). 
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Table 6.3 Acute Phase Protein Results and Ulcer Scores in 100 Thoroughbred 
Horses on 3 Occasions over 6 weeks 
  
SAA (ug/mL) 
Haptoglobin 
(mg/mL) 
Fibrinogen 
(g/L) 
Ulcer score 
median 
range 
Median Median  Median 
Range Range Range 
Time Point 
1 
767 1.8 2.0 4 
284-34420 0.5-3.2 1.0-4.0 1-9 
Time Point 
2 
732 1.8 2.0 4 
140-29010 0.1-3.2 1.0-4.0 0-8 
Time Point 
3 
446 1.7 2.0 4 
18.61-27335 0.1-4.0 1.0-4.0 0-9 
 
Figure 6.2 Box plot showing SAA concentration for each time point 
 
 
 
 
 
 
 
A Wilcoxin signed rank test determined that there was no significant difference between the 
median results for SAA concentration at each time point  (P=0.117). The range of SAA 
concentrations was broadly similar for each group, however there were a considerable 
number of outlying results at every time point. 
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Table 6.4 Median SAA results and ulcer scores for each time point for horses 
affected by clinical levels of gastric ulceration (gastric ulcer score >4) and for 
horses not affected by gastric ulceration 
  
SAA (ug/mL) 
Ulcer score 
Median 
Range 
Median 
Range 
 
Time Point 1 1269 5 
Ulcerated 
(n=51) 
126-34420 4-9 
Time Point 1 384 2 
Non-
ulcerated 
(n=49) 
1.0-6475 0-3 
Time Point 2 
Ulcerated 
(n=53) 
756 5 
102-28450 4-9 
Time Point 2 734 2 
Non-
ulcerated 
(n=26) 
170-29010 0-3 
Time Point 3 1927 5 
Ulcerated 
(n=44) 
204-27337 4-9 
Time Point 3 614 2 
Non-
Ulcerated 
(n=31) 
172-12915 0-3 
A Mann Whitney u test was used to compare the concentration of SAA in the ulcerated versus 
non-ulcerated groups at each time point.  There was a significant difference between these 
values for time point 1 and 3 (P<0.000 and P=0.001), but no significant difference for time 
point 2 (P=0.50).
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6.3.6 Statistical association between explanatory and outcome 
variables  
There was a significant association between SAA concentration (p-value = 0.008) 
and an ulcer score of 4 or above across all the observation time points. 
Fibrinogen and haptoglobin concentration were not associated with ulcer score 
at any of the time points. There was a significant difference between SAA 
concentration for horses with and without clinical gastric ulceration for the 
horses at time point 1 and 3, but not time point 2 (Table 6.4).  
6.3.7 Further hypotheses  
Due to the fact that, of the three acute phase proteins measured, only SAA 
concentration was significantly associated with the outcome variable of gastric 
ulcer score of 4 or more, the data were re-organised and examined based on 
whether or not there was an ulcer score and an SAA concentration for each of 
the time points. There was a complete set of data for 57 of the 100 horses. 
Based on the results presented thus far further questions arose. Graphical 
representations of ulcer score versus SAA concentration were reviewed to 
explore this data (Figures 6.1 and 6.2).  
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Figure 6.3 Box plot of SAA concentration vs Ulcer Score at time point 1 
SAA concentration appeared to increase with ulcer score, however there were a considerable 
number of outliers. SAA concentration was significantly associated with an ulcer score of 4 or 
above for all time points (p-value = 0.008). 
Figure 6.4 Box plot of SAA concentration vs Ulcer Score at time point 2 
SAA concentration was significantly associated with an ulcer score of 4 or above for all time 
points (p-value = 0.008). Again there were a considerable number of outlying results. 
Figure 6.5 Box plot of SAA concentration vs Ulcer Score at time point 3 
SAA concentration was significantly associated with an ulcer score of 4 or above for all time 
points (P value = 0.008). A number of outliers are visible; the reason for these is unknown. 
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Figure 6.6 Box plot of Haptoglobin concentration vs Ulcer Score at time point 1 
Haptoglobin concentration was not significantly associated with any ulcer score. The results 
appeared similar across the range of scores. 
Figure 6.7 Box plot of Haptoglobin concentration vs Ulcer Score at time point 2 
Haptoglobin concentration was not significantly associated with any ulcer score. The results 
appeared similar across the range of scores. 
Figure 6.8 Box plot of Haptoglobin concentration vs Ulcer Score at time point 3 
Haptoglobin concentration was not significantly associated with any ulcer score. The results 
appeared similar across the range of scores. 
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Figure 6.9 Box plot of Fibrinogen concentration vs Ulcer Score at time point 1 
Fibrinogen concentration was not significantly associated with any ulcer score. The results were 
very variable across each ulcer score. 
Figure 6.10 Box plot of Fibrinogen concentration vs Ulcer Score at time point 2 
Fibrinogen concentration was not significantly associated with any ulcer score. The results were 
very variable across each ulcer score. 
Figure 6.11 Box plot of Fibrinogen concentration vs Ulcer Score at time point 3 
155	  
6.3.8 Model building 
Univariable analysis 
Of the nine explanatory variables screened at the univariable level, three were 
taken forward for consideration in each of the manual forward stepwise 
analyses. These variables were SAA concentration, race type and work level. 
Multivariable analysis 
In the final multivariable models, SAA concentration and race type were found 
to be significantly associated with the outcome variable, gastric ulcer score of 4 
or more. 
Because the relationship between the explanatory variable SAA concentration 
and the outcome variable, gastric ulcer score of 4 or more, was non-linear, SAA 
concentration was separated into quartiles (Table 6.5). For each multivariable 
model the 1st and 2nd quartiles, represented an SAA concentration of 0.5 µg/mL 
to 771µg/mL. The third quartile represented an SAA concentration of 772µg/mL 
to 2185µg/mL and the 4th quartile represented an SAA concentration of 
2186µg/mL to 34420µg/mL.  
A single level, multivariable logistic regression model was created,  (Table 6.5) 
describing the association between the explanatory variables SAA and race type 
and the outcome variable, ulcer score 4 plus. SAA concentration in the 3rd 
(P=0.03, O.R. 2.04, C.I.1.08-3.85) and 4th (P=0.001, O.R. 4.32, C.I. 2.14-8.72) 
quartiles was significantly associated with a gastric ulcer score of 4 or above as 
was race type with flat race training significantly associated with an ulcer score 
of 4 or above (P=0.002, O.R. 4.87, C.I. 1.78-13.36). 
Two-level, multivariable logistic regression models were created to describe the 
association between the explanatory variables SAA and race type and the 
outcome variable, ulcer score 4 plus. In these models, horse or yard were 
included as a random effect to account for the fact that multiple examinations 
were performed on each horse at the three different time points (horse level 
Rho = 0.37, p-value = 0.001), and to account for the fact that the 100 study 
horses were distributed between nine different yards (Yard level Rho = 0.08, p-
value = 0.027), (Tables 6.6 and 6.7). 
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In the first two level model, in which any clustering within horse was accounted 
for, SAA concentration in the 3rd (P=0.049, O.R. 2.34, C.I.1.00-5.89) and 4th 
(P=0.001, O.R. 7.67, C.I. 2.67-22.04) quartiles were significantly associated with 
a gastric ulcer score of 4 or above as was race type with flat race training 
significantly associated with an ulcer score of 4 or above (P=0.007, O.R. 7.54, 
C.I. 1.72-32.93), (Table 6.7).
In the second two level model, in which any clustering within yard was 
accounted for, SAA concentration in the 3rd (P=0.046, O.R. 1.99, C.I.1.01-3.92) 
and 4th (P=0.001, O.R. 4.70, C.I. 2.23-9.92) quartiles were significantly 
associated with a gastric ulcer score of 4 or above as was race type with flat 
race training significantly associated with an ulcer score of 4 or above (P=0.022, 
O.R.4.76, C.I. 1.25-18.04), (Table 6.7). 
A three level multivariable logistic regression was also performed taking into 
account clustering within horse within yard (Table 6.8a). This model describes 
the association between the explanatory variables SAA and race type and the 
outcome variable, ulcer score 4 plus. In this model, quartile 4 was compared 
with an aggregate of quartiles 1-3 indicating that SAA concentration significantly 
predicts an ulcer score of 4 or more (P =0.001, O.R. 5.69, C.I. 2.12-15.27). When 
the effect of race type (Flat vs National Hunt) was included the effect remained 
significant (P=0.024, O.R. 7.47, C.I. 1.30-43.01). 
The final model was an alternative analysis using three-level, multivariable 
logistic regression (Table 6.8b) to describe the association between the 
explanatory variable SAA and the outcome variable, ulcer score of 4 or more. In 
this model SAA concentration per increase of 1000 units associated with an ulcer 
score of 4 or above (P <0.005, O.R. 1.12, C.I. 1.04-1.22). For every extra 1000 
unit increase in SAA concentration, the likelihood of an ulcer score of 4 or more 
increased by 1.12 times (12%). When the effect of race type (Flat vs National 
Hunt) was included the effect remained significant (P=0.02, O.R. 7.01, C.I. 1.35-
36.29). 
Hosmer–Lemeshow goodness of fit testing was performed on the final single-level 
model. Hosmer-Lemeshow goodness of fit tests failed to identify any evidence of 
a lack of fit of the final model (p-value =0.99). 
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Table 6.5 Single-level, multivariable logistic regression model describing the 
association between explanatory variables SAA and race type and the outcome 
variable, ulcer score four plus (based on 106 non ulcerated and 148 ulcerated 
observations). 
Variable Odds ratio P-value 95% confidence interval 
SAA 1st and 2nd quartiles (0.5 to 771) 
SAA 3rd quartile (772 to 2185) 
 
SAA 4th quartile (2186 to 34420) 
1(reference) 
2.04 
 
4.32 
 
0.03 
 
<0.001 
 
1.08 – 3.85 
 
2.14 – 8.72 
Flat race training 
No 
Yes 
 
1 (reference) 
4.87 
 
 
0.002 
 
 
1.78 – 13.36 
SAA concentration in the 3rd and 4th quartiles and Race type, in this case flat race training, 
were significantly associated with an ulcer score of 4 or more. 
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Table 6.6 Two-level, multivariable logistic regression model describing the 
association between explanatory variables SAA and race type and the outcome 
variable, ulcer score four plus (based on 106 non ulcerated and 148 ulcerated 
observations). 
Horse is included as a random effect to account for the fact that multiple examinations were 
performed on each horse at three different points in time. (Horse level Rho = 0.37, p-value = 
0.001).  
Variable Odds ratio P-value 95% confidence interval 
SAA 1st and 2nd quartiles (0.5 to 771) 
SAA 3rd quartile (772 to 2185) 
SAA 4th quartile (2186 to 34420) 
1(reference) 
2.34 
7.67 
0.049 
<0.001 
1.00 – 5.48 
2.67 – 22.04 
Flat race training 
No 
Yes 
1(reference) 
7.54 0.007 1.72 – 32.93 
159	  
Table 6.7 Two-level, multivariable logistic regression model with yard fitted as a 
random effect, describing the association between explanatory variables SAA 
and race type and the outcome variable, ulcer score four plus (based on 106 non 
ulcerated and 148 ulcerated observations). 
Variable Odds ratio P-value 95% confidence interval 
SAA 1st and 2nd quartiles (0.5 to 771) 
SAA 3rd quartile (772 to 2185) 
SAA 4th quartile (2186 to 34420) 
1(reference) 
1.99 
4.70 
0.046 
<0.001 
1.01 – 3.92 
2.23 – 9.92 
Flat race horse 
No 
Yes 
1(reference) 
4.76 0.022 1.25 – 18.04 
Yard is included as a random effect to account for the fact that the 100 study horses were 
distributed between nine different yards. (Yard level Rho = 0.08, p-value = 0.027).   
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Table 6.8a Three-level, multivariable logistic regression model describing the 
association between explanatory variables SAA and race type and the outcome 
variable, ulcer score four plus (based on 106 non ulcerated and 148 ulcerated 
observations). 
Variable Odds ratio P-value 95% confidence interval 
SAA 1st, 2nd and 3rd quartiles (0.5 to 
2185) 
SAA 4th quartile (2186 to 34420) 
1(reference) 
5.69 
 
0.001 
 
2.12 – 15.27 
Flat race horse 
No 
Yes 
 
1(reference) 
7.47 
 
 
0.024 
 
 
1.30 – 43.01 
Yard is included as a random effect to account for the fact that the 100 study horses were 
distributed between nine different yards and horse is included as a random effect to account for 
the fact that multiple examinations were performed on each horse at three different points in 
time. (Examination nested within horse which is nested within yard).  (Horse level Rho = 0.3843, 
yard level Rho = 0.0729, overall  p-value for random effects = 0.0016).   
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Table 6.8b Alternative analysis, three-level, multivariable logistic regression 
model describing the association between explanatory variables SAA and race 
type and the outcome variable, ulcer score four plus (based on 106 non 
ulcerated and 148 ulcerated observations). 
Variable Odds ratio P-value 95% confidence interval 
SAA (per 1000 units) 1.12 0.005 1.04 – 1.22 
Flat race horse 
No 
Yes 
1(reference) 
7.01 0.02 1.35 – 36.29 
Yard is included as a random effect to account for the fact that the 100 study horses were 
distributed between nine different yards and horse is included as a random effect to account for 
the fact that multiple examinations were performed on each horse at three different points in 
time. (Examination nested within horse which is nested within yard).  (Horse level Rho = 0.3385, 
yard level Rho = 0.0729, overall  p-value for random effects = 0.0046).   
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6.3.9 Receiver operating characteristic curves (ROC)  
The aim of the study was to determine whether SAA concentration could be used 
in a clinical setting to identify horses that should be subjected to gastroscopy. In 
order for this test to be clinically robust, it would require to have a high 
sensitivity for detecting horses with ulceration, in other words there would need 
to be few false negatives when using SAA as a test for ulceration. Receiver 
operating characteristic curves (ROC) were produced to determine what 
concentration of SAA could be considered as a likely cut point for a gastric ulcer 
score of 4 or above for all horses (Figure 6.12) and for flat and national hunt 
trained horses respectively (Figures 6.13 and 6.14). Roctab results suggested 
that a concentration range for SAA of 642µg/mL to 950µg/mL has the best 
combination of sensitivity and specificity and is likely to correctly classify over 
60% of horses. A range is given because at these concentrations sensitivity and 
specificity vary by very small amounts. 
The areas under the ROC curves (AUC) represent a global summary of diagnostic 
accuracy. Guidelines suggest that a non-informative test has an AUC of 0.5, an 
accurate test has an AUC of 0.5 to 0.7, a very accurate test has an AUC of 0.7 -
0.9 and a highly accurate test has an AUC of 0.9 to 1. In the study described, the 
areas under the ROC curves were 0.67, 0.69 and 0.67 respectively. This indicates 
that 67%, 69% and 67% of animals would be classified correctly using this model. 
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Figure 6.12 ROC Curve demonstrating the relationship between Ulcer Score 4 
and above and SAA concentration at Time Point 1   
 
 
 
 
 
 
 
 
The ROC curve is a measure of performance of the test, with the area under the curve indicating 
the percentage of horses (67%) classified correctly (in this case animals with a gastric ulcer score 
of 4 or more).  
Figure 6.13 ROC Curve demonstrating correlation between Ulcer Score 4 and 
above and SAA concentration for horses trained for Flat racing 
 
 
 
 
 
 
 
 
The ROC curve is a measure of performance of the test, with the area under the curve indicating 
the percentage of horses (69%) classified correctly (in this case animals with gastric ulceration).  
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Figure 6.14 ROC Curve demonstrating correlation between ulcer score 4 and 
above and SAA concentration for horses trained for National Hunt racing 
  
 
 
 
 
 
 
 
The ROC curve is a measure of performance of the test, with the area under the curve indicating 
the percentage of horses (67%) classified correctly (in this case animals with gastric ulceration).  
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6.3.10 Power calculations 
Power calculations performed following data collection based on a prevalence of 
gastric ulceration in the range present over the 3 time periods (51-69%) 
suggested that between 66 and 83 horses were required to identify significant 
odds ratios of the magnitude observed in the final models.   
6.4 Discussion 
6.4.1 Summary of findings 
In this Chapter a population of 100 Thoroughbred horses in training were 
subjected to serial gastroscopy, and acute phase protein analysis. There was a 
high prevalence of gastric ulceration with 51-67% of horses affected at any one 
time. A number of alternative analyses were performed using multivariate 
logistic regression methods and at all three examination time points there was a 
statistically significant, although variable, association between SAA 
concentration and a gastric ulcer score of 4 or above. In addition to this Flat 
Racehorses were shown to be at increased risk of having a gastric ulcer score of 
4 or above. Work level was also shown to be a risk factor for the presence of 
gastric ulceration of grade 4 or above but was only present at the univariable 
level. A cut point was established using ROC curves whereby an SAA 
concentration range of 642µg/mL to 950µg/mL could indicate the presence of a 
gastric ulcer score of 4 or above with a sensitivity of 63% and a specificity of 
62%. The results describe the extent to which SAA concentration is associated 
with gastric ulceration. However, the association was not strong and varied 
between time points. A considerable number of outlying results were identified 
at each time point; the reason or reasons for these values were not apparent 
and there was scant evidence of other disease processes amongst the horses 
aside from low-grade lameness. It had been further hypothesised that changes in 
the concentration of the three acute phase proteins might occur as the grade of 
ulceration changed, hence the reasoning for serial examination of the stomachs. 
However, based on the work presented here, it was not possible to determine an 
association between these factors. 
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6.4.2 Relevance to previous and on-going work 
Previous work concurs with the findings presented here that there is a high 
prevalence of gastric ulceration in horses in race training (Vatistas et al., 1999; 
Begg and O’Sullivan, 2003; Luthersson et al., 2009). The effects of moderate and 
severe levels of gastric ulceration on performance are poorly understood; 
nevertheless, there is growing evidence to suggest that gastric ulceration can be 
performance limiting in horses (Nieto et al., 2009; Tamzali et al., 2011). This 
work represents details of some of the first horses to be examined 
gastrocopically in Ireland, and it is interesting that the prevalence results are 
similar to those recorded by other workers. 
In humans, comparable syndromes to equine gastric ulceration, such as gastro-
oesophageal reflux disease (GERDs), are commonly encountered in athletes and 
symptoms are frequently proportional to exercise intensity (Worobetz and 
Gerrard, 1985; Collins et al., 2003). The development of GERDs may be related 
to posture during a number of sporting disciplines, and this effect may be 
replicated in horses during faster gaits such as canter and gallop during which 
increased intra-abdominal and intragastric pressure push gastric acid into the 
squamous portion of the stomach (Lorenzo-Figueras and Merritt, 2002).  For this 
reason, a number of workers have also postulated that gastric ulceration could 
be used as a measure of overtraining in horses (De Graaf-Roelfsema et al., 
2010).  
Gastroscopy remains the gold standard technique for detection of equine gastric 
ulceration. Several other tests for detection of gastric ulceration in the horse 
have been described, including measurement of urine and plasma sucrose 
concentration (O'Conner et al., 2004; Hewetson et al., 2006), the measurement 
of faecal occult blood (Pelligrini and Carter, 2007), and serum alpha-1-
antitrypsin (Taharaguchi et al., 2007).  All have variable levels of complexity 
and ability to detect horses with gastric ulceration, and to date none of these 
tests have gained real acceptance and are not part of the routine screening 
process for performance horses. In humans, the use serum alpha-1-antitrypsin 
has been used as a biomarker of ulceration and SAA has been used to detect 
gastric neoplasia (Chan et al., 2007; Hsu et al., 2007). 
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6.4.3 Factors that may have influenced results 
There are a number of factors that may have affected the results of the study 
described in this Chapter. Most notably, determination of training level and 
intensity is subjective, and quantification of the level of work in Thoroughbred 
racehorses remains a real challenge. To this end, work level was left out of the 
final models. In the case of these 100 horses across nine distinct training 
establishments, it is likely that the degree of training intensity across the 4 
categories of work that were recorded varied from yard to yard. Furthermore 
while there was an association between a gastric ulcer score of 4 or above and 
SAA concentration, the measurement of SAA concentration is not a specific test 
and for that reason, it might be more appropriate as a screening tool to identify 
horses which then should be subsequently subjected to a period of starvation 
and gastroscopy. Such a test might be most appropriately and effectively used in 
animals that had been pre-screened for other causes of inflammation common in 
performance horses, such as respiratory disease. The considerable number of 
outlying results suggests that there may have been other factors contributing to 
the high concentration of SAA recorded in some of the horses. While a number of 
the horses had a history of low-grade lameness and several had evidence of 
transient upper respiratory tract infection during the course of the study, it was 
not possible to associate any of these findings with particularly high SAA 
concentrations. The gastric ulcer scoring system used during this work to 
describe ulceration of the squamous and glandular portions of the equine 
stomach was that defined by Murray et al., (1996) and has been largely 
superseded by the scoring system from 0 to 4 as prepared by the Equine Gastric 
Ulcer Council (Andrews et al., 1999). However, it was felt that it was more 
appropriate to use the system that was in widespread use at the time the work 
was carried out. Furthermore the conflation of squamous and glandular results 
into one score, as was practised at the time, and would not be standard practice 
today, may also have affected the results. However, the vast majority of horses 
had only squamous ulceration and consequently this conflation is likely to have 
had limited effect. The videos were watched by the author and another clinician 
and a combined score agreed, no effort was made to determine how repeatable 
the scores were, however generally there was a high level of agreement 
between the scorers. Because a score of 4 or more was required to classify the 
horse as ulcerated, it was considered reasonable to assume that considerable 
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tissue damage had to be present and the risk of including animals that were only 
mildly affected by gastric pathology was therefore low. 
It is worth considering the relationship between SAA concentration and the 
inflammatory events surrounding the development and healing of equine gastric 
ulcers. Firstly, equine gastric ulcers are examples of chronic disease and as a 
result do not really fit the profile for the use of an acute phase protein. 
Consequently, if the use of acute phase proteins to detect gastric ulceration 
became widespread in clinical practice, such a test could only be used if the 
presence of other pro inflammatory inciting factors or events had been ruled 
out. The association between work level and race type at a univariable level, 
suggest other variables may have a role in to play in induction of SAA production 
in Thoroughbreds. Work investigating the inflammatory process during wound 
healing in horses suggests, somewhat counter intuitively, that an increasing 
intensity of inflammation is associated with effective healing (Wilmink et al., 
2003). It could therefore be postulated that SAA production might increase as 
the ulcer begins to heal, perhaps accounting for the variation in association 
between ulcer grade and SAA concentration at different time points. Future 
work could concentrate on different groups of animals, for example larger 
numbers of horses with increasing or decreasing ulcer scores. It would also be 
important to investigate the effect of different training regimens, the age at 
which animals enter training and the effect of other equine performance 
disciplines, some of which are believed to have different prevalence of gastric 
ulceration (Andrews et al., 1999).  
6.4.4 Performance of models 
As with all epidemiological models, it would be of value to test the models 
against observations from a new group of horses to assess the ability of the 
model to predict animals with a gastric ulcer score of 4 or more. Furthermore, 
given the myriad of objective and subjective measurements commonly recorded 
in a modern racing establishment, it may be that there are other appropriate 
explanatory variables that should be included in future models. In addition, 
proteomic and metabolomic methodology is likely to identify other acute phase 
proteins in the horse in the years ahead, some of which could be included in a 
testing regimen to develop an acute phase signature for gastric ulceration. 
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6.4.5 Conclusion and future hypotheses 
The results of this study suggest that SAA concentration is associated with 
equine gastric ulceration, although the association is variable and many other 
factors, which were not identified, may have a role to play. Based on evidence 
generated by these studies, it is currently impossible to recommend a testing 
regimen based around the concentration of currently recognised APPs that would 
substantially alter current diagnostic approaches to EGUS.  
The question of why equine gastric ulceration, an apparently chronic process, is 
associated with increased SAA concentration remains. 
Although complex, the ability to measure quantitatively the intensity of work 
and performance, and to determine its effects on both ulceration and the acute 
phase response is of considerable importance. As with the situation in human 
medicine, whereby a particular acute phase protein or proteins are used to 
diagnose, prognosticate and monitor response to treatment for a particular 
disease or syndrome, the recognition of gastric ulceration by a repeatable acute 
phase profile or "signature" in horses would be a major advance.  
A number of other "stress" related conditions are commonly encountered in 
horses, including flexor tendon injuries and fatigue fractures, and express their 
effects on bone and soft tissue (Smith and Goodship, 2008; Whitton et al., 
2010). It may be that these produce a reliable, distinct and characteristic acute 
phase profile. Thus, the future of disease and welfare surveillance could be 
irrevocably changed, reducing the need for invasive and expensive diagnostic 
testing. As demonstrated in Chapter 3, acute phase proteins including SAA are 
excellent markers of normality in the Thoroughbred. 
The health of equine athletes in training is of considerable public interest and 
the presence of subclinical disease, such as gastric ulceration, has implications 
for welfare and performance. Wastage from the thoroughbred racing industry as 
a consequence of poor performance is common and may be related to financial 
pressures precluding or limiting veterinary intervention. In this respect, the 
results described above are a significant first step in the use of applied acute 
phase protein analysis in identifying important stressors of horses and assessing 
the general health of the horse. 
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Chapter 7 
Acute Phase Proteins: Detection of Sub-Clinical Infectious 
Disease  
171	  
7.1 Introduction 
A major challenge in the clinical setting is the identification of subclinical 
disease. Animals that are either incubating or in the early stages of infection 
may appear clinically normal but nevertheless act as reservoirs and serve to 
disseminate infectious agents throughout the environment. Delays in identifying 
such an individual may lead to the development of significant pathology, 
resulting in irreversible damage for the individual, and an increased risk of 
infection for other, in contact animals (Yager, 1987; Giguere et al., 1997; 
Giguere, 2001). A number of infectious agents in horses are insidious in onset 
and become increasingly difficult to treat as fulminant disease develops. The 
consequences of such infection may be death or permanent damage with 
resulting effects on long-term health and performance (Wilsher et al., 2006; 
Richard et al., 2010; Fraipoint et al., 2011). The ability to detect infected 
individuals prior to the onset of clinical signs has advantages both in terms of 
animal welfare and from a commercial perspective given the potential value of 
lifetime earnings of a high quality Thoroughbred. 
A number of markers of disease have been described in horses, including the 
acute phase proteins SAA, haptoglobin and fibrinogen (Copas et al., 2013). 
Several of these have been used as an aid to diagnosis in neonatal foals with 
clinical signs of disease (Chavatte et al., 1991; Hulten and Demmers, 2002; Turk 
and Habus, 2010; Copas et al., 2013) and in other species including cattle, pigs, 
small animals and wild animals (Zhu et al., 2004; Akerstedt et al., 2007; Gerardi 
et al., 2009; Szczubial et al., 2012; Korman et al., 2012; Stanton et al., 2013). 
However, most of these are used mainly after the onset of clinical signs. In 
human medicine, the use of markers of subclinical disease is well established for 
a variety of conditions including atherosclerosis, neoplasia and some infectious 
diseases. In the human clinical setting the use of CRP as a nonspecific marker for 
inflammation, infection and other forms of tissue damage is considered to be 
clinically useful (Pepys and Hirschfield, 2003). Critically, CRP and other human 
acute phase proteins are rarely considered to be diagnostic alone, instead 
changes in their concentrations are used to identify individuals who require 
further screening. Diagnosis can then be made following clinical examination and 
after further diagnostic testing (Pepys and Hirschfield, 2003).  In addition, these 
markers are used to follow the progress of recovery following treatment, to 
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determine individual patient prognosis and to identify patients with neoplastic 
metastasis (Paracha et al., 2000; De Backer et al., 2002; Anuradha et al., 2012).  
7.1.1 Background to the study 
A unique opportunity arose during these studies when a yard in which the author 
was researching (Chapter 3) experienced an outbreak of Rhodococcus equi (R. 
equi). The surveillance programme on the yard involved monthly blood sampling 
of all foals, hence samples were available for testing from animals with 
subclinical infections prior to the onset of disease. In foals, disease caused by R. 
equi is characteristically insidious in onset (Yager, 1987; Giguere et al., 1997; 
Giguere, 2001) and the resulting respiratory infection leads to an extensive 
bronchopneumonia (Hondalus, 1997). Dissemination of infection from the lung to 
other sites has been described, leading to a variety of clinical syndromes 
including: septic arthritis, septic physitis, discospondylitis, serositis, cutaneous 
ulcerative lymphangitis, ulcerative colitis and/or mesenteric lymphadenitis (Zink 
et al., 1986; Hondulas, 1997; Muscatello, 2012). Diagnosis of R. equi is not 
straightforward (Anzai et al., 1997; Bertone, 1998; Ramirez et al., 2004). 
Haematological examination may indicate the presence of a neutrophilia, 
increased fibrinogen concentration and thrombocytophilia, and it is these 
analytes that have been used to detect infected foals until now (Giguère, et al., 
2003). A number of serological tests have been described, although none have 
gained widespread acceptance for early detection and diagnosis of the disease 
(Vivrette et al., 2000; Sellon et al., 2001; Arriaga et al., 2002; Martens et al., 
2002; Giguere, 2003; Cohen et al., 2005). Prognosis is dependent on early 
recognition of individuals with clinical signs and treatment of the disease. A 
number of long-term effects on future health and performance have been 
described including reduced performance and failure to compete (Ainsworth et 
al., 1998; Bertone, 1998). 
The welfare and financial consequences for stud farms producing foals affected 
by R. equi are significant and, as such, a great deal of research has been 
devoted to investigating the epidemiology, diagnosis and treatment of this 
disease (Giguere et al., 1997; Giguere 2001; Cohen et al., 2005). The need for 
early detection, prior to the onset of fulminant disease, is vital. 
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The use of acute phase proteins as markers of subclinical infectious disease in 
the horse has produced some conflicting results, with Hulten et al., (2002) 
suggesting that SAA was a sensitive marker for infectious respiratory disease in 
foals and Cohen et al., (2005) concluding that results were highly variable when 
SAA was used in isolation to diagnose R. equi infections. 
The aims of this study were as follows: 
1. To determine whether SAA, haptoglobin and fibrinogen could be used in a
group of foals, clinically normal at the time of sampling, which subsequently
developed fulminant signs of R. equi infection.
2. To compare SAA, haptoglobin and fibrinogen as potential markers of
subclinical R. equi infection, to the traditional haematological markers
(haemoglobin concentration, WBC count and platelet count) of infectious
respiratory disease.
3. To explore whether SAA could be used to identify foals that should
subsequently undergo diagnostic testing for the presence of subclinical disease,
in this case R.equi.
7.2 Materials and methods
7.2.1 Experimental design and study animals 
This study included two groups of Thoroughbred foals, and had a prospective and 
retrospective element. Group 1, the normal group, consisted of 17 clinically 
normal Thoroughbred foals between the ages of 3 and 7 months of mixed sex, 
selected randomly from one well-managed stud farm in Co. Kildare, Ireland. Full 
details of this group can be found in Chapter 3. These foals were sampled 
prospectively. 
Group 2 consisted of 12 Thoroughbred foals from the same commercial stud farm 
as, but kept geographically remote from, Group 1. They were aged between 
three and six months and were part of a larger group of approximately 200 foals. 
These foals had been subjected to a regular screening regimen, including daily 
examination for unthriftiness, malaise, respiratory signs, and inappetance. Blood 
sampling was conducted at monthly intervals for haematological and clinical 
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biochemical parameters to monitor the traditional markers of infection with R. 
equi. These samples were obtained retrospectively. 
All of the foals were kept as “foals at foot”, that is to say with their natural 
mother or with a foster mother. Each foal was stabled throughout the night and 
kept at pasture during the day. 
7.2.2 Ethics 
Ethical approval for this study was granted by the Ethics and Welfare 
committee, School of Veterinary Medicine, University College Dublin. This 
particular equine premises was chosen due to the numbers of horses available 
and the fact that a routine sampling regimen was already in place, allowing 
surplus samples to be collected for the purpose of this study with minimal 
disruption to the animals and to the routine. 
7.2.3 Sampling procedures 
Samples from the infected foals were made available retrospectively for acute 
phase protein analysis following confirmation of R. equi. The foals in Group 2 
were clinically normal at the time of blood sampling, but within 4 weeks of the 
date of blood sample acquisition developed clinical signs of infection with R. 
equi, confirmed by bronchoalveolar lavage (BAL) and culture of the organism 
from the BAL fluid. 
7.2.3.1 Sample collection 
Blood was obtained from each horse by jugular venepuncture using a vacutainer 
system. Each horse was restrained by the regular handler and subjected to a 
clinical examination prior to jugular venepuncture. Full details of the sampling 
methods, haematology, biochemistry and acute phase protein assays are given in 
chapter 2.  The author personally collected all of the samples from the Group 1 
foals in August 2003, Group 2 foals were sampled by the yard veterinary surgeon 
3 months after the Group 1 samples were obtained. 
7.2.3.2 Acute phase proteins 
The following acute phase proteins were measured: SAA, haptoglobin and 
fibrinogen. 
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7.2.3.3 Haematological examination 
Haematological examination included determination of haemoglobin 
concentration (Hb), packed cell volume (PCV), erythrocyte count (RBC), mean 
corpuscular haemoglobin concentration (MCHC), mean corpuscular volume 
(MCV), mean corpuscular haemoglobin (MCH), and a differential white blood cell 
count.  
7.2.3.4 Clinical examination 
Each foal was observed from a distance (usually over the stable door) for a 
period of not less than one minute; thereafter the foals were caught and 
restrained by the regular handler. A full clinical examination including 
measurement of heart and respiratory rate, rectal temperature, and palpation 
of superficial lymph nodes was performed.  
7.2.4 Diagnostic techniques for the detection of Rhodococcus equi 
Of approximately 200 foals subjected to monthly blood sampling, as part of a 
routine screening regimen, the clinical signs of R. equi were detected and the 
disease confirmed by positive culture of bronchoalveolar (BAL) lavage fluid and 
BAL cytology in 12 foals. Any foal with any of the clinical signs associated with R. 
equi infection was subjected to BAL. Full details of the techniques and 
methodology used to confirm R. equi are given in Chapter 2. 
7.2.4.1 Bronchoalveolar lavage 
In the 12 foals in Group 2, there were broadly similar findings in the BAL 
cytology. Multiple gram positive rod- to coccoid- shaped, pleomorphic (water 
melon seed like) organisms were noted within neutrophils and macrophages; 
there were multiple degenerative neutrophils and alveolar macrophages.  
7.2.4.2 Microbial culture 
The inclusion criteria dictated that all affected animals must have a positive 
culture of BAL fluid for R. equi. In all 12 foals, R. equi grew on sheep blood agar 
at 30oC. Gram stains of the cultured organisms yielded multiple gram-positive 
rods and cocci and cytology of the BAL fluid demonstrated macrophages 
containing multiple cocci-shaped bacteria (See Chapter 2). 
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7.2.5 Data processing and statistical methods 
7.2.5.1 Data processing 
All data were entered into a Microsoft Excel spread sheet (Microsoft Excel for 
mac). Data were checked for errors, consistency and validity using standard 
functions in MS Excel. The data, separated into the two groups were imported 
into Minitab version 16, and Microsoft Excel for mac.  
7.2.5.2 Statistical methods 
Statistical analysis was performed using Minitab, version 16.0. The results from 
the variables of interest from foals affected by R. equi were compared with the 
results from the normal foals, Group 1, presented in Chapter 3. 
Analysis of each variable was performed using a Mann-Whitney U test and 
comparisons were made for SAA, haptoglobin, fibrinogen, haemoglobin, white 
blood cell count and platelet numbers. 
7.2.5.2.1 Normality testing 
Given the small number of animals it was considered inappropriate to perform 
testing for normality and the data were analysed using a non-parametric test. 
7.3 Results 
7.3.1 Clinical findings 
The foals in Group 1 were clinically normal and displayed behaviour common to 
animals of their type and age. The foals in Group 2 (the R. equi group), which 
were all clinically normal, as assessed by full clinical examination by the yard 
veterinary surgeon, at the point of blood sampling, developed clinical signs 
between 3 and 4 weeks after blood sampling.  Consequently all of these foals 
developed reduced activity, lethargy, diminished willingness to nurse the mare, 
and in 10 of the 12 an increased respiratory rate (42-48bpm) was noted 
(tachypnoea). Two of the 12 foals had enlargement of one or more synovial 
structure (1 tarsocrural joint and femeropatellar joint, 1 femeropatellar joint 
only), and two had diarrhoea. One foal had a concurrent cough with intermittent 
bilateral mucopurulent nasal discharge. This foal, the most severely affected, 
177	  
was additionally subjected to thoracic radiography, which demonstrated the 
presence of an alveolar pattern and multiple coalescing areas of consolidation 
(Figure 7.1). 
7.3.2 Acute phase protein profile 
In the Group 1 (normal foals) (Table 7.1), median SAA concentration was 
143.80μg/mL, median haptoglobin concentration was 3.25mg/mL and median 
fibrinogen concentration was 2.0g/L ± (Figures 7.2, 7.3. 7.4). All of the results 
fell with the previously described reference ranges. An in depth discussion of 
these results can be found in Chapter 3. 
In the Group 2 foals (infected with R. equi) (Table 7.1), median SAA 
concentration was 406.0 μg/mL, median haptoglobin concentration was 
3.70mg/mL and median fibrinogen concentration was 4.0g/L (Figures 7.2, 7.3. 
and 7.4). The results for SAA concentration were all outwith the reference range 
for the horse. Two of the foals had particularly high values.  
7.3.3 Haematology results 
In the Group 1 foals (normal) (Table 7.1), median Hb concentration was 131g/L, 
mean white blood cell count was 10.10x109/L, and median platelet count was 
131.50 ± (Figures 7.5, 7.6, 7.7).  
In the Group 2 foals (infected with R. equi.) (Table 7.1); median Hb 
concentration was 121.0g/L ± 54.59, mean white blood cell count was 
11.75x109/L, and mean platelet count was 563.0 (Figures 7.5, 7.6, 7.7). 
7.3.4 Graphical review of data 
As a first step in examining the data, box plots were produced showing each 
variable the concentration of the acute phase proteins, SAA, haptoglobin and 
fibrinogen, and the haematological parameters WBC count, Hb concentration 
and platelet count, by group (Figures 7.2-7.7).  
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Figure 7.1 Lateral radiograph of the thorax of one of the foals in Group 2 
There is a diffuse alveolar pattern 
with evidence of a number of 
discrete and coalescing areas of 
consolidation typically associated 
with abscessation. 
Table 7.1 Results for APPs and selected haematological parameters for the foals in groups 1 and
Age Sex SAA (ng/mL) Hapto (mg/mL) Fb (g/L) Hb (g/L) WBC ((x109/L)) Platelets 
Foal ID Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 
3  
months  
6  
months   F   F   1183   176.7   4.6   2.9   2   2   141   128   20   11   702   128  
4  
months  
5  
months   M   F   451   130   3   3.2   4   4   143   153   13.3   11.2   1271   153  
6  
months  
7  
months   M   M   10570   139.3   3.7   3.9   3   2   141   122   14.3   8   608   122  
5  
months  
8  
months   M   M   38260   94.5   2.2   2.4   2   2   15.1   128   16.6   9.7   836   128  
3  
months  
8  
months   F   M   395   155.5   3.8   4.1   4   4   138   135   11.9   11.4   518   135  
3  
months   5months   F   F   417   189   2.8   3.4   4   2   123   136   11.5   8.5   259   136  
4  
months  
6  
months   F   M   1030   103.5   3.9   2.4   2   2   111   112   10   7.7   442   112  
5  
months  
6  
months   M   F   388   113.5   3.9   3.8   4   3   115   126   10.8   9   1802   126  
3  
months  
7  
months   F   F   368   242   3   2.4   2   2   119   128   11.6   10.1   514   128  
3  
months  
7  
months   M   F   375   196.1   3   2.7   4   2   139   143   17.5   15   926   143  
4  
months  
6  
months   F   M   358   53.5   4   3.3   2   2   101   135   7.4   8.8   270   135  
5  
months  
5  
months   F   M   375   146.5   3.7   4.6   2   2   101   121   7.3   11.8   204   121  
5  
months   F   174.1   3   2   141   8.6   141  
5  
months   M   115   3.6   3   137   10.1   137  
5  
months   M   141   2.1   4   114   11.6   114  
5  
months   F   148.5   4.2   2   152   14.3   152  
Median N/A NA N/A NA 406 143.8   3.7   3.25   4   2   121   121   11.75   10.1   563   131.5  
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7.3.5 Statistical analysis and conclusions 
In the Group 1 foals, SAA, haptoglobin and fibrinogen concentration were all 
within normal ranges (Chapter 3 and published ranges), and within the limits of 
the sample size there was no effect of sex, or age on SAA or haptoglobin 
concentration. 
All Group 2 foals had a significantly higher concentration of SAA, and fibrinogen 
than the normal foals (p=0.000 and p=0.0087).  
There were no significant differences between haptoglobin concentration 
between the group 1 and  group 2 foals. 
The selected haematological values for the normal group (Group 1) foals were 
all within the reference ranges specified by the laboratory. There was no 
association with age group or sex for platelet numbers, Hb concentration or WBC 
count.  
The foals in Group 2 had a significantly higher number of platelets than normal 
foals (Group 1)(p=0.001), There were no statistical differences between WBC or 
Hb concentration between the foals in groups 1 and 2.  
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Figure 7.2 Box plot of SAA concentration for the 2 groups of foals 
The Group 2 foals had a significantly higher concentration of SAA, than the normal foals 
(p=0.0001). 
Figure 7.3 Box plot of Haptoglobin concentration for the 2 groups of foals 
There were no significant differences in haptoglobin concentration between the two groups. 
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Figure 7.4 Box plot of Fibrinogen concentration for the 2 groups of foals 
The Group 2 foals had a significantly higher concentration of Fibrinogen than the normal foals 
p=0.0087). 
Figure 7.5 Box plot of Platelet number for the 2 groups of foals 
The foals in Group 2 had a significantly higher number of platelets than normal foals (Group 1), 
(p=0.001). 
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Figure 7.6 Box plot of Hb concentration for the 2 groups of foals 
There were no significant differences in haemoglobin concentration between the two groups. 
Figure 7.7 Box plot of WBC Count for the 2 groups of foals 
There were no significant differences in white blood cell count between the two groups. 
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7.4 Discussion 
The findings of this Chapter indicate that SAA concentration could be used to 
identify individual foals that ought to be screened for the presence of subclinical 
disease. Median SAA concentration in foals subclinically infected with R. equi 
was significantly greater than normal foals of the same breed and age reared 
under almost identical conditions. The same was true for fibrinogen 
concentration. As previously described, platelet count was also significantly 
associated with subclinical infection. Previous work on the use of acute phase 
proteins in relation to the diagnosis of R. equi showed that SAA concentration is 
increased in foals with fulminant signs of the disease (Chavatte et al., 1991; 
Hulten et al., 2002). In these studies, the foals also showed significant increases 
in fibrinogen concentration, WBC count, platelet numbers and Hb concentration 
(Giguere and Prescott 1997; Stoneham et al., 2001; Hulten et al., 2002	   Giguère 
et al., 2003). No previous studies have investigated the association between 
subclinical infection with R. equi and haptoglobin concentration, or compared 
changes in a number of acute phase proteins with the more traditional 
haematological markers of R. equi infection such as platetet count, WBC count 
or Hb concentration. 
A number of serological assays have been described for the diagnosis of R. equi 
in foals (Martens et al., 2002; Giguere et al., 2003), and recently a PCR 
technique has been described (Bolton et al., 2010). However, none of these has 
been used to detect subclinical disease.  
Cohen et al., (2005) investigated the use of SAA concentration for early 
diagnosis of R. equi in a large group of foals. In contrast to the current study, 
the concentration of SAA in foals between 7-14 and 21-28 days of age was not 
significantly different between infected and non-infected foals. Cohen et al., 
(2005) concluded that SAA concentration could not be reliably used to detect 
subclinical R. equi infection. It is notable that the foals in the Cohen study were 
considerably younger than the foals described in this Chapter and sampling was 
carried out on three occasions, 2 weeks and 4 weeks after birth and at the onset 
of clinical signs of R. equi. The foals in the Cohen study were sampled on two 
separate farms where R. equi was endemic and as such represent a quite 
different population to the foals described here. In this study, blood samples 
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from similarly aged normal foals were obtained from the same farms as the 
infected animals. The median age for onset of clinical signs of R. equi in the 
Cohen study was 64 days (range 26-144). As a result, it may have been that some 
of the foals were not actually infected with R. equi at the time of their initial 
sampling. Furthermore, the difference in findings between the two studies may 
be related to the speed with which SAA concentration can return to normal after 
an inflammatory insult, as demonstrated in Chapter 4. In the study by Hulten et 
al. (2002), SAA concentration returned to normal between 3 and 8 days after 
hospitalisation in diseased foals. The study by Cohen et al., (2005) also 
acknowledges that some of the foals, used as controls, assumed to be normal, 
may have in fact been subclinically infected with R. equi. There is some 
evidence that a proportion of foals that have been exposed to the R. equi 
organism, but are not affected with the disease, can yield positive cultures from 
tracheobronchial aspirates (Ardans et al., 1986) and this may also partially 
account for the differences noted between the two studies. The foals in Group 
2, presented in this Chapter, were between 3 and 6 months of age, the age 
group in which R. equi infection is most prevalent on Thoroughbred stud farms in 
Ireland (Muscatello et al., 2012).  
One might conclude that given the severe consequences of infection with R. 
equi, owners and stud farm managers might elect to treat foals considered to be 
at risk despite a lack of clinical signs. Treatment is classically based on the use 
of the synergistic bacteriostatic antimicrobials erythromycin, azithromycin or 
clarithromycin in combination with rifampin. While often highly effective, this 
therapy is not without risk to the foal in which adverse reactions are common. 
Complications of treatment include diarrhoea, idiosyncratic hyperthermia, 
tachypnoea, anorexia, bruxism, and salivation (Muscatello et al., 2007). In 
addition acute and frequently fatal colitis has been reported as a complication 
of the accidental ingestion of foal faeces containing antimicrobials, by the mares 
of foals undergoing treatment. Finally, antimicrobial resistance of R. equi to 
erythromycin-rifampin combination has been reported (Giguere et al., 2001). In 
conclusion, the need for treatment must be clear prior to instigation of therapy. 
186
7.4.1 Developing the test using SAA and other acute phase proteins in 
clinical practice 
The results of the study presented here suggest that SAA concentration would be 
a sensitive marker for the presence of disease if measured as part of a monthly 
sampling programme such as was in place on the farm in this study. In addition, 
the finding that that fibrinogen concentration may also be increased suggests 
that these analytes could be combined in a panel for use in clinical practice. 
Many professional Thoroughbred breeding operations run a continuous 
monitoring programme with regular sampling. From a financial perspective, the 
cost of monitoring is considerably less than the long-term costs of the disease. 
A number of specific questions arise with respect to the use of a group of 
biomarkers to detect subclinical cases of R. equi in foals, based on the findings 
of the study presented here. 
1. Could analysis of SAA concentration in combination with measurement of
fibrinogen and platelet count differentiate infected from non-infected foals
across a range of management systems and at appropriate sensitivity and
specificity to make the tests sufficiently robust for clinical practice?
2. Could the markers described be used to determine which foals should be
subjected to therapy and are there specific concentration cut points at which
therapy should be instigated?
3. Could the measurement of SAA concentration be further used to determine
which foals are responding to treatment, and/or which foals may be subject to
any of the long-term consequences of infection?
7.4.2 Limitations and further investigation 
Although both groups of foals in this Chapter were drawn from large groups in a 
commercial Thoroughbred stud farm setting, the numbers of animals sampled in 
each group were relatively small. In clinical studies, welfare, commercial 
implications and time constraints are all factors limiting numbers. Furthermore, 
the ability to access animals of this quality is restricted to a small number of 
farms across the globe breeding large numbers of horses and subjecting those 
horses to a regular sampling regimen. For that reason, the results presented 
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must be regarded as a “snapshot” that could inform a larger study. In contrast to 
previous studies, the samples used in this Chapter were analysed either 
immediately or within 3 months of collection removing any potential effect of 
long-term storage on acute phase protein analysis. The foals in Group 1, normal 
animals, were not subjected to BAL, and therefore one could speculate that they 
could have been infected with R equi. However, this is considered unlikely and 
the commercial and welfare implications of performing unnecessary and 
potentially damaging diagnostic procedures on apparently normal animals meant 
that this information is unlikely to ever be available to researchers. None of the 
normal foals subsequently developed R. equi.  
The two groups of foals also differed temporally in terms of data collection with 
group 1 foals collected prospectively and group 2 collected and analysed 
retrospectively. This arose due to the opportunistic nature of the acquisition of 
the samples for Group 2. Given the value, and rarity, of samples from a group of 
animals which although clinically normal at the time of sampling, subsequently 
developed, and were confirmed with R.equi, it was considered worth working 
with this limitation in study design. The foals were managed in exactly the same 
way, on the same premises, but geographically separated, by the same group of 
people and this will have limited many of the potential confounding factors. 
A wide range of clinical signs were reported for the foals in group 2 which 
developed R.equi, this is common when dealing with this disease and all of the 
foals had a confirmed diagnosis based on the positive identification of the 
organism from a BAL and a positive culture. No other disease was identified 
amongst these individuals. 
With access to a larger group of foals, both normal and subclinically infected 
with R. equi, the goals would be to determine whether the results presented 
here were repeatable and further to determine what combination of markers 
and clinical parameters was most effective for identifying infected foals. 
Furthermore, to determine if there was a specific acute phase signature or foot 
print for R. equi and perhaps utilising ROC curves to determine cut points for the 
marker or markers. 
At the time the work described in this Chapter was conducted, the PCR (Sellon 
et al., 1997; Vivrette et al., 2000; Selon et al., 2001; Arriaga et al., 2002) for 
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detection of R. equi was at an experimental stage and not readily available; if 
the study was repeated the use of this technique would be an obvious and useful 
addition.  
To date there has been no investigation into the effect of animals carrying, but 
not infected with a pathogen, on the acute phase response in horses. In cattle, 
experimental work with Salmonella sp. infection and the viral disease Foot and 
Mouth, suggests that this may be an area worth investigating (Oikawa, et al., 
1997; Stenfeldt et al., 2011). 
It is true to say that there are many potential causes for an increase in SAA 
concentration, indeed a number of these are presented in this thesis. The 
strength of the measurement of the acute phase response is not in its ability to 
diagnose a specific disease, but rather in the ability to identify individuals that 
are abnormal and therefore require clinical scrutiny or more specific diagnostic 
testing just as is commonplace in human medicine (Pepys and Hirschfield, 2003). 
7.4.3 Conclusions and way forward 
Rapid diagnosis and the instigation of treatment are fundamental to the 
effective treatment of diseased foals. However, successful early diagnosis is 
perhaps one of the most challenging scenarios facing the equine clinician 
(Muscatello et al., 2007). Failure to identify infected individuals early in the 
course of any disease, including infection with R. equi, has major implications 
for wellbeing, welfare, finance and future performance (Ainsworth et al., 1998). 
The work presented in this Chapter suggests that monitoring SAA concentration, 
particularly when coupled with traditional haematological markers of infection, 
could play an important role in better identifying foals in need of specific 
diagnostic testing prior to the onset of debilitating clinical signs. This description 
of the use of SAA concentration in this study mirrors exactly the routine use of 
CRP in human medicine in order to identify individuals with potentially serious 
disease but with few or no clinical signs in the early stages of infection. 
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Chapter 8 
General Discussion and Conclusions 
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8.1 Introduction and Summary of Findings 
The assessment of health remains one of the great challenges in veterinary and 
human medicine. Indeed, the acceptance that health is more than just the 
absence of disease is a key starting point in the quest to improve the welfare of 
all veterinary species (Gunnarsson, 2006). Methods used to diagnose, 
prognosticate and monitor the treatment of disease were described in antiquity 
by Imhotep of Egypt and Hippocrates of Greece and in ancient China where the 
four diagnostic methods; inspection, auscultation-olfaction, interrogation, and 
palpation were employed (Ralston, 1977; Savel and Munro, 2014). These 
methods are based upon the identification of abnormalities noted during clinical 
examination and are still employed today. More recently, the findings of 
haematological and clinical biochemical examination and the use of advanced 
imaging techniques have been employed to the same end. Such techniques rely 
upon recognition of a pattern whereby a set of clinical signs is associated with a 
particular disease or syndrome. The success or failure of this method is 
somewhat dependent upon the experience of the diagnostician and is therefore 
potentially imperfect. 
The development of acute phase markers that can be used to identify disease 
that is fulminant and overt, latent or subclinical has become commonplace in 
human medicine (van der Linden et al., 2010; Tilemann et al., 2011; Kiefer et 
al., 2012) and a small number of veterinary species; however, to date, with the 
exception of fibrinogen, this approach has not gained widespread acceptance in 
horses. While a number of studies have described changes in the concentration 
of serum acute phase proteins subsequent to the development and diagnosis of 
disease (Jacobsen and Andersen, 2007; Hobo et al., 2007; Christoffersen et al., 
2010; Lavoie-Lamoureux et al., 2012; Copas et al., 2013; Andersen et al., 
2014;), few have used specific markers to identify the disease or syndrome in 
the first instance (Cohen et al., 2005, Pihl et al., 2015) 
The objective of the studies presented in this thesis was to evaluate whether 
changes in the concentrations of acute phase proteins in horses, specifically SAA 
and haptoglobin, could be used to detect clinical disease, subclinical infection 
and to determine which individuals might have a good prognosis for recovery 
from major inflammatory diseases such as equine colic. To date, studies of acute 
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phase proteins in horses have principally described the effect of a disease or 
inflammatory state on the concentration of the protein; the studies presented 
here attempted to bridge the gap between observation of the effect of a known 
disease on the protein to that of a diagnostic and prognostic tool.  Ultimately, 
the aim must be that these markers could be used as a measure of the fitness of 
individuals for surgical intervention and as a general measure of health. The 
findings, albeit in not necessarily representative populations of horses, 
presented suggest that SAA and haptoglobin are easy to measure, have a tight 
normal range and return to normal concentrations rapidly following recovery. 
Serum Amyloid A concentration increases in response to surgical trauma in both 
clinically normal horses and those with pre-existing disease. In horses with 
surgical colic, SAA and haptoglobin concentration, when modeled with other 
routinely measured clinical parameters, were associated with outcome following 
surgical intervention. The study also suggested that increasing SAA concentration 
was associated with the presence of gastric ulceration in Thoroughbred race 
horses, such that SAA concentration might be used, along with other clinical 
parameters, as a tool to select which animals should be subjected to more 
invasive and specific investigative techniques such as gastric endoscopy. The 
final section of the study suggested that the measurement of SAA concentration 
in foals in a commercial stud farm setting could be an effective method for 
determining which individuals could be subclinically infected with disease, in 
this case, the respiratory pathogen Rhodococcus equi.   
The studies on the kinetics of acute phase proteins, most notably SAA are a 
contribution to disease and welfare management in horses. They can be used to 
identify acute and chronic inflammation, and therefore be of value in the 
diagnosis and prognostication of disease as well as determining response to 
treatment. However, the non-specific nature of the acute phase response, as 
exemplified in the studies presented here, might lead one to speculate that 
their value as diagnostic and prognostic markers lies primarily in their use 
alongside other ancillary diagnostic methods to confirm the presence of a 
disease of which there is a strong suspicion. It would be fair then, to suggest 
that the horse with a low serum concentration of SAA could be assumed to be 
normal, in the same manner that a human with a low CRP is unlikely to be 
suffering from significant pathology (Pepys and Hirschfield, 2003).  
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8.2 The relationship between these studies and previous work 
Previous work in this field demonstrated the normal ranges for SAA and 
haptoglobin in horses and showed that SAA increases in response to surgical 
intervention and to surgery of different intensities (Hulten et al., 2002, 
Jacobsen et al., 2005; Jacobsen et al., 2009, Pihl et al., 2015). To date no one 
has compared elective and non-elective surgery. The results presented here 
agree with previous work indicating that surgical trauma produces an acute 
phase response but that the response is variable amongst individuals and 
depends on the markers used (Allen et al., 1988, Pepys et al., 1989; Ellis and 
Humphreys, 1992; Hulten et al., 1999; Jacobsen et al., 2005; Jacobsen et al., 
2009). 
Despite a myriad of studies investigating methods used to predict the outcome 
of horses affected by colic (Orsini et al., 1989; Pascoe et al., 1990; Reeves et 
al., 1990; Furr, et al., 1995; Blikslager and Roberts, 1995; Thoefner et al., 2000; 
Proudman et al., 2002a, 2002b; Mair et al., 2007) there is little specific work on 
the use of acute phase proteins (Sandholm et al., 1995); however, one study 
suggests that non survivors had statistically greater concentrations of SAA than 
survivors in a large group of horses (Vandeplas et al., 2005). Recently Pihl et al., 
(2015) suggested that SAA and other clinical parameters could be used to 
differentiate between horses that could be treated medically from those which 
should be subjected to surgical intervention. These findings are broadly similar 
to those presented in Chapter six in that they both use the concentration of 
acute phase proteins to inform decision making in the management of horses 
with clinical signs of colic. However, the Pihl et al., (2015) study also focused on 
comparisons between paired serum and peritoneal fluid acute phase protein 
concentration and on establishing reference intervals for peritoneal 
concentrations of acute phase proteins. 
To date there are no markers of gastric ulceration routinely used in equine 
practice; this is in contrast to the situation in human medicine in which serum 
alpha-1-antitrypsin is used as a biomarker of ulceration and SAA is used to detect 
gastric neoplasia (Chan et al., 2007; Hsu et al., 2007). Currently, definitive 
diagnosis of gastric ulceration in equidae requires gastric endoscopy, a relatively 
invasive procedure.  
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Previous work on the use of acute phase proteins in relation to the diagnosis of 
R. equi suggested that SAA concentration is increased in foals with fulminant 
signs of the disease (Chavatte et al., 1991; Hulten et al., 2002). In these studies, 
infected foals also showed significant increases in fibrinogen concentration, WBC 
count, platelet numbers and Hb concentration (Giguere and Prescott, 1997; 
Stoneham et al., 2001; Hulten et al., 2002;	   Giguère et al., 2003). No previous 
studies have investigated the association between subclinical infection with R. 
equi and haptoglobin concentration, or compared changes in a panel of acute 
phase proteins with the more traditional haemtological markers of R. equi 
infection. Cohen et al., (2005) investigated the use of SAA concentration for 
early diagnosis of R. equi in a large group of foals and concluded that SAA 
concentration alone was too variable to be of benefit during diagnosis; 
nevertheless, the sampling regimen and population of foals used by Cohen et al., 
are sufficiently different to explain the differences in findings compared to the 
work presented here. Given that the long-term consequences of infection with 
R. equi can be devastating with regard to potential future performance (Giguere 
et al., 1997; Giguere 2001), a simple and reliable initial test to identify 
abnormal individuals, applicable in the field, is potentially very welcome. 
In light of the findings presented here and the significant body of literature on 
the topic of acute phase proteins in horses, it is perplexing that routine use of 
the measurement of acute phase proteins concentration in horses is not more 
widespread. Reasons for the lack of uptake amongst equine veterinary surgeons 
may be related to lack of availability of the tests in commercial veterinary 
laboratories, or cost, but are more likely to be due to a lack of large evidence 
based studies of the type which have informed the use of acute phase proteins 
in human medicine (Tilemann et al., 2011; Kiefer et al., 2012). 
8.3 Factors that may have affected the outcomes and conclusions 
presented 
There is no doubt that undertaking studies utilising populations of non-
experimental animals, that is “real” animals, living and working within a normal 
or typical environment, is extremely challenging. Modern experimental study 
design parameters can be difficult to accommodate and owners, keepers, 
trainers, and indeed the horses themselves, are apt to introduce variables that 
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the researcher had not considered prior to undertaking the projects described. 
The majority of horses that were included in these studies (221 of 246) were 
Thoroughbreds (either racehorses, youngsters destined to race, or former 
racehorses that had become brood mares). These animals are often subject to 
major changes in management related to commercial pressures, injury or 
disease and environmental conditions. Many of the factors which may have 
affected the results, and therefore conclusions, have been discussed in the 
preceding chapters; however, as is the case in many clinical studies a greater 
number of animals would have been of benefit, particularly in relation to the 
animals affected by surgical colic and R. equi. In addition, the opportunity to 
apply some of the models that were developed to a different population of 
horses would have added another level of validation, and this is something that 
could be considered in any future work. As a consequence of some of the 
management conditions for the horses included in these studies, there were 
some clustering effects due to relationships between individual horses, groups of 
horses or premises; where possible, an attempt was made to account for these 
during the analysis.  
8.4 Future and ongoing work – the way ahead 
The potential for future work in the area of acute phase proteins in horses is 
enormous and it is this author’s view that within a decade, in-clinic, “horse-
side” acute phase protein testing will be a reality. As alluded to throughout this 
thesis, it is likely that there is an acute phase “signature” or “footprint” for 
many of the commonly encountered pathologies in horses and other veterinary 
species. These “footprints” may utilise existing and yet to be discovered acute 
phase markers and, in all likelihood, many disease states may be most 
appropriately monitored by a panel of markers, perhaps in concert with clinical 
observations. 
The use of proteomic and metabolomic technologies is likely to “open a window” 
on many existing and new biomarkers (Bouwman et al., 2010). In addition, it is 
likely that further site specific analogues of existing markers will be used, 
allowing better localisation of pathology (Jacobsen et al., 2006). Perhaps these 
might include specific markers that could be measured in diagnostic samples of 
body site specific fluid, such as material recovered from a bronchoalveloar 
lavage, an arthrocentesis or cerebrospinal fluid puncture. The use of SAA to 
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monitor the response to treatment in septic arthritis is already being trialed in a 
number of clinics in the UK and Ireland. 
Perhaps the most important conclusion of the work presented in this thesis is the 
need to use SAA and other acute phase protein results in conjunction with 
commonly measured clinical parameters that can then be incorporated into a 
model. The most obvious next step is to test the models generated with an 
unknown and new group of horses to determine how effectively, if at all, the 
model would perform in the clinical setting. 
8.5 Mapping the results of the work presented onto the aims and 
general hypothesis as stated in Chapter One 
The specific objectives of this project, laid out in Chapter one, were to answer 
the following questions; 
(1)  Are there age, sex and breed differences in the plasma concentrations of 
the acute phase proteins, serum amyloid A and haptoglobin in clinically 
normal horses within the normal horse population? 
Although based on small numbers of horses, the concentration of the acute 
phase proteins studied in this project were tightly conserved across a range 
of horses of mixed age and sex.   
(2)  Are the results of the serum amyloid A and haptoglobin tests consistent 
across the various groups of animals studied, and do the results fall within 
a tight range? 
The behaviour of the acute phase proteins measured during this project were 
similar across all of the groups of horses studied, that is that their 
concentrations increased rapidly in response to the presence of disease and 
inflammation and began to reduce in concentration in the postoperative 
period. 
(3)  Is surgical stress a significant factor in the plasma concentration of serum 
amyloid A and haptoglobin in the horse? 
The findings presented in this project suggest that surgery results in a 
measurable acute phase response in horses, and that the response is similar 
following elective and non-elective intervention.  
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(4)  Is the intensity of training a significant factor in the plasma 
concentrations of serum amyloid A and haptoglobin within a group of 
Thoroughbred racehorses? 
Although there was an apparent weak association between the level of 
exercise and SAA concentration in Thoroughbred racehorses, the 
methodology for assessing work level and the similarities between the level 
of work between groups was such that further investigation is required to 
confirm these findings.  
(5)  Does gastric ulceration have a significant association with the plasma 
concentrations of serum amyloid A and haptoglobin, and are these acute 
phase proteins useful markers for identification of different grades of 
ulceration within a group of Thoroughbred racehorses in training? 
The results of the work presented here suggest there is an association 
between the concentration of SAA and the presence of gastric ulceration. 
Although the association was in some cases weak, the results suggest that 
measurement of SAA could be used as a broad screening tool for the 
identification of horses that should be considered for gastroscopic 
examination. 
(6)  Are the plasma concentrations of the acute phase proteins serum amyloid 
A and haptoglobin associated with the severity and eventual outcome in 
horses with acute gastrointestinal compromise 
Studies investigating the association between acute phase protein 
concentration and the outcome in horses presented for surgical investigation 
of colic suggest that both SAA and haptoglobin concentration could be used 
to help assess whether surgical intervention is likely to be effective.  
(7)  Are the concentrations of serum amyloid A and haptoglobin significantly 
increased in foals subclinically infected with Rodococcus equi, but lacking 
clinical signs. 
 
Increases in the concentration of SAA, and haptoglobin were associated with 
disease caused by R. equi in the foals studied and presented in Chapter seven 
	   197	  
and as such SAA concentration could be used to identify individuals worthy of 
further investigation for the presence of subclinical disease. 
(8)   Do serum amyloid A and other acute phase proteins have a role to play as 
a general measure of health in horses? 
 
This project sought to investigate the association between a variety of different 
factors that initiate inflammation, both acute and chronic, and acute phase 
protein concentration. The findings broadly support the general hypothesis that 
the acute phase proteins serum amyloid A and haptoglobin can be used to test 
accurately for the presence of inflammation, tissue injury and training stress in 
horses and, as such, can be used to detect the presence of subclinical pathology, 
and for the diagnosis and prognostication of disease in horses. Ultimately these 
markers could be used as a general measure of health. 
8.6 Conclusion 
The work presented in this thesis represents a series of field based observational 
studies of populations of horses revealing the potential of acute phase proteins 
to identify overt, latent and subclinical disease and to inform the prognosis for 
surgical intervention in horses. A number of the associations between the 
disease and inflammatory states identified here were relatively weak and, as 
such, they should not be over interpreted. There is no doubt that further 
confirmatory studies, in other populations of horses, are needed. However, if 
the lessons from human medicine are to be learned, the results presented here 
set the tone for an overhaul of current thinking on the use of acute phase 
proteins in order to allow these ideas to be incorporated into everyday clinical 
veterinary medicine. This is something that has not happened to date, and that 
has the potential to contribute an evidence-based approach to the management 
of many significant equine disease and syndromes with the long-term aim of 
improving equine welfare. 
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Appendix 1 – Signalment, haematology and biochemistry results for the normal 
horses discussed in Chapter 3  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 Sex Age Use of Horse 
1 F 6 months Youngster bred for sale 
2 F 5 months Youngster bred for sale 
3 M 7 months Youngster bred for sale 
4 M 8 months Youngster bred for sale 
5 M 8 months Youngster bred for sale 
6 F 5months Youngster bred for sale 
7 M 6 months Youngster bred for sale 
8 F 6 months Youngster bred for sale 
9 F 7 months Youngster bred for sale 
10 F 7 months Youngster bred for sale 
11 M 6 months Youngster bred for sale 
12 M 5 months Youngster bred for sale 
13 F 11 yrs Brood mare 
14 F 5 months Youngster bred for sale 
15 M 5 months Youngster bred for sale 
16 M 5 months Youngster bred for sale 
17 F 5 months Youngster bred for sale 
18 F 7 yrs Brood mare 
19 F 10 yrs Brood mare 
20 F 16 yrs Brood mare 
21 F 14 yrs Brood mare 
22 F 10 yrs Brood mare 
23 F  2 yrs In training 
24 F 2 yrs In training 
25 F 2 yrs In training 
26 F 2 yrs In training 
27 F 2 yrs In training 
28 F 2 yr In training 
29 F 2 yrs In training 
30 F 2 yrs In training 
31 M 2 yrs In training 
32 M 2 yrs In training 
33 M 2 yrs In training 
34 M 2 yrs In training 
35 M  2 yrs In training 
36 M 2 yrs In training 
37 M  2 yrs In training 
38 M 2 yrs In training 
39 M 2.5 yrs In training 
40 M 3 yrs In training 
41 M 3 yrs In training 
42 M 3 yrs In training 
43 F 3 yrs In training 
44 M 3 yrs In training 
45 M 3 yrs In training 
46 M 3 yrs In training 
47 M 3 yrs In training 
48 M 2.5 yrs In training 
49 F 3 yrs In training 
50 F 3 yrs In training 
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Appendix 2 –  
Signalment and Yard Number for the 100 Thoroughbred Horses in Race Training. 
Horse name ID No. YOB Age Sex Yard No. 
Clonmel Commercial 1 1991 9 M 1 
Feelin' Looser 2 1993 7 F 1 
Galaxy Desine 3 1997 3 F 1 
Faateq 4 1993 7 M 1 
Hebron Rose 5 1993 7 F 1 
Lady Monilousha 6 1996 4 F 1 
Princess Pearl 7 1993 7 F 1 
Crimson Tirol 8 1994 6 M 1 
Stradbally Hall 9 1990 10 M 1 
Etak 10 1996 4 F 1 
Ace Conqueror 11 1996 4 F 1 
Bayyanna 12 1996 4 F 1 
UN by Camden Town 13 1996 4 F 1 
Its Time For A Win 14 1992 8 M 2 
Joe Cullen 15 1995 5 M 2 
Ikdam Melody 16 1996 4 M 2 
Tryphaena 17 1995 5 F 2 
Peggy's Lad 18 1993 7 M 2 
Punters' Friend 19 1996 4 M 2 
Prince Kay 20 1995 5 M 2 
Ammericanconnection 21 1996 4 M 2 
UN by Warcraft 22 1996 4 M 2 
Mossy Green 23 1994 6 M 2 
Micko's Dream 24 1992 8 M 2 
Summer in Siberia 25 1996 4 M 2 
Killultagh Storm 26 1994 6 M 2 
Bassett Tiger 27 1996 4 M 2 
Ballyamber 28 1995 5 M 2 
Be My Royal 29 1994 6 M 2 
The Bunny Boiler 30 1994 6 M 3 
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Hill Society 31 1992 8 M 3 
Miss Emer 32 1995 5 F 3 
River Pilot 33 1994 6 M 3 
Royal Jake 34 1994 6 M 3 
Saddlers' Mark 35 1995 5 M 3 
Hirapour 36 1996 4 M 4 
Creux Noir 37 1996 4 M 4 
Beautiful Drifter 38 1998 2 F 4 
Among Equals 39 1997 3 M 4 
Worldly Treasure 40 1997 3 M 4 
Medkhan 41 1997 3 M 4 
Tarry Flynn 42 1994 6 M 4 
Moving On Up 43 1994 6 M 4 
Amplified 44 1997 3 M 4 
Jammaal 45 1997 3 M 4 
Bust Out 46 1996 4 M 5 
Stormy 47 1994 6 F 5 
Super Gale 48 1996 4 M 5 
Summer Soldier 49 1994 6 M 5 
Lisabrack Native 50 1996 4 F 5 
Eurobus 51 1995 5 M 5 
Spirit Leader 52 1996 4 F 5 
Captain Stewart 53 1994 6 M 5 
Shadowing 54 1995 5 F 5 
UN by Dancing Dissident 55 1997 3 F 5 
Buffallo Bill 56 1996 4 M 6 
Kilcash Castle 57 1995 5 M 6 
Kaldan Khan 58 1991 9 M 6 
UN by Danehill 59 1998 2 F 6 
UN by Indian Ridge 60 1998 2 F 6 
Hurmuzan 61 1993 7 M 7 
Buck Leader 62 1994 6 M 7 
Southern County 63 1995 5 M 7 
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Impeccable Dante 64 1995 5 M 7 
Shaiydari 65 1995 5 M 7 
Lady Marlan 66 1996 4 F 7 
Samapour 67 1994 6 M 7 
Native Hall 68 1996 4 M 7 
Aungier Gale 69 1994 6 M 7 
World Leader 70 1996 4 M 7 
Cronin's Boy 71 1994 6 M 8 
La Colina 72 1995 5 M 8 
Earlshill Song 73 1994 6 M 8 
Roca Maderia 74 1994 6 F 8 
Louises Glory 75 1995 5 M 8 
Yash Can Step 76 1994 6 M 8 
Camden West 77 1994 6 M 8 
Magical Fun 78 1992 8 M 8 
Supreme Chanter 79 1992 8 M 8 
Satco Express 80 1996 4 M 8 
UN Louis 81 1997 3 F 9 
UN John N 82 1997 3 M 9 
UN Billy G 83 1995 5 M 9 
Oriental Buck 84 1993 7 M 9 
Gallaghers Walk 85 1993 7 M 9 
Persian Tiger 86 1993 7 M 9 
Inagh Road 87 1995 5 M 9 
Native Scout 88 1996 4 M 9 
UN Garvey 89 1997 3 M 9 
UN Eamon 90 1996 4 M 9 
Mac An Ri 91 1994 6 M 9 
Legal Crack 92 1996 4 M 9 
Largy Line 93 1995 5 M 9 
Abbadore 94 1996 4 F 9 
Work Away Horse 95 1995 5 M 9 
UN by Phardante 96 1996 4 M 9 
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Dustin 97 1994 7 M 9 
UN Slattery 98 1995 5 M 9 
Aye Surely 99 1994 6 M 9 
Killimor Castle  100 1992 8 M 9 	  
